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Calcific aortic valve (AV) disease is a progressive disease that ranges from mild 
thickening (sclerosis) to severe calcification with impaired leaflet motion 
(stenosis) (1). AV calcification is a multifactorial disease involving different types 
of calcification, including inflammation-driven calcification (2), ectopic calcification 
(3, 4), and passive accumulation of hydroxyapatite crystals (5, 6).  AV 
calcification is one of the major causes of cardiovascular related deaths and 
shares the risk factors associated with atherosclerosis of blood vessels (7, 8). 
Calcified AVs show signs of endothelial injury, extensive lipid deposition, 
fractured extracellular matrix fibers and inflammation. These markers occur 
preferentially in the fibrosa side of the valve(9). This side dependency can be 
attributed to the mechanical environment, matrix composition, and underlying 
gene expression that differ on either side of the valve (10).  
 
The objective of this dissertation was to understand the molecular mechanisms 
involved in this side-dependent calcific AV disease. We hypothesized that 
“sclerosis, inflammation, and calcification preferentially occur in the fibrosa 
compared to the ventricularis due to differential gene expression and oscillatory 
shear stress”. Using an ex vivo approach and porcine AVs, three specific aims 
were designed to test this hypothesis: 1) to identify side- and shear-dependent 
microRNAs (miRNA) involved in AV sclerosis, inflammation and calcification, 2) 
to determine the relationship between a key side- and shear-dependent miRNA 
 xxv 
and AV pathogenesis, and 3) to investigate the role of pyrophosphate in AV 
calcification. Aims 1 and 2 addressed the shear-dependent mechanisms while 
Aim 3 focused on the chemical imbalance aspect of side-specific AV 
pathogenesis.   
 
In aim 1, we developed a side-dependent sclerosis and calcification model of AV 
disease and used it to identify the miRNAs and mRNAs that are potentially 
involved. We showed that low magnitude oscillatory shear stress (OS) induced 
changes in the ECM (increased collagen crimping, disrupted elastin fibers), and 
increased thickness of the fibrosa layer and collagen turnover consistent with the 
characteristic features in the fibrosa of sclerotic and calcified valves (9, 11). We 
also showed that two out of four side-dependent miRNAs, miR-181a and miR-
214 showed significantly higher expression in the fibrosa compared to the 
ventricularis in the presence of OS. We performed a bioinformatics analysis and 
identified 26 and 16 potential side- and shear-dependent targets of miR-181a 
and miR-214, respectively. These filtered targets are well known for their 
involvement in AV pathogenesis. Since miR-214 is associated with fibrosis (12, 
13), inflammation, osteogenic differentiation (14) and coronary artery disease 
(15), we reported that miR-214 could be a key side- and shear-dependent 
miRNA involved in calcific AV disease.  
 
In aim 2, we chose to investigate the functional role of miR-214 in AV 
pathogenesis. Five potential target genes (Klf4, Enos, Ctnnb1, Bcl2l11, Sma) 
 xxvi 
showed an inverse relationship with miR-214 in the fibrosa when exposed to OS. 
Further a down regulating trend of these markers in the fibrosa when exposed to 
OS is indicative of the OS induced pro-inflammatory environment. We developed 
an ex vivo miRNA silencing protocol and knocked down the expression of miR-
214. Silencing miR-214 in the fibrosa exposed to OS, significantly upregulated 
Klf4 while downregulating Tgfβ1. Silencing of miR-214 alone, however, was not 
sufficient to affect AV inflammation and calcification in fibrosa exposed to OS.  
This suggests the possibility that other miRNAs and cytokines may be involved. 
This work shows that miR-214 could be involved in OS induced AV endothelial-
to-mesenchymal transition and fibrosis by regulating Klf4 and Tgfβ1 in a side- 
and shear-dependent manner.   
 
In aim 3, we developed an ex vivo AV calcification model to understand the role 
of an endogenous inhibitor (pyrophosphate, PPi) of calcification. Freshly isolated 
porcine AV leaflets were cultured in serum-free medium under static conditions 
for up to 8 days. As a result, calcification occurred predominantly in the fibrosa 
side, and required both a high phosphate concentration (3.8 mM) and removal of 
PPi with alkaline phosphatase (ALP) or inorganic pyrophosphatase (IP). 
Calcification was arrested by etidronate (bisphosphonate), a non-hydrolyzable 
analog of PPi. AV leaflets actively produced PPi when the tissue non-specific 
alkaline phosphatase (TNAP) was inhibited. The AV leaflets also synthesized PPi 
from extracellular ATP, which was reduced by β, γ-methylene-ATP, an inhibitor of 
ENPP1. We thus showed that the extracellular PPi is a key endogenous inhibitor 
 xxvii 
of calcification and its levels appear to be controlled through synthesis by ENPP1 
and hydrolysis by TNAP.  Future investigations on preventative therapeutics to 
treat AV disease could be similarly based on bisphosphonates or inhibitors of 
TNAP.  
 
In conclusion, we determined the side- and shear-dependent miRNAs (miR-214 
and miR-181a), which may serve as master regulators of AV biology and 
disease. Further, we began to understand the role of miR-214 in regulating 
targets that are involved in tissue remodeling, inflammation and calcification, 
processes that lead to calcific AV disease.  We also demonstrated the potential 
of synthetic analogs of PPi for use as a drug to inhibit AV calcification. These 
findings improve our current understanding of the molecular mechanisms 
involved in AV inflammation and calcification. Moreover, based on these findings, 
we have proposed hypotheses and research directions that emphasize the great 









CHAPTER 1  INTRODUCTION  
 
Calcification of AV results in stenosis and regurgitation that requires clinical 
intervention when detected(16). To date, the gross pathological changes and 
surgical treatments of sclerotic valves have received much attention while the 
molecular mechanisms underlying AV disease have not been well studied or 
understood. Further, identification of biomarkers that can be used to detect early 
stage AV disease is also understudied but vital to successfully preventing and/or 
treating AV disease. This work focuses on understanding the mechanobiology of 
AV disease, particularly the role of adverse patterns of shear stresses ex vivo.  
 
This work mainly focuses on identifying the shear-dependent miRNA(s) and 
mRNAs that are associated with the AV disease ex vivo. The functional studies 
carried out in this work aim to link the mechanosensitive miRNAs to the genes 
involved in inflammation, endothelial-to-mesenchymal transition, and cell 
apoptosis etc, which eventually causes AV leaflets to calcify. These 
mechanosensitive miRNAs could be potentially used as disease biomarkers and 
in the development of drugs for non-surgical treatments.   
 
Moreover, this work also aims to evaluate the role of shear stresses in inducing 
side-dependent AV calcification. This particular study allows us to understand the 
extent of calcification induced by shear stresses compared to that of pathological 
stretch (17) and pressure.  Further, an ex vivo AV calcification model was also 
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developed to understand the role of endogenous pro- and anti-calcification 
factors, such as inorganic pyrophosphate, orthophosphate, and alkaline 
phosphatase.  
 
This chapter discusses the relevant background and the clinical rationale for this 
thesis work. Initial sections are focused on the anatomy, hemodynamics, and 
cellular components of the AV. A section is also dedicated to highlight the 
prevalence and significance of calcific AV disease and its molecular pathways. 
The next subsections outline the literature review on the micromechanical 
environment experienced by the valve and mechanobiology (stretch, shear and 
pressure) with respect to the degenerative AV disease. The final section will 
discuss the miRNAs and their function in the cardiovascular system. In 
CHAPTER 2, the rationale for this research and the hypothesis is discussed. The 
specific aims designed to test this hypothesis are also discussed. The next three 
chapters address each specific aim in detail. The approach, methodology, 
results, discussion, conclusions and limitations of each specific aim are 
discussed in detail. Briefly, in CHAPTER 3, the side- and shear-specific miRNAs 
involved in AV pathogenesis are identified and in CHAPTER 4, the relationship 
between a key miRNA, miR-214 and AV pathogenesis is investigated. CHAPTER 
5 determines the role of pyrophosphate, an endogenous inhibitor of calcification 
in AV ectopic calcification. In CHAPTER 6, all the key results are discussed in 
the context of the overall rationale and hypothesis of this thesis work. CHAPTER 
7 presents the conclusions of this research work and the potential impact of this 
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thesis work. With CHAPTER 8, this dissertation concludes with the 
recommendations and the future work based on the findings in this thesis work.  
 
1.1 Aortic valve anatomy  
The aortic valve is one of the semilunar or outflow tract valves of the heart and 
regulates the blood flow direction between the left ventricle and aorta. A healthy 
AV (Figure 1.1) is comprised of three semilunar cusps, each of which is attached 
to the fibrous annulus ring at the base. Directly behind each cusp is an elliptical 
depression called the sinus of valsalva or aortic sinuses. Two of the sinuses give 
rise to coronary arteries that branch off the aorta, providing blood supply to the 
heart itself. The AV sinuses and the corresponding valve leaflets are named 
according to the presence of the coronaries. The sinuses with the right and left 
coronary artery ostium are known as the right and left coronary sinuses 
respectively, and the corresponding leaflets are known as right and left coronary 
leaflets. The sinus without any coronary attachment is the non-coronary sinus, 
and the associated leaflet is the non-coronary leaflet. The superior base of the 
leaflet is connected to the valve commissure, which inserts into the surrounding 
aortic root. The aortic valve commissures provide load-bearing support to the 




Figure 1.1 The AV, cut open along the axial line 
demonstrating the anatomy of the valve (18). 
 
 
1.2 Aortic valve hemodynamics 
The structure and function of the AV is influenced by its surrounding 
hemodynamics and mechanical microenvironment as shown in the Figure 1.2. At 
the beginning of systole, the valve leaflets rapidly open, and blood accelerates 
through the valve with a positive gradient (higher pressure upstream in the 
ventricle than downstream in the aorta).  Forward flow velocities are at their peak 
value of 1.35 + 0.35 m/s (19), during the first third of systole. At the end of 
systole, when the ventricular pressure drops below aortic pressure, the valve 
starts to close as the forward flow begins to decelerate to zero, with very little 
flow reversal. The adverse axial pressure difference across the valve causes the 
low inertia flow in the developing boundary layer along the aortic wall to 
decelerate, and then to reverse direction resulting in vortices in the sinuses 
behind the AV leaflets. This action forces the leaflet tips towards a closed 
position, resulting in a very fast and efficient closure of the leaflets. During 
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diastole, when the left ventricle relaxes, the valve remains completely closed. 
The flow patterns in the outflow tract of the valve depend on the valve geometry 
and can be used to evaluate the function and health of the valve (20). Thus, the 
AV is a highly dynamic organ, opening and closing approximately one billion 
times during the average human lifetime, experiencing transvalvular pressures, 







Figure 1.2 Schematic of different mechanical stimuli experienced by the AV 




1.3 Aortic valve tissue structure and cell types 
Each aortic valve leaflet cusp is comprised of three layers: fibrosa - facing the 
aorta; ventricularis - facing the left ventricle; and spongiosa - the layer between 
the fibrosa and ventricularis (Figure 1.3A). These three layers vary in their 
organization of extracellular matrix (ECM) components (collagen and elastin), 
especially along the radial direction. The fibrosa is predominantly made of type I 
fibrillar collagen that is arranged in circumferential direction in parallel bundles, 
surrounded by a matrix of elastins. The ventricularis is mostly comprised of 
elastin fibers oriented along the radial direction, while the spongiosa is primarily 
made up of glycosaminoglycans, which act as shock absorbers and provide the 
deformability function of the valve leaflets (21).  
 
The AV leaflets are composed of two cell types - interstitial cells (ICs), which 
make up the majority of the valve, and endothelial cells (ECs), which line the AV 
along the fibrosa as well as the ventricularis. The ECs form single cell 
monolayers, express Von Willebrand factor, produce vasoactive agents such as 
endothelin-1 and nitric oxide, and exhibit prostacyclin activity. The ICs are a 
heterogeneous (three phenotypes: myofibroblasts, fibroblasts, smooth muscle 
cell like phenotype) and dynamic population of cells responsible for the constant 
renewal of ECM (21). The ICs play a critical role in normal functioning of the 
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valve and in the initiation and progression of valve pathology. Both complex 
genetic programming as well as local hemodynamic factors such as leaflet strain 
and surface shear stresses influences the phenotype of ICs. Human AV ECs 
align parallel to the direction of the flow (22), although this alignment has been 
observed to be species specific because the porcine AV ECs align perpendicular 
to the direction of blood flow (23). Valvular ECs share some similarities with 
vascular ECs in terms of responses to mechanical stimuli, however they are 
genetically different and have a higher propensity to undergo endothelial to 
mesenchymal transition. 
 
Aortic valve ECs on either side of the leaflets show differential gene expression 
profiles, which could be attributed to the conditioning due to different 
microenvironments on either side. Particularly, the genes that inhibit local and 
global calcification such as OPG, CNP, PTH, chordin etc., are expressed at 
significantly lower levels on the fibrosa endothelium compared to that on the 
ventricularis, indicating that fibrosa has a higher susceptibility to calcify. On the 
contrary, fibrosa endothelium also shows higher expression of the antioxidative 
markers such as MGST2, NOS3, PRDX2 etc., which could be protecting the 
fibrosa from oxidative stress induced inflammation (24). Interestingly, the ECs on 
fibrosa are characterized by an elongated shape and are more compliant than 




Figure 1.3 AV structure and composition. 
A) Trilayered structure of the healthy porcine AV consisting of fibrosa (F), 
spongiosa (S), and ventricularis (V). B) A calcified human AV showing obvious 
signs of altered ECM, preferentially on the fibrosa (F) (26). 
 
 
1.4 Aortic valve disease: prevalence and clinical significance 
A normally functioning AV ensures the uni-directionality of blood flow from the left 
ventricle to aorta, with physiological hemodynamics. Abnormalities of the valve 
(Figure 1.3B) arise due to a variety of risk factors such as hypertension, high LDL 
content, old age, hyperphosphatemia, diabetes, obesity, smoking etc (27). These 
abnormalities of valve range from mild thickening to severe calcification with 
impaired leaflet motion (Figure 1.4). AV stenosis refers to narrowing of the AV 
opening during systole and leads to greater pressure gradient across the valve 
(28) AV stenosis is caused by both age-related progressive calcification and 
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congenital malformations such as bicuspid AV (BAV), a congenital condition 
occurring in 1-2% of all live births (29). Elevated levels of turbulence measured 
downstream of the stenosed valve are enough to cause significant damage to the 
endothelial layer of ascending aorta (30). The classic symptoms of the AS are 
syncope, angina and congestive heart failure. 
 
Aortic regurgitation (AR) is a condition when there is a backflow of the blood into 
the left ventricle. Around 50% of the cases of aortic insufficiency are due to 
dilatation of the aortic root, which is idiopathic in most instances. In about 15% of 
regurgitation cases, the cause is innate BAV, while another 15% of the cases are 
due to retraction of the cusps as part of post-inflammatory processes of 
endocarditis in rheumatic fever and various collagen vascular diseases (31).  
 
Thus, calcific AV disease is a strong risk factor for cardiovascular related deaths 
(9, 32, 33) and is a significant source of mortality worldwide, with the number of 
patients requiring AV surgery expected to triple from 250,000 to 850,000 by 2050 
(34). The most common forms of the AV disease can be distinguished clinically 
by age at the onset and by their characteristic echocardiographic findings. 
Currently, one of the viable options is to treat AV disease is to surgically replace 
the diseased valve with a mechanical or biological valve.  Recent developments 
are aimed towards the use of transcather AV replacement of the diseased valve, 
especially in elderly patients who are not qualified for a surgery. However, as of 




Figure 1.4 Native and diseased AV. 




1.5 Aortic valve pathology 
1.5.1 Molecular pathways 
Calcific AV disease is a slowly progressive disorder with a disease continuum 
that ranges from mild thickening of the valve to severe calcification with impaired 
leaflet motion.  Calcification of the AV is a side-dependent disease, preferentially 
occurring on the fibrosa of the AV. It is typically characterized by inflammation, 
fractured matrix fibers, thrombus formations, sclerotic and calcific lesions (Figure 
1.3). The cellular and molecular events leading to AV disease are interdependent 
and entwined with extracellular matrix maladaptation. Endothelial dysfunction or 
leakage is speculated to be one of the first events triggered when VECs are 
subjected to an insult, be it abnormal hemodynamics or mechanical stress or 
pathological injury (Figure 1.5) (35). Mechanotransducers in the extracellular 
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matrix transmit these stimuli to the quiescent VICs (qVICs), and activate them. 
Following this activation is the deposition of low density lipoprotein (LDL) 
particles, infiltration of inflammatory cells, and release of inflammatory cytokines. 
These events lead to abnormal collagen synthesis and ECM remodeling by 
collagenases, matrix metalloproteinases (MMPs) and tissue inhibitors of matrix 
metalloproteinases (TIMPs), cathepsins (36). Hyperphosphatemia, a condition 
seen in CKD, upregulates the expression of Runx2/ Cbfa-1, an osteogenic 
transcription factor (37). In the presence of such factors, cells exhibit markers of 
the osteogenic or chondrogenic lineage, resulting in osteoblast VICs (obVICs) 
that actively participate in the valve calcification process. In addition, 
hyperphosphatemia enhances production of apoptotic bodies and matrix vesicles 
that nucleate vascular mineral deposition (38). The transforming growth factor 
(TGF)-β/ TGF-like cytokine and TGF-β1 can also enhance the osteogenic 
phenotype (17). On the other hand, Fetuin-A, an abundant plasma protein 
prevents extracellular and intravesicular basic calcium phosphate growth in 
matrix vesicles and thus reduces calcium-induced apoptosis in vascular smooth 
muscle cells. In the absence of extracellular Fetuin-A, cells fail to properly handle 
a high mineral load because of elevated extracellular calcium phosphate and 
succumb to apoptosis (39). Apoptotic bodies containing high amounts of mineral-
like matrix vesicles readily mineralize and form a potent nidus for further 
extracellular matrix calcification. Unlike matrix vesicle mediated mineralization, 
AB-mediated mineralization does not require alkaline phosphatase and annexins. 
Apart from TGF-β1 and BMP family, other pathways that can promote the 
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transcription by RunX2 are Mitogen activated protein kinase (MAPK) and Protein 
Kinase-A (PKA) pathways, indicating that RUNX2 is a focal point for the 
integration of a variety of signals affecting osteoblast activity (40).  
 
 
Figure 1.5 Molecular mechanisms involved in AV disease. 
The osteogenic differentiation of the valve cells can be initiated by a myriad of 
sources such as endothelial mesenchymal transition of ECs, circulating 
macrophages, trans-differentiation of the valve ICs into osteoblast like phenotype 
to name a few (41). 
 
1.5.2 Soft tissue calcification 
There are distinct types of calcification processes identified in the soft tissues 
(vessels, valves) and the end result of all these calcification processes is the 
same, which is bone formation. From a pathomorphological perspective (5), 
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calcification can be distinguished into four types on the basis of location, 
association with plaque, and mode of formation: 1) Dystrophic or passive 
calcification (minor form of widespread non-specific organ and soft tissue 
calcification as a result of abnormal Ca/P products) 2) Calcification of cardiac 
valves, 3) Calcification in arterial intimal layers in association with macrophages, 
lipids and vascular smooth muscle cells (VSMCs) as in classical atherosclerosis, 
popularly referred as intimal calcification, and 4) Calcification in arterial medial 
layers as a result of elastin fiber mineralization, VSMCs degeneration, and 
upregulation of osteogenic programs as in chronic kidney disease or diabetes, 
popularly referred as medial calcification. The last three types of calcification are 
all occur in the absence of raised Ca/P levels and are actively regulated 
mechanisms, which require complex regulatory networks that involve 1) Positive 
and negative regulators; 2) temporal expression or activation of modulators; 3) 
multiple amplification or suppressive feedback loops that orchestrate cell 
recruitment, differentiation, function, survival, and interactions with other cells or 
matrix molecules. Osteopontin, osteoprotegerin (inhibitor of osteoclastogenesis), 
matrix-gla protein, Fetuin A, inorganic pyrophosphate that prevent calcification 
and tissue non specific alkaline phosphatase, receptor activator of NF-KB 
(induces maturation of osteoclast progenitors) or NF-KB ligand are some of the 
compounds that play a major role in promoting calcification (4). Intraperitoneal 
delivery of PPi for duration of a few hours can inhibit aortic calcification in uremia 
without affecting the bone formation (42). Thus, by understanding mechanisms 
underlying calcification, it is feasible to slow down the progression of calcification. 
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1.6 Aortic valve mechanobiology 
AV degradation is not a passive process brought about by wear and tear due to 
aging but an active process involving perturbation of valvular ECs and ICs by the 
local mechanical forces such as strain, shear, and transvalvular pressure (43). 
Ex vivo studies have shown that different mechanical forces act in synergy to 
modulate and maintain a normal cellular phenotype. Another important aspect of 
AV cellular mechanobiology is the interactions between ECs and ICs. There are 
relatively few co-culture studies performed on AV cells or tissues. Butcher et al. 
developed a 3D model of the AV leaflet comprising both ICs and ECs and 
determined the cellular responses when exposed to different luminal flow 
patterns and suggested that ECs are necessary to regulate the ICs phenotype 
and ECM synthesis (44). The significance of interactions between ECM and 
valvular cells has been investigated as well. The following sections describe 
individual mechanical stimuli experienced by the native AV, under normal and 
pathological conditions, with an emphasis on their relevance to AV 
mechanobiology.  
1.6.1 Shear stress 
Physiologically, shear stress occurs on AV leaflet surface due to friction with 
flowing blood. Shear stresses experienced by the AV depend on flow conditions 
through the valve as well as cyclic dynamic leaflet motion. Shear stresses directly 
affect the ECs lining each valve cusp, which in turn transmit the signal to the 
underlying matrix and ICs. Different shear stress patterns are known to elicit 
different EC responses, and disturbed flow has been shown to promote cell 
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proliferation, as well as morphology and gene expression dissimilar to laminar 
flow in ECs (45). Further, shear stresses on the valve can also change with 
developing pathology. Thus, an accurate estimation of shear stresses 
experienced by the AV under both physiological and pathological hemodynamics 
is critical for mechanobiology studies.   
 
Fluid mechanics of AV such as flow profiles, Reynolds shear stresses, and 
turbulence characteristics, have been estimated using both experimental 
techniques (laser doppler velocimetry, hot film anemometry, PIV, MRI, doppler 
ultrasound) as well as computational modeling (46-49). Recently, Yap et al. 
measured shear stresses on both the fibrosa and ventricularis of the leaflet using 
two-component Laser Doppler Velocimetry. The ventricularis shear stress 
resembled a half-sinusoid during systole with peak magnitude of 64-71 dyn/cm2, 
and the direction of this shear reversed during late systole with a significant 
magnitude of 40-51 dyn/cm2.  In contrary to the popular belief, fibrosa do not 
experience oscillatory shear stress profile, rather a profile similar to a half sine 
wave with little or no reverse flow, with a magnitude of up to 20dyn/cm2. These 
shear stresses are dependent on cardiac output and heart rate. As alterations in 
the hemodynamics such as high heart rate and low cardiac output have been 
shown to affect several stages of cardiovascular disease continuum such as 
endothelial dysfunction, plaque rupture and myocardial infarction, the shear 
stresses under these altered conditions can be used in mechanobiology studies 
to gain more insights into AV pathobiology.  
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A growing body of evidence suggests that the morphology of BAV can lead to 
adverse hemodynamics both near the valve as well as in the ascending aorta 
resulting in turbulence and higher leaflet surface shear stresses compared to that 
of normal TAV (30, 50). Both systolic and diastolic shear stresses were higher on 
non-fused leaflet than the fused leaflet. Although genetic factors have been 
implicated in the formation of BAVs, this altered microenvironment due to the 
BAV morphology itself could be the reason behind accelerated progression of the 
disease condition. 
1.6.2 Shear stress: mechanobiology 
Shear stress regulates expression of proteins in ECs that control many opposing 
functions such as vasodilation and vasoconstriction, thrombo-resistance and 
thrombogenesis, and normal cell morphology and atherosclerosis. The 
morphological changes of ECs under shear were induced by the assembly and 
re-orientation of the stress fibers, accompanied by translocation and remodeling 
of cell substrate adhesion complexes, and transient formation of punctate cell-
cell adherent junctions, that may signal the nucleus to elicit a specific cellular 
response. Several studies have characterized the role of shear stresses on 
vascular biology and indicated that low and oscillatory shear stress is 
atheroprone; whereas, high shear is atheroprotective (45). It is also speculated 
that the reduced shear stresses on the non-coronary leaflet of the AV due to the 
lack of coronary flow is responsible for the increased susceptibility to calcification 
of that leaflet (1). 
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Although AV stenosis may be akin to atherosclerosis, there exist distinct 
differences in the phenotypes of both the cell types, warranting further studies on 
AV cells and its biology. Further, compared to vasculature, there have been very 
few studies on the effects of shear stress on AV. Two types of shear stress 
bioreactors – parallel plate system (51) and cone and plate viscometer (52) have 
have been used thus far to investigate the role of shear stress in AV biology and 
pathobiology, both in vitro and ex vivo. The parallel plate system is typically used 
to apply a uniform laminar shear stress while the cone and plate device can be 
used to impose uni-directional laminar shear or oscillatory and much more 
complex shear stress variations. Recently Sun et al. refined the design of the 
original cone and plate device to be able to expose either sides of AV to different 
shear stresses simultaneously that closely mimics the in vivo scenario (53). 
Using parallel plate flow chamber, earlier studies clearly demonstrated that 
changes in shear stress patterns (steady or pulsatile) are capable of affecting the 
ECM protease and protein turnover balance in short durations (51, 54).  
 
As discussed in the previous section, the magnitude and nature of shear stress 
experienced by either side of the valve differs greatly and is perhaps responsible 
for the differential gene transcription profiles observed in healthy, porcine AVs 
(24). Gene profiling of porcine AV ECs showed that the expression of protective 
markers such as osteoprotegerin (key regulator of inflammation), parathyroid 
hormone (regulates Ca+2 level and osteogenesis), c-type natriuretic peptide 
(cardiac and smooth muscle cell growth regulator) and chordin (BMP antagonist) 
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that regulate the ectopic calcification were relatively low on fibrosa suggesting 
that fibrosa is more prone to disease initiation compared to ventricularis. This 
difference is more pronounced in the calcified valves, where the expression of 
the markers related to canonical BMP pathway such as phosphorylated SMAD-
1/5/8 were found to be higher on the fibrosa endothelium corroborating the fact 
that fibrosa is more prone to disease initiation and progression (55). Side- and 
shear-specific expression on fibrosa side was also seen in response to altered 
shear stresses, where inflammation markers such as VCAM-1, ICAM-1, TGFβ-1, 
and BMP-2, 4 were significantly upregulated compared to ventricularis and were 
detected in the endothelial and sub-endothelial regions . Expression of these 
markers on fibrosa endothelium in the presence of altered shear stresses 
indicates that the disease initiation could be side-specific and shear-dependent 
and could be potentially mediated by BMP-dependent pathway. Holliday et al. 
investigated the side- and shear-dependent miRNA and mRNA expression in 
human AV ECs and identified some of the mechanosensitive-miRNAs, which 
were found to be important in remodeling, inflammation, cell proliferation and 
migration (22).  
 
One of the studies that looked at the biological implications of the altered shear 
stresses due to BAV morphology was by Sun et al. Wall shear stresses 
experienced by the non-fused leaflet of BAV maintained homeostasis whereas 
the shear stress of fused leaflet of BAV activated the fibrosa endothelium by up-
regulating the expression of ECM proteases, inflammatory markers as well as 
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osteogenesis related proteins (56). These findings demonstrate that altered 
shear stresses can significantly alter the valve cell phenotype, inducing 
inflammation, osteogenic differentiation in a side specific manner and thus 
eventually cause valve degeneration and calcification, apart from the underlying 
genetic factors.  
1.6.3 Stretch 
The mechanics of valve tissue is complex with a highly non-linear stress-strain 
relationship. During the course of each cardiac cycle, the AV undergoes a 
combination of normal, bending, tensile, compressive, and shear stresses. A 
majority of these stresses and strains are induced by a complex interplay 
between blood flow dynamics and valve cusp tissue. The stress distribution in the 
leaflet is majorly affected by the internal changes induced by strain. Bending 
stress in AV is both tensile and compressive, with the inflow-side experiencing 
tensile stress while the outflow-side experiences compressive stress. Indeed, the 
curvature of the leaflet is integral in ensuring proper coaptation and long-term 
functionality and viability of the valve cusp (57). Ragaert et al. have characterized 
the flexural mechanical properties of porcine AV leaflets (coronary and non-
coronary) using indentation and static rupture tests, and quantified the maximum 
extension before breaking (~3mm), stiffness (~6N/mm) and maximum load 
before rupture (~13N) (58). Layer specific flexural properties have been 
extensively studied as well (59).  
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The AV leaflets exhibit anisotropic strain because the collagen in the 
circumferential direction provides greater tensile strength. Leaflet strain may be 
rapidly lost as the tissues become less extensible with increasing age. This is 
primarily because continued collagen fibrillogenesis over the lifetime of an 
individual increases the diameter of some of the constituent fibrils, requiring 
greater force to produce the same extension (60). This progressively reduces the 
AV strain with age, with drastic reduction occurring before the age of 25 (61). The 
radial direction, which is mainly composed of elastic fibers, shows higher strain. It 
has been reported in vivo AV leaflet strains are approximately 10% and 40% in 
the circumferential and radial directions (62, 63), respectively and is comparable 
across different species. Yap et al. measured the strains on porcine AV cusps 
under different hypertensive pressure conditions in an ex vivo flow loop system 
by tracking markers on leaflet surface using stereo photogrammetry (64). In 
terms of strain profile, the diastolic strain of the leaflets followed the transvalvular 
pressure gradient and the systolic strain followed the flow curve. These dynamic 
strain characteristics were used as the reference value for various physiological 
and pathophysiological ex vivo studies from the same investigators, as explained 
in the next section. Efforts are underway to measure strain in surgically stitched 
BAV models. Sacks et al. have characterized the biaxial mechanical behavior of 
fibrosa and ventricularis layers separately and found out that these layers exhibit 
different nonlinear anisotropic (quasi-elastic) behavior (65). The fibrosa behaved 
similar to the intact native tissue, but less compliant, biaxial loading. They also 
inferred that the ventricularis dominates the mechanical response of the intact 
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tissue in the radial direction at higher stress levels. This biomechanics study 
sheds light on the layer specific properties of the AV leaflets, which is very critical 
in developing constitutive models of the AV for numerical studies.  
 
Numerical models are gaining prominence in recent times to characterize the 
stress distribution on native AV leaflets and malformed (bicuspid) leaflets (66). 
Weinberg et al. also developed a multiscale finite element model for comparing 
BAV and normal TAV and they observed that cellular deformations between 
these two are not significantly different.  Stenotic bicuspid valve experiences 
more bending strain compared to that of the stenotic tricuspid valve and this 
strain was more pronounced on the central region of the fused leaflets of BAV 
(67). 
 
1.6.4 Stretch: mechanobiology 
Ex vivo and in vitro stretch simulation studies on AV leaflets have been focused 
on two main areas: Effect of cyclic strain on 1) native leaflets in terms of 
remodeling, inflammation and calcification markers 2) isolated AV cells loaded in 
scaffolds, and studying them from tissue engineering perspective. Native porcine 
AV leaflets when subjected to varying stretch magnitudes, the responses were 
either biphasic in terms of MMP activity and TIMP expression, or reached a 
plateau. Elevated cyclic stretch also increased the collagenase and gelatinase 
activity. However, there was an overall increase in the collagen content with 
increased stretch levels, pointing out that the leaflets adapt to altered mechanical 
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loading by either increasing synthesis, or decreasing degradation of collagen 
(68).  
 
In terms of ECM remodeling enzymes, it was observed that cathepsin L 
expression was reduced by elevated cyclic stretch, while cathepsin S and K 
expression was increased and similar expression was also observed in stenotic 
aortic valves (69). Further, pathological level of stretch has been shown to induce 
AV calcification in a BMP-dependent manner (17). BMPs have been established 
as markers in early calcification progression in cultured vascular and valvular 
cells. It was also observed that the BMP antagonist noggin was able to 
downregulate the stretch induced osteogenic and calcification events (ALP 
activity, Runx2 expression and calcium levels in the leaflets). On the other hand, 
the fibrosis effect of neurotransmitter serotonin (5-hydroxytryptamine, 5HT) on 
heart valves has been well documented. Peña-Silva et al. reported that elevated 
serotonin levels can result in increased oxidative stress in the valve cusp 
potentially leading to stenotic valve disease (70). 5-HT-induced valve stiffening 
may occur throughout the valve cusp resulting in reduced valve curvature and 
ability of the valve to coapt effectively (71).  
 
Cell level cyclic strain studies have been garnering lot of interest from the tissue 
engineering and regenerative medicine community. These cell level models have 
progressed from 2D strain (72) application to 3D cultures (73). Valve fibroblasts 
in these 3D models have shown cell differentiation and matrix synthesis. Different 
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substrates (fibrin, collagen based) for tissue engineered heart valves were 
investigated and their mechanical behavior, fiber orientation and resultant ECM 
of the construct in response to mechanical conditioning have been reported (74). 
On the other hand, it was found that a synergistic combination of biological 
(BMP4) and mechanical forces are required to induce the same level of SMA, 
runx2 and OPN expressions in human valvular ICs populated scaffolds as that of 
isolated cells (75). Butcher et al. demonstrated that cyclic strain induces time 
dependent (48 hours, 96 hours) valvular IC orientation and collagen alignment, 
which in turn influenced α-SMA levels (73). Recent gene expression studies by 
Warnock et al. indicated that 15% cyclic strain reduces expression of pro-
inflammatory genes by ICs loaded in collagen constructs (76). Any other strain 
value induced inflammatory response by the valvular ICs as measured by 
inflammatory marker VCAM-1 and mechanosensitive gene OPN. Thus, leaflet 
strain plays a significant role in maintaining valve phenotype and ECM structure, 




During the course of a single cardiac cycle, the pressure on the aortic cusps 
cyclically varies changing the stress and the strain in the leaflet tissue. In healthy 
individuals, the AV offers negligible resistance to the forward flow of blood 
(systole) and the pressure drop across the valve is under a few mmHg. In mild 
stenosis cases, the mean systolic pressure drop is around 20mmHg during 
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systole. In severe cases, the mean systolic pressure drop is higher than 
40mmHg (77). During diastole, a closed AV endures a transvalvular pressure 
gradient of approximately 80-100 mmHg acting normal to the leaflet area. With 
systemic hypertension, the transvalvular gradient can reach as high as 180-200 
mmHg during diastole. This normal force is supported by the AV leaflets’ fibrosa 
layer and transmitted from the collagen fibers to the preferentially aligned ICs 
(60, 63). 
 
1.6.6 Pressure: mechanobiology 
Hypertension plays an important role in the initial stages of aortic stenosis as it is 
found in one-third of patients with symptomatic aortic stenosis. Elevated 
pressures experienced during mild to severe hypertension increase the 
mechanical strain experienced by the leaflets and may play a key role in 
activation of several complex biological networks that induce endothelial 
dysfunction, altered remodeling, and inflammation (78). Apoptosis, ECM 
composition and stiffness, cell proliferation signaling and adhesion are influenced 
by pressure and the modulation levels of these processes are mixed depending 
on the pressure level (79-82). However, it is unclear as to how hypertensive 
pressure is involved in early AV disease pathophysiology. 
 
In vitro studies have progressed from static pressure experiments to investigating 
the effects of dynamic pressure on AV mechanobiology. One of the early studies 
that examined the effects of pressure on AV leaflets demonstrated an increase in 
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pressure decreased the α-SMA expression whereas the isolated pathological 
stretch on the other hand increased the α-SMA expression (83). The opposing 
effects of stretch and pressure on α-SMA expression therefore suggest that the 
combined normal physiological hemodynamic forces may act to maintain the 
quiescent phenotype and prevent expression of activated contractile phenotype 
which was also shown using a novel ex vivo stretch and pressure bioreactor. 
Calponin and Caldesmon, associated with the actin bundling and polymerization, 
showed similar trends to that of α-SMA, indicating that these markers play a role 
in maintaining the valve IC phenotype. Vimentin, a protective cytoskeletal 
component that provides stiffness, also decreased at combined pathological 
stretch and pressure, indicating that its protective function may be compromised 
under pathological conditions. Hypertensive pressure significantly reduced 
cathepsin L activity and down regulated MMP-2/9 expression moderately, 
indicating the pressure-dependent regulation of these proteases (54), and 
further, thickness of fibrosa and spongiosa increased relative to ventricularis in 
case of pathological stretch and pressure conditions, owing to altered ECM 
remodeling. Warnock et al. investigated the immediate response of the elevated 
pressure on valve ICs, and found significant up regulation of VCAM-1 
(inflammatory marker) and down regulation of osteopontin (endogenous 
downregulator of ectopic calcification) (84). Further, gene array results indicated 
that approximately 50% of the genes including MMP-1, MMP-3, Interleukin (IL)-6 
and Pentraxin-3 that are involved in Tumor necrosis factor (TNF)-alpha network 
were impacted by the hypertensive conditions. In a separate study by the same 
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group using AV ICs on collagen constructs, it was found that cyclic strain up 
regulated the expression of VCAM-1, suggesting that cyclic strain might be a 
more significant stimulus in evoking this response (76). These markers are 
known to be involved in inflammation, tissue remodeling, and calcification, and 
indicate that the pathological processes can be triggered due to hypertensive 
pressures. Thus these studies indicate that hypertensive pressures alter the 
inflammatory and remodeling responses mediated by valvular ICs, and thus 
contribute to the AV disease progression.  
 
Although the above studies have investigated the mechanobiological effects of 
pressure in isolation, it must be noted that pressure causes increased stretch on 
the leaflets through tensile-compressive and bending forces. Hence, future 
studies must investigate these two forces in combination, rather than in isolation.  
 
1.6.7 Combined mechanical stimuli: mechanobiology 
Independent mechanobiology studies of AV in the presence of each of the 
isolated mechanical stimuli (shear, stretch or pressure) aid in understanding how 
each mechanical stimulus plays a role in regulating AV biology and pathology. 
Knowledge gained from the studies where the AV is subjected to the combined 
mechanical stimuli, i.e., mimicking its native in vivo state is as critical and helps 
us understand the interplay of each stimulus in regulating the AV health. There 
have been recent initiatives to study the mechanobiological effects of combined 
stimuli. One such attempt was made by Konduri et al. using an ex vivo pulsatile 
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organ culture system, subjecting a native AV along with its root to its 
physiological hemodynamics (85). ECM composition (sGAG, elastin and collagen 
content), cell viability, proliferation as well as the α-SMA content were preserved 
in cultured leaflets. However, under static conditions, a decrease in sGAG, 
elastin and α-SMA content with significant cell death compared to fresh and 
cultured AVs was seen indicating that mechanical stimuli are indeed required to 
preserve native composition and function of the AV leaflets. Warnock et al. 
studied the inflammatory response of AV ICs when subjected to cyclic strain and 
pressure together (76), and found the synergistic response to be different than 
the individual response in terms of inflammatory markers such as VCAM and 
OPN mechanosensitive genes. Another group developed a flexure, stretch and 
flow bioreactor where each of these stimuli can be independently controlled and 
can be used for studying the mechanobiological responses to physiological and 
pathological stimuli (86). Apart from understanding the effect of complex 
mechanical stimuli on AV biology, bioreactors like these could potentially be used 
to mechanically condition the tissue-engineered AVs to develop the natural ECM 
and also assess the resultant deformations experienced by the valves using real 
time non-invasive measurement techniques (87).  
 
1.7 MicroRNAs and cardiovascular diseases 
1.7.1 Biogenesis of microRNAs 
MicroRNAs (miRNAs) comprise a novel class of endogenous, small, non-coding 
RNAs that negatively regulate gene expression via degradation or translational 
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inhibition of their target mRNAs. The miRNAs are transcribed as long primary 
transcripts termed pri-miRNAs, which are then trimmed into approximately 70-
nucleotide stem loop forms called pre-miRNAs in the nucleus by RNase III type 
protein, Drosha. After this initial processing, pre-miRNAs are exported to 
cytoplasm by Exportin-5 and processed to generate 18 to 22 nucleotide mature 
duplex miRNAs by Dicer, another RNase III type protein. The duplex is then 
loaded into the miRNA associated multiprotein RNA-induced silencing complex 
(miRISC), where one strand of miRNA is preferentially retained in the complex 
and becomes the mature miRNA and the opposite strand, known as the 
passenger strand miRNA is eliminated from the complex (88) (Figure 1.6). 
Another biogenesis of miRNAs is the mirtron dependent noncanonical pathway 
and is microprocessor independent (89). Mirtrons are a type of miRNAs that arise 
from spliced out introns and is initiated by splicing and debranching into a pre-
miR hairpin, cleaved by Dicer and directly incorporated into silencing complexes. 
Another possibility is by bypassing the Drosha processing to produce miRNAs by 
Dicer. Small nucleolar RNAs (snoRNAs), endogenous short-hairpin RNAs (endo-
shRNAs) and tRNA precursors also provide a secondary source of pre-miRNAs 
that is independent of the microprocessor-mediated processing (90). Improper 
functioning or genetic mutation of Drosha or Dicer can impair the miRNA 
biogenesis (91, 92). In order for a miRNAs to regulate mRNAs, the seed region 
of the miRNAs on 5’ end (2 to 8 nucleotides), must have exact base pairing with 
the 3’ untranslated region of mRNAs and partial complementarity with the rest of 
the mRNA sequence. Mature miRNAs can negatively modulate gene expression 
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by either degrading or blocking the mRNA depending on the degree of 
complementarity between the miRNAs and target mRNAs. Also, the upstream 
and downstream signaling is different for miRNAs as both miRNA-regulator and 
miRNA-target availability often differs in cells and especially during disease 





Figure 1.6 Biogenesis of miRNAs: canonical and non-canonical pathways. 
The canonical pathway produces pri-miRNA transcript from miRNA genes by 
RNA polymerase II/III followed by DROSHA processing of the pri-miRNA 
transcript into pre-miRNA. Noncanonical pathways are mirtron pathway, by 
passing the DROSHA pathway. Pre-miRNAs generated by both pathways are 
exported into the cytoplasm by exportin, followed by formation of miRNA-miRNA* 
duplex and cleavage into mature form of miRNA by DICER and Argonaute 
proteins (Ago). The RNA-silencing inducing complex (RISC) incorporates the 
mature miRNA and interacts with the 3’-UTR of the target mRNA and regulates 
gene expression by translational inhibition or mRNA degradation (94). 
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1.7.2 Role of miRNAs in cardiovascular diseases 
The miRNAs have emerged as key players in cardiovascular development 
especially during embryogenesis, and cardiovascular diseases such as 
myocardial infarction, cardiac arrhythmia, cardiac hypertrophy, heart failure, 
cardiac fibrosis, ischemia, and atherosclerosis, thus can serve as potential 
targets for cardiovascular disease prevention, diagnostics and therapy. Several 
miRNAs such as miR-1, miR21, miR-29, miR-92a, miR-133, miR-199a and miR-
320 are involved in ischemic injury, cardiac remodeling via MMP-9 and collagen 
synthesis, TGF-β - BMP-4 and SMAD pathway (95, 96). MiRNAs-1, 133 are anti-
hypertrophic and 129, 18b, 195, 21, 23a, 23b, 24, 208 and 212 are pro-
hypertrophic (97).  Further, over expression of miR-221/222, miR-92a inhibits 
tube formation, migration, and wound healing by possibly regulating the 
expression of several pro-angiogenic genes (98). MiR-126 has been shown to 
regulate the expression of TNF-alpha stimulated VCAM-1 expression, thus 
playing a role in vascular inflammation (99). A recent study on human AV 
endothelial cells (HAVEC) has shown that miR-139-3p, miR-187, and miR-486-
5p are shear sensitive indicating that there are indeed mechanosensitive 
miRNAs (22). Further, it was also shown that shear responsive miRNAs in 
HUVECs, i.e., miR-23b and miR-19a are not found in HAVECs, supporting the 
idea that shear regulation of miRNAs in HAVECs is unique from HUVECs. 
Further, circulating levels of serum miRNAs such as miR-126, 92a, 133a etc., are 
also associated with various types of cardiovascular diseases and might serve as 
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potential biomarkers (94). Thus the miRNA family involved in cardiovascular 
diseases is growing rapidly, however, many unsolved issues remain, and our 
present understanding of the regulation of individual miRNAs in physiology and 
pathophysiology of AV is in its infancy. This work proposes the identification and 
characterization of miRNAs that are shear responsive and side dependent in 
porcine AV leaflets ex vivo. 
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CHAPTER 2   HYPOTHESIS AND SPECIFIC AIMS 
 
2.1 Rationale and hypothesis 
 Calcific AV disease is a strong risk factor for cardiovascular related deaths 
and is a significant source of mortality worldwide, with the number of patients 
requiring AV surgery expected to increase from 250,000 to 850,000 by 2050 (34).  
Explanted calcified valves show signs of endothelial damage, inflammation, 
disrupted ECM, angiogenesis, and ossification in the fibrosa side of the leaflets, 
while the ventricularis side remains relatively unaffected (9, 100). Spatial 
differences in complex genetic programming and local hemodynamics could be 
strong factors in this side-dependent calcific valve disease (22). When valvular 
endothelial cells are subjected to injury due to abnormal hemodynamics or 
humoral insult, a cascade of events leads to the triggering of inflammation. These 
events include infiltration of macrophages and increased expression of adhesion 
molecules, cytokines, growth factors, and enzymes (2). As a result, endothelial 
cells become activated and display a myofibroblast-like phenotype via endothelial 
mesenchymal transition.  Eventually, inflammatory cells and cytokines invade the 
ECM and degrade the collagen and elastin. This causes phenotypic changes of 
valve interstitial cells and leads to ossification and calcification. Understanding 
the basis for the increased susceptibility of the fibrosa to inflammation and 
calcification can provide important clues about the regulatory mechanisms 




Another common form of calcification is ectopic calcification. It occurs when there 
is a loss of mineralization inhibitors such as pyrophosphate (PPi), matrix γ-
carboxyglutamic acid Gla protein (MGP), fetuin, and osteopontin, or when there 
is increased expression of mineralization promoters such as tissue non-specific 
alkaline phosphatase, phosphates, or both (3, 4, 35, 101). However, the exact 
mechanisms of how these calcification inhibitors and promoters participate in the 
AV calcification process are not well understood. Thus, calcification of aortic 
valves may occur through overlapping yet distinct molecular mechanisms, each 
with different clinical implications. 
 
Shear stress is a mechanical stimulus that greatly differs on either side of the 
valve and plays an important role in this side-dependent disease. It is speculated 
that the reduced shear stresses on the non-coronary leaflet of the AV due to the 
lack of coronary flow is responsible for the increased susceptibility to calcification 
of that leaflet (1, 8). Altered shear stresses induce increases in inflammatory 
markers such as VCAM1, ICAM1, TGFβ1 BMP4 in the fibrosa than the 
ventricularis in endothelial and sub-endothelial regions (102). Shear stresses are 
also known to regulate the expression of MicroRNAs (miRNAs) (22, 103, 104). 
MiRNAs are partially complementary to one or more messenger RNA (mRNA) 
molecules, and their main function is to downregulate gene expression in a 
variety of manners, including translational repression, mRNA cleavage, and 
deadenylation.  
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MiRNAs are emerging as potential master regulators as well as biomarkers for 
various cardiovascular diseases such as atherosclerosis, myocardial infarction, 
coronary artery disease, diabetes mellitus, hypertension, aortic stenosis, and 
bicuspid aortic valve (35). Shear dependency of miRNA expression in human AV 
endothelial cells was demonstrated by a recent study which discovered miRNAs 
(miR-187, miR-214, miR-199a-5p, miR-181a, miR-181b, and miR-486-5p) that 
could potentially regulate key cellular processes in AV disease progression (22).  
Fang, et al. showed that miR-10a regulates a pro-inflammatory state in 
endothelium susceptible to atherosclerosis both in vivo in porcine aortic ECs and 
in vitro in human aortic ECs (105).  Moreover, Nigam, et al. has identified 
miRNAs expressed differently in aortic stenosis and aortic insufficiency (miR-26a, 
miR-30b, and miR-195) in vivo using whole, bicuspid valves.  In addition, they 
linked them to calcification-related genes, such as Smad1/3, Runx2, and Bmp2 in 
AV interstitial cells in vitro (106). Recently Yanagawa et al. showed that miR-
141a regulates the BMP-2 pathway as well, and it restores the valvular interstitial 
cell activation induced by TGF-β1 (107). Although there is a growing body of 
evidence suggesting the involvement of miRNAs in side-dependent AV disease, 
the function of these miRNAs remains largely unknown. Understanding the 
function of miRNAs can uncover potential molecular mechanisms underlying AV 
disease. Further, secreted, circulating miRNAs could act as potential biomarkers 
for AV disease. 
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The current standard of care for AV calcification is to replace the calcified valve 
with a prosthetic heart valve via surgery or transcatheter implantation. Lack of 
effective therapeutic treatment of AV calcification is attributed to the scarcity of 
in-depth understanding of AV disease mechanisms. This thesis aims to address 
this issue by specifically focusing on the initial events such as extracellular matrix 
remodeling, inflammation etc., which lead to AV calcification.  
 
The overall hypothesis of this work is “sclerosis, inflammation and 
calcification preferentially occurs in the fibrosa compared to the 










Three aims are designed to test this hypothesis using an ex vivo approach. They 
are:  
1. Identification of side- and shear-dependent miRNAs involved in aortic 
valve sclerosis, inflammation and calcification  
2. Determination of the relationship between a key side- and shear-
dependent miRNA and aortic valve pathogenesis 




2.2 General approach 
Porcine AVs will be used in this study because of their anatomical and structural 
similarity to human AVs and ease of availability.  A validated ex vivo cone and 
plate viscometer will be utilized to study the effects of shear stresses on AV 
tissue (52). These ex vivo studies provide a critical experimental platform to 
determine the role of shear in a side-dependent manner, while excluding 
naturally occurring confounding factors including pressure, strain and circulating 
factors found in blood. In addition, this system enables experimental conditions 
that are difficult to achieve in in vitro systems such as natural ECM and valvular 
interstitial cells.  
 
2.3 Specific aims 




Specific Aim 1: Identification of side- and shear-dependent miRNAs 
involved in aortic valve sclerosis, inflammation and calcification.   
The hypothesis of this specific aim is that oscillatory shear stresses induce 
altered gene expression, preferentially in the fibrosa side, that leads to aortic 
valve sclerosis, inflammation and calcification. 
 
The popularly used idealized shear stress paradigm is where the fibrosa (F) 
experiences oscillatory shear stress and the ventricularis (V) side experiences 
unidirectional pulsatile shear stress (48). Physiological pulsatile unidirectional 
shear stress (LS) of 0-79 dyne/cm2 with peak magnitude 79dyne/cm2 was used 
to investigate the mechanobiology in the ventricularis side. Oscillatory shear 
stress of low magnitude ± 5 dyne/cm2 at 1 Hz (OS) was chosen to study the 
mechanobiology in the fibrosa side (108). Tissues from four conditions will be 
investigated: 1) fibrosa exposed to OS, 2) fibrosa exposed to LS, 3) ventricularis 
exposed to OS, and 4) ventricularis exposed to LS. These four conditions will 
help us understand if the preferential calcification in the fibrosa side is a result of 
its inherent matrix and cellular composition or the shear it experiences (OS or 
LS) or both.  These four shear conditions will be investigated for 48 hours and AV 
tissue morphology (collagen and elastin stain) will be assessed upon completion. 
The valve cell phenotype (Sma) and collagen turnover marker (Col1a1) will also 
be assessed via qPCR. To further understand the role of shear stress in AV 
calcification, freshly isolated porcine AV leaflets will be exposed to OS in the 
presence of osteogenic medium (17). A time course study for 3 and 7 days will 
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be carried out. A calcium assay and stain will be performed to quantify 
calcification, and TUNEL stains will be done to identify apoptosis.  
 
To identify the key miRNAs that are side- and shear-dependent, four miRNAs 
(181a, 181b, 214 and 199a-5p) are chosen. These miRNAs are preferentially 
upregulated in the fibrosa side in porcine AV leaflets in vivo, but nothing is known 
about their role in AV disease progression. Fibrosa and ventricularis will be 
exposed to OS or LS like mentioned earlier. Total RNA will be isolated and qPCR 
analysis will be performed to identify the side- dependency (fibrosa exposed to 
OS vs. ventricularis exposed to LS) and shear-dependency  (fibrosa exposed to 
OS vs. LS, ventricularis exposed to OS vs. LS) of these miRNAs. Freshly 
isolated and or statically cultured AV tissues will be used as controls as needed.  
In silico analysis will be performed using programs such as miRWalk (109), 
miRTarBase (110) to identify potential mRNA targets of the side- and shear-
dependent miRNAs. These mRNA targets will be filtered using existing mRNA 
databases to finalize the targets that are also major transcription regulators and 
related to altered remodeling, apoptosis, inflammation and calcification.  
 
  
Specific Aim 2: Determination of the relationship between a key side- and 
shear-dependent miRNA and AV pathogenesis. 
This specific aim will focus on investigation of the functional role of a key miRNA 
(identified in specific aim 1) in AV sclerosis, inflammation and calcification and 
the hypothesis of this specific aim is that side- and shear-dependent miRNA 
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modulates mRNA with sclerosis, inflammatory and calcific AV disease 
implications.  
 
Selected mRNA targets of this key miRNA, identified in specific aim 1 will be 
experimentally validated with qPCR analysis. AV leaflets will be sheared and the 
mRNA targets that show an inverse relationship with the miRNA expression will 
be chosen.  To further understand the role of this key miRNA, and to validate its 
target mRNAs, the levels of this miRNA will be modulated using a miRNA 
inhibitor. Transfection protocol of miRNA inhibition in statically cultured AV 
tissues will be optimized using fluorescently-tagged, non-targeting anti-miRNA. 
The extent of transfection will be visualized using confocal microscopy and the 
effect of transfection will be assessed using qPCR. This optimized transfection 
protocol and qPCR will then be used to determine dosage of anti-miRNA of the 
key miRNA for its successful inhibition in statically cultured AV tissues. The same 
dosage will then be used to inhibit miRNA in sheared samples as well. After 
successful inhibition of the key miRNA, qPCR will be done to quantify the 
expression of the target mRNA genes that were identified previously. Additional 
functional studies will be performed by assessing the extent of inflammation, 
endothelial-mesenchymal transition, and calcification after knocking down this 
key miRNA. Furthermore, based on the results, a pathway will be proposed to 




Specific Aim 3:  Investigation of the role of pyrophosphate in aortic valve 
calcification.  
The hypothesis of this specific aim is that loss of mineralization inhibitors such as 
pyrophosphate results in ectopic calcification of AV. 
 
An ex vivo model of AV calcification will be developed in order to understand the 
protective role of pyrophosphate in ectopic calcification of the AV. AV leaflets will 
be statically cultured in a serum-free media with different dosages of phosphate 
(0.8, 2.6, 3.2, 3.8 mM) and pyrophosphate inhibitor. A calcium assay and stain 
will be performed to quantify calcification, and TUNEL stains will be done to 
identify apoptosis. Tissue architecture will be assessed with elastin stain. 
Furthermore, experiments will be performed to assess if the AV leaflets actively 
produce PPi. The synthesis of PPi from statically cultured AV leaflets will be 
assessed using a PPi production assay. Enzymatic production of PPi from 
extracellular ATP by ectonucleotide pyrophosphatase/phosphodiesterase 1 
(ENPP1) will also be investigated using autoradiography analysis. Finally, 
therapeutic benefit of supplementing etidronate (a non-hydrolyzable synthetic 




CHAPTER 3   IDENTIFICATION OF SIDE- AND SHEAR-
DEPENDENT MIRNAS INVOLVED IN AORTIC VALVE 
SCLEROSIS, INFLAMMATION AND CALCIFICATION 
 
3.1 Summary 
Aortic valve calcification preferentially occurs in the fibrosa side; it is 
hypothesized that the disturbed shear stress experienced by the fibrosa could 
contribute to this side-dependent disease. Low magnitude oscillatory shear 
stress induced calcification in the fibrosa compared to the ventricularis. This 
preferential calcification in the fibrosa required the existence of both low 
magnitude (5 dyne/cm2) and oscillatory nature (+/-) of the shear stress. Also, low 
magnitude oscillatory shear stress induced changes in the collagen, elastin and 
phenotype of the AV, which were otherwise preserved by the unidirectional 
pulsatile shear stress. To investigate the changes induced by the low oscillatory 
shear stress at the miRNA level, four miRNAs (miR-181a, miR-181b, miR-199a-
5p, and miR-214) were selected based on their involvement in the cellular 
processes related to the AV pathophysiology. Two out of four miRNAs tested, 
miR-214 and miR-181a were highly expressed in the fibrosa exposed to OS 
compared to other shear conditions, and showed side- and shear-dependency in 
the fibrosa but not the ventricularis. Further miR-214 has potential targets that 
play critical roles in early and later stages of AV disease progression and thus 




AV calcification is a side-dependent disease that primarily affects the fibrosa side 
and is typically characterized by inflammation, fractured matrix fibers, thrombus 
formations, and calcific lesions (6). The mechanical environment, matrix 
composition and underlying gene expression that differ on either side of the valve 
are believed to play a role in this side-dependent disease (10).  
AV experiences shear stresses that drastically differ on either side.  It is possible 
that this differing shear stress is responsible for the differential gene transcription 
profiles observed in healthy, porcine AVs (24). Furthermore, shear stresses 
experienced by the fibrosa can also change with developing pathology such as 
high heart rate or low cardiac output (111). Shear stresses when altered, can 
create a pro-inflammatory environment in the fibrosa but not the ventricularis 
(112). Disturbed or non-uniform shear stresses can also cause altered 
extracellular matrix remodeling, which in turn can affect the cell phenotype and 
gene expression (45). Another possible mechanism is via preferential activation 
of the miRNAs and mRNAs involved in remodeling, inflammation, and 
calcification on the fibrosa (22). However, the functional role of miRNAs 
regulated by shear stresses in a side-dependent manner, is not well understood. 
This information can uncover potential molecular mechanisms underlying AV 
disease and can be a crucial step towards developing medical therapies to treat 




The hypothesis of this specific aim is that the side-dependent AV calcification 
occurs due to low, unsteady shear stresses present on the fibrosa, which induces 
differential expression of mechanosensitive miRNAs compared to the 
ventricularis. These mechanosensitive miRNAs in turn regulate their target 
mRNAs that are involved in shear induced AV inflammation and calcification.  
 
3.4 Materials and Methods 
The overall workflow of this specific aim is outlined in Figure 3.1 
 
Figure 3.1 The overall workflow of specific aim-1. 
The effect of idealized and realistic shear stress profiles on AV calcification was 
determined. Based on calcification studies, the effect of idealized shear stress on 
AV ECM, phenotype, and miRNAs was investigated. 
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3.4.1 Aortic valve tissue harvest for this ex vivo study 
Hearts were obtained from healthy, female, non-pregnant pigs (aged 6 to 12 
months) immediately after slaughter from a local abattoir (Holifield Farms, 
Covington, GA). The AV leaflets were immediately excised and thoroughly rinsed 
in sterile nuclease-free Dulbecco’s phosphate buffered solution (dPBS; Sigma-
Aldrich, MO) at 4 oC. Valves were placed in nuclease-free dPBS on ice and 
transported back to the laboratory.  Upon arrival in the laboratory, dissected AVs 
were transferred to clean, sterile dPBS at 4 oC under the sterile laminar flow 
hood and processed accordingly.  
 
3.4.2 Shear stress and aortic valve calcification 
To determine the role of shear stress in inducing AV calcification, an ex vivo 
shear stress bioreactor was used. To investigate the mechanobiological 
implications of shear stress alterations, currently two shear stress paradigms are 
available in the literature: idealized (computational) (48) and realistic 
(experimental) (113). It is important to use the shear stress profile that can 
induce changes at macroscopic (changes of ECM) as well as microscopic 
(calcification, mRNAs, miRNAs) levels within a reasonable time frame ex vivo.  
Both types of shear stress profiles were tested in this specific aim. The profile 
that induced preferential calcification in the fibrosa was chosen as the shear 
stress model for further investigation. The shear stress bioreactor and shear 
stress conditions are described in detail in sections3.4.2.1, 3.4.2.2, and 3.4.2.3, 
followed by the details of the experimental set up in section 3.4.2.4. Calcification 
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assays were carried out as described in the sections 3.4.2.5, 3.4.2.6 and 3.4.2.7. 
AV cell apoptosis was assessed using TUNEL stain as detailed in the section 
3.4.2.8. An attempt was made to understand the contribution of shear stress to 
AV calcification, compared to other mechanical stimuli (stretch and pressure). 
Complete details of the calcification study carried out using the ex vivo stretch 
and pressure bioreactor is not described in this specific aim and is compiled as a 
separate appendix A.23. 
 
3.4.2.1 Ex vivo cone and plate shear stress bioreactor  
An ex vivo shear stress bioreactor was used to study the effect of shear stresses 
on the AV leaflets in a side-dependent manner. This bioreactor has been 
designed and extensively validated to expose AV tissues to well-defined shear 
stress profiles (52).  It is a modification of the cone and plate viscometer. Briefly, 
as shown in Figure 3.2, the bioreactor consists of a dish with a plate at the 
bottom, where the valve leaflet tissues are held. In addition, a cone angled at 
0.5o is placed at 200 µm above the plate. A programmable servomotor is coupled 
to this cone and it rotates the cone depending on the specific shear stress 
program. The device can hold 9 tissue samples of diameter 7 mm. The motors 
were programmed by the Motion Planner© software (version 4.3.2.0, Parker 
Hannifin Corp, CA). A perfusion system consisting of a reservoir of media, 
powered by a slow moving peristaltic pump (Model SP202.100, APT Instruments, 





Figure 3.2 Ex vivo cone and plate shear system. 
A) The cone and plate bioreactor setup. It consists of a rotating cone (via motor) 
on top of a stationary plate (with AV samples). The perfusion system maintains 
constant flow of media in the cone and plate set up. The whole set up is held in a 
bioreactor table and can be placed in an incubator. B) Schematic of the cone and 
plate only. The plate can fit 9 AV samples, all placed at a radial distance of 20 
mm from the center of the cone. C) Samples extracted from AV leaflet tissue. D) 
Plate with 9 samples and the highlighted portion shows agarose filled into the 
well that holds tissue samples. 
 
The rotating cone rotates the media between the cone and plate and imparts the 
shear stress to the surface of the AV tissues in the circumferential direction. 
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Shear stress on the plate is calculated by the formula, , where 
is the wall shear stress, ρ and ν are the density and the viscosity of the fluid, 
ω is the angular velocity of the cone, and r is the radial coordinate of shear stress 
calculation on the plate, h is the gap between the apex of the cone and the plate, 
and α is the cone taper angle, which is 0.5o. This equation for calculating shear 
stress experienced by the plate has been validated by computational fluid 
dynamics simulations of the cone and plate bioreactor, as well as by Laser 
Doppler Velocimetry measurements of the apparatus (52). Further, the actual 
rotational velocity measured by the tachometer on the motor was shown to match 
the desired velocity programmed into the controller.  The cone was coupled to a 
servomotor (Model SM232AE-NPSN Brushless Servo Motor, Parker Hannifin 
Corp., Rohnert Park, CA), which was controlled by a servo drive (Model GV6K 
Gemini Servo, Parker Hannifin Corp., Rohnert Park, CA).  Additional details of 
this bioreactor are explained in-depth in appendices A.1 and A.2. 
 
3.4.2.2 Idealized shear stress profile 
The most commonly used idealized shear stress paradigm (Figure 3.3) is the one 
where the fibrosa (F) experiences oscillatory shear stress and the ventricularis 
(V) experiences unidirectional pulsatile shear stress (48, 102, 112).  As per this 
paradigm, the ventricularis side experiences pulsatile unidirectional shear stress 




Figure 3.3 Idealized shear stress profile.  
A) Fibrosa experiences an oscillatory shear stress (OS). B) Ventricularis 
experiences a pulsatile shear stress (LS). 
 
A recent study showed that maximum calcification in the fibrosa was observed 
when exposed to ± 5 dyne/cm2 (low magnitude) compared to ±10 dyne/cm2 
(physiological) and ± 25 dyne/cm2 (high magnitude), within 3 days of culture in 
osteogenic media (114). Thus, oscillatory shear stress of low magnitude ± 5 
dyne/cm2 at 1 Hz (OS) was chosen to study the mechanobiology in the fibrosa. 
Samples were exposed to a steady shear stress of 5 dyne/cm2 to test if the 
calcification induced in the fibrosa was due to the oscillatory nature (+/-) or the 
low magnitude (5 dyne/cm2) of the oscillatory shear stress. Then to determine if 
the calcification induced by OS was side-dependent, the ventricularis side was 
also exposed to OS. Although the ventricularis side never sees the low 
magnitude shear stress, this particular experiment will help us understand how 
the endothelial cells on the ventricularis side will respond to this calcification 
inducing OS. As the oscillatory shear stress did not induce calcification in the 
ventricularis side, this control experiment was not done on the ventricularis side. 
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Physiologically, ventricularis experiences LS and does not calcify as much as the 
fibrosa side, the LS shear was not tested in this calcification model, but was 
tested in the other experiments.  
 
To investigate AV ECM, phenotype, and expression of miRNAs, tissues from four 
conditions were used: 1) fibrosa exposed to OS, 2) fibrosa exposed to LS, 3) 
ventricularis exposed to OS, and 4) ventricularis exposed to LS. Fibrosa exposed 
to OS and ventricularis exposed to LS are physiologically relevant as the sides’ 
fibrosa/ventricularis are exposed to their respective shear stresses. Thus the 
fibrosa exposed to OS vs. ventricularis exposed to LS comparison indicates side-
dependency. Fibrosa exposed to LS and ventricularis exposed to OS are referred 
to as altered conditions as the physiological shear stress profiles are switched 
between the two sides. Fibrosa exposed to OS vs. LS and ventricularis exposed 
to OS vs. LS comparisons were used to compare the shear dependency of the 
fibrosa and the ventricularis, respectively. Thus, these four shear conditions were 
used to understand if the preferential calcification in the fibrosa is a result of its 
inherent extracellular matrix and cellular composition, or the shear it experiences 
(OS or LS), or both.  
 
3.4.2.3 Realistic shear stress profile 
Recently, dynamic shear stress data obtained from Laser Doppler Velocimetry 
measurements on AV under normal and altered hemodynamics (111, 113) 
showed that shear stresses experienced by fibrosa changes with the 
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hemodynamics. According to this study, as shown in the Figure 3.4A, the fibrosa 
experiences a peak shear stress of about 15 dyne/cm2 under physiological 
hemodynamics (4.7 L/min, 70 beats/min). Under altered hemodynamics, the 
fibrosa experiences a peak shear stress of 6.4 dyne/cm2 (low cardiac output, CO: 
3 L/min, 70 beats/min) and 78 dyne/cm2 (high heart rate, HR: 90 beats/min, 4.9 
L/min). The ventricularis side, as shown in the Figure 3.4B, experiences a peak 
shear stress of 64 dyne/cm2 and beyond this peak, the shear stress decreases 
rapidly and experiences a peak negative of -40 dyne/cm2. One of the most 
striking features of this realistic shear stress profile is that the shear stress on the 
fibrosa side is unidirectional and the ventricularis side is oscillatory unlike the 
idealized shear stress profile described in section 3.4.2.2. 
 
 
Figure 3.4 Realistic shear stress profile.  
A) Shear stress experienced by fibrosa at physiological and altered 




In this study, fibrosa was exposed to the shear stresses at physiological and 
altered hemodynamic conditions. High HR and low CO are known to affect 
several stages of the cardiovascular disease continuum such as endothelial 
dysfunction, plaque rupture and myocardial infarction (115-117). Calcification 
experiments were carried out for 7 days using osteogenic media. Freshly isolated 
AV tissues were used as controls. Since the ventricularis side did not show 
calcification compared to the fibrosa side in our idealized shear stress study, the 
ventricularis side was not tested as part of this preliminary study. However, the 
future studies should include the calcification experiments on the ventricularis 
side as well.  
 
3.4.2.4 Shear stress experimental setup 
In the laboratory, circular 7-mm radius samples were cut aseptically from the 
basal region of each leaflet under the sterile laminar flow hood. As detailed by 
Sucosky et al (52), each well of the shear stress bioreactor was filled with 
approximately 750 µL of 1.2% agarose (Agarose, Thermo Fisher Scientific, NJ), 
which acted as a tissue holder, and the circularly cut tissue samples were placed 
on top of the agarose bed (Figure 3.2C, D). Since the thickness of the AV tissue 
slightly varies from pig to pig, the height of this agarose bed must be adjusted 
based on the thickness of the tissue. This is to ensure that the tissue samples 
are flush mounted, i.e., are placed at the same level as the plate that holds all the 
tissues in place. To verify this, a micro-cover-slide can be slided from the center 
of the plate to the top of the tissue. If the micro-cover-slide does not move 
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smoothly over the tissue (which happens when the tissues are not flush 
mounted), the height of the agarose bed must be re-adjusted. These steps are 
crucial because if the level of the tissue increases relative to the plate (e.g. by 0.1 
mm), it decreases the height between the cone and the plate. This variation of 
the tissue height significantly increases the shear stress experienced by the 
tissues (1.36 times). This calculation is based on the fact that there are no 
secondary flows in this cone and plate system and that the velocity profile is 
linear as detailed by Sucosky et al (52). Additional details are also available in 
Appendix: Cone and Plate manual A.2 
 
Either the fibrosa or the ventricularis side was exposed to the shear stress during 
an experiment. Statically cultured tissues and/or freshly isolated AV leaflets were 
used as a control. To investigate the changes in gene expression (miRNA and 
mRNA) and valve histology, leaflets were cultured for 48 h using regular DMEM 
media (118).  We chose a 48 h culture duration, as it is well known that this 
culture duration is sufficient to induce changes in gene expression and makes it 
possible to investigate the early onset of AV disease (102).   
 
For calcification-related studies, leaflets were sheared for a time course of 3 and 
7 days to determine the time at which detectable calcification occurs. To 
accelerate the calcification process that occurs over decades in vivo, an 
osteogenic media was used. This osteogenic media contained normal DMEM 
supplemented with 1 mmol/L glycerophosphate, 10µmol/L dexamethasone, 3.8 
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mmol/L PO43-, and 1 ng/ml TGF-β1. This media has been previously validated to 
accelerate the calcification of the porcine AV leaflets in the presence of cyclic 
stretch (17). 
 
Media (osteogenic) was changed every 48 h to replenish the nutrients. The entire 
setup was placed in a 5% CO2 incubator at 37 °C.   Post-culture, the portion of 
the tissue unexposed to shear stress was carefully excised (without touching the 
exposed tissue) using sterile tools under the sterile laminar flow hood. Tissues 
were briefly rinsed in multiple changes of sterile nuclease-free dPBS maintained 
at 4 oC until the media was completely removed.  
 
To prepare paraffin sections, the tissues were fixed in 10% neutral buffered 
formalin (Fisher Scientific, PA) for at least 24 h, saturated in 70% ethanol (VWR, 
GA), processed in ascending grades of ethanol, embedded in paraffin, and cut 
into 5 µm sections. The blocks and the tissue sections were stored at room 
temperature. The cryopreserved tissue blocks were prepared by embedding the 
tissue in optimal cutting temperature (OCT) medium (Electron Microscopy 
Sciences, PA) and freezing it using liquid nitrogen. Sections with thicknesses of 5 
to 7 µm were cut. The blocks and tissue sections were stored at -80 oC. 
 
3.4.2.5 Calcium arsenazo assay 
Total calcium content in tissue samples was quantified using the calcium 
arsenazo assay. This was used as a marker to represent calcification of the 
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tissue. At a neutral pH, the Ca2+ forms with arsenazo III a purple-colored 
complex, the color intensity of which is directly proportional to the concentration 
of calcium in the sample. Tissue samples from calcification experiments were 
pulverized by mortar and pestle in liquid nitrogen, and collected in pre-weighed 
vials. After sample collection, the vials were re-weighed before and after drying 
the samples overnight at 37 oC. The dry weights of the tissue were then 
computed. Subsequently, the ground samples were incubated in 1 M acetic acid 
at 4 oC for 24 h, to solubilize calcium. The samples were then centrifuged at 
15,000 rpm for 9 min, and the supernatant was collected. The supernatant as 
well as calcium standards were assayed for calcium content by using a calcium 
specific Arsenazo dye reagent (Fisher-Scientific, MA): 25 µL of the supernatant 
or the calcium standard was mixed with 300 µL of Arsenazo solution in a 96 well 
plate.  
 
The absorbance of the various samples at a wavelength of 650 nm was 
measured through spectrophotometry, using a 96 well plate reader (BioTek, VT). 
The absorption calibration curve was established with the calcium standard 
spectrophotometry readings, and was thereafter applied to readings from the 
samples. The amount of total calcium per dry weight of sample tissue was 
calculated. Total calcium content induced by each shear condition was 
normalized to the mean of the fresh AV leaflets and expressed as relative 
calcium content.  
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3.4.2.6 Von Kossa mineralization stain 
Von Kossa staining was performed to visualize tissue mineralization. In this 
method, cryopreserved tissue sections were treated with a silver nitrate solution 
and the silver is deposited by replacing the calcium reduced by ultraviolet light, 
thereby visualized as metallic silver. Frozen sections were allowed to warm to 
room temperature, and were hydrated in PBS for 2 min. They slides were then 
incubated in 1% silver nitrate solution in a clear glass coplin jar placed under 
ultraviolet light for 2 h. After washing in several changes of distilled water, excess 
silver nitrate was removed by incubating in 5% sodium thiosulfate for 5 min. The 
slides were rinsed in distilled water, dehydrated through graded alcohol and 
cleared in xylene before being mounted in a resinous medium and coverslipped. 
Calcium deposits appeared black when viewed under normal white light. 
 
3.4.2.7 Alizarin Red stain 
Alizarin Red was used to stain for tissue calcification. Alizarin Red S, an 
anthraquinone derivative, may be used to identify calcium in tissue sections. The 
reaction is not strictly specific for calcium, since magnesium, manganese, 
barium, strontium, and iron may interfere, but these elements usually do not 
occur in sufficient concentration to interfere with the staining. Calcium forms an 
Alizarin Red S-calcium complex in a chelation process, and the end product is 
birefringent. Deparaffinized slides were hydrated and stained in 2% Alizarin Red 
solution (pH: 4.1 - 4.3) for 5 min while checking for staining microscopically. The 
slides were then dehydrated in acetone- xylene, cleared in xylene before being 
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mounted in a resinous medium and coverslipped. Calcium deposits appeared 
orange-red when viewed under normal white light. Slides were stored in a dry 
place at room temperature.   
 
3.4.2.8 Aortic valve apoptosis stain 
A cell apoptosis stain was performed to assess the cell death and viability of 
samples from calcification and miR-214 inhibition studies. This staining was done 
using the In Situ Cell Death Detection Kit; TMR red, TUNEL kit (Roche 
Diagnostics, Germany). Cryopreserved tissue sections were fixed with 4% 
paraformaldehyde (Sigma-Aldrich, MO) in dPBS (pH 7.4) for 20 min, rinsed with 
dPBS for 30 min, permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, MO) in 
dPBS (2 min at 4 oC), and rinsed twice with dPBS. Staining was performed by 
incubating tissue sections for 1 h at 37 °C in a humidified chamber in the dark in 
50 µL of TUNEL reaction mixture followed by counterstaining with DAPI for 5 
min. A positive control was prepared by incubating the fixed and permeabilized 
tissue section with DNAse-I solution (3-3000U/ml RNAse free DNAse-I (Qiagen, 
CA) in 50mM TrisCl (Sigma-Aldrich, MO), pH 7.5, 1mg/mL BSA (Fisher Scientific, 
PA) for 10 min prior to labeling with TUNEL reaction mixture. A negative control 
was prepared by incubating fixed and permeabilized tissue sections in 50 µl of 
TUNEL label solution (without terminal transferase). Apoptotic cells appeared red 
and nuclei appeared blue under fluorescence microscopy. 
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3.4.3 Shear stress and aortic valve extracellular matrix 
Alterations in the extracellular matrix can activate valvular interstitial cells (119) 
and thus, affect the valve cell phenotype. Further, stress induced changes in the 
extracellular matrix can dictate various signaling pathways that regulate the 
miRNA expression (120, 121). In this specific aim, the shear stress induced 
changes to the AV ECM was investigated to understand if these changes are 
possibly related to the shear induced expression of miRNA(s) (investigated in the 
later sections).  Changes in the AV ECM were assessed using the Verhoeff-Van 
Gieson elastin stain and picrosirius red collagen stain and is described in detail in 
sections 3.4.3.1, 3.4.3.2, and 3.4.3.3. The activation of AV interstitial cells was 
assessed using smooth muscle α-actin, Sma, as there is no reliable marker to 
directly assess the changes in its native (quiescent) phenotype. An ECM related 
gene (collagen type-I, Col1a1) was also assessed at the mRNA level. These two 
markers were assessed using methods listed in sections 3.4.3.4 through 3.4.3.7.  
 
3.4.3.1 Verhoeff-Van Gieson elastin stain 
To visualize the elastin fibers as well as the assess the overall thickness of the 
fibrosa, spongiosa and ventricularis layers of the AV ECM, a Verhoeff-Van 
Gieson elastin stain was performed.  AV leaflet samples stained with this elastin 
stain distinctly show the tri-layered components of the AV ECM: fibrosa, 
spongiosa and ventricularis layers.  Elastin fibers stain blue-black to black, nuclei 
stains blue to black, collagen stains red, and muscle and other matrix 
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components stain yellow. ACCUSTAIN Elastic kit (Sigma-Aldrich, MO) was used 
according to the manufacturer’s directions.  
 
The thickness of each of these layers was measured using ImageJ software (83). 
Briefly, fibrosa thickness was measured from the edge of the tissue to where the 
collagen ends. The thickness of ventricularis was measured from the start of the 
black elastin lines to the edge of the tissue. The remaining thickness of the tissue 
was measured and reported as the thickness of spongiosa. Each layer was 
measured at the thickest and thinnest in each image and was averaged. For 
consistency, the data was normalized with respect to itself by dividing the 
average percent thickness of each layer by the sum of the average percent 
thicknesses of all three layers so that the percent thicknesses add up to 1.  
 
3.4.3.2 Picrosirius Red collagen stain 
Picrosirius red staining was performed to examine collagen fiber structure and 
morphology. In bright-field microscopy collagen is red on a pale yellow 
background. Nuclei, if stained, are ideally black but may often be grey or brown. 
The long incubation time in picrosirius red solution causes appreciable destaining 
of the nuclei. When examined through a circularly polarized filter the larger 
collagen fibers are bright yellow or orange, and the thinner ones, including 
reticular fibers, are green. This birefringence is highly specific for collagen (122). 
A few materials, including Type IV collagen in basement membranes, 
keratohyaline granules and some types of mucus, are stained red but are not 
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birefringent. Deparaffinized slides were stained in picrosirius red solution 
(saturated picric acid solution, ready to use, Sigma-Aldrich, MO) for one hour. 
The slides were then washed in 0.5% acidified water (5 mL glacial acetic acid in 
995 mL distilled water), three changes of 100% ethanol, and xylene before being 
mounted in a resinous medium and coverslipped.  
 
The relative proportion of the collagen fibers in the sheared AV leaflets was 
quantified using a custom Matlab (The Mathworks, Natick, MA) code (18). 
Picrosirius red images were first imported into Matlab R2009b and converted into 
their hue, saturation and value components. Only the hue components were 
retained, and a histogram of hue frequency was obtained from the 8-bit hue 
images that contained 256 possible colors. The colors were defined as follows: 
red 2 to 9 and 230 to 256; orange 10 to 38; yellow 39 to 51; and green 52 to 128 
(123). All other hue values corresponded to interstitial space and were confirmed 
by visual inspection. The number of pixels within each hue range were 
determined and expressed as a percentage of the total number of collagen pixels 
(sum of all pixels) and plotted. Since the red and orange correspond to the 
mature collagen, their percentages were combined for analysis in this study.  
 
3.4.3.3 Imaging 
A Zeiss Axioscope A1 (Germany) was used for brightfield and fluorescence 
imaging. Circular polarizer, analyzer and a rotating stage were used with this 
microscope to image the tissue sections stained with picrosirius red.  
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3.4.3.4 RNA isolation 
From 48 h shear experiments, total RNA was isolated from whole tissue (both 
endothelial and interstitial tissue) using the miRNeasy kit (Qiagen, CA). It was not 
feasible to isolate endothelial-enriched RNA from the sheared AV samples and it 
was more practical to isolate total RNA from entire tissue (interstitial and 
endothelial cells). To achieve sufficient RNA yield for qPCR, three sheared 
tissues were pooled per isolation.  In the case of static culture, it was sufficient to 
pool just two tissues. 
 
Post experiment, media from the tissues was completely removed by washing 
the tissues with sterile nuclease-free dPBS, as mentioned earlier. The tissues 
were then incubated in 700 µL of Qiazol for about 5 min at room temperature. 
The phenol-chloroform extraction was done and subsequent purification steps 
were performed as per the manufacturer’s protocol. Alternatively, the tissue can 
be pulverized, homogenized as opposed to direct incubation with the Qiazol. The 
concentration and the purity of the samples were measured using the Take 3 
plate attachment of Synergy H4 Hybrid Reader (Biotek, VT). Samples showed 
260/280 and 260/320 ratios in the range 1.2 to 1.8 and had concentrations 




3.4.3.5 Preparation of mRNA and miRNA cDNA 
To prepare cDNA for mRNA, High-Capacity cDNA Reverse Transcription kit with 
RNAse inhibitor kit (Life Technologies, NY) was used. To prepare cDNA for 
miRNA, miScript II RT kit (Qiagen, CA) was used. A Veriti® 96-Well Thermal 
Cycler (Life Technologies, NY) was used for this purpose.   
 
3.4.3.6 Real-time qPCR 
Real-time qPCR was used to test the AV cell phenotype (Sma), collagen type-I 
(Col1a1), and shear- and side-dependency of the four shortlisted miRNAs. The 
primers for Sma and Col1a1 were designed and ordered from Integrated DNA 
Technologies (IA). The primer sequence is listed in Table 3-1. The primers for 
miRNAs were purchased from Qiagen (CA).  
 
 
Table 3-1 Porcine specific primers to test AV cell phenotype changes. 
Gene Forward Primer Reverse Primer 
Col1a1 5-GGCCAAGAAGAAGACATCCCA-3 5-ACAACACATTGCCGTTGTCG-3 
Sma 5-GGTGGGAATGGGACAAAAAGAC-3  5-TGGTGATGATGCCGTGTTCTATT-3 
18S 5-CCCCAACTTCTTAGAGGGACAAG-3 5-AGGGCATCACAGACCTGTTATTG-3 
 
 
The qPCR analysis of miRNAs in sheared AV samples was carried out with 
miScript SYBR Green PCR kit (Qiagen, CA). RNU6B included in this PCR kit 
was used as the endogenous control. The expression of Sma and Col1a1 was 
also assessed via qPCR using the VeriQuest Fast SYBR Green (Affymetrix, CA). 
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StepOnePlusTM Real-Time PCR system (Life Technologies, NY) was used to run 
the qPCR analysis.  
 
3.4.3.7 Analysis of qPCR data 
A sample size of at least 3 to a maximum of 12 was used for data analysis. As 
mentioned earlier, each sample infact represents 2 or 3 tissue samples (due 
pooling of tissues). To analyze qPCR data for all other experiments, ΔCT method 
was used and fold changes (2^(-ΔCT)) were calculated. When comparing two 
groups, e.g. fibrosa exposed to OS vs. LS, the fold changes were normalized to 
the mean of the second group (here fibrosa exposed to LS) (which was set as 
the baseline) (14).  
 
3.4.4 Shear stress and expression of miRNAs in aortic valve 
As previously discussed, shear stress can influence the expression of miRNAs. 
The miRNAs chosen for this study are discussed in detail in 3.4.4.1 and their 
expression was assessed using real-time qPCR, as detailed in the sections 
3.4.3.4 through 3.4.3.7. To identify and investigate the function of key miRNAs 
involved in AV sclerosis, inflammation and calcification, their potential targets 
must be determined. For this purpose, a systems biological analysis was carried 
out (3.4.4.2). 
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3.4.4.1 Selection of MiRNAs Involved in Sclerosis, Inflammation and 
Calcification Pathways 
Side-specific miRNAs identified in sheared human AV ECs (in vitro) (22) and 
freshly isolated porcine AVs (in vivo) (124) were selected for further investigation 
in this specific aim. Since there are several miRNAs that are potentially involved 
in AV inflammation and calcification, the miRNAs investigated in this specific aim 
were prioritized based on the following criteria: 1) have potential mRNA targets 
that are expressed in early stages of calcific AV disease progression; 2) regulate 
fundamental cellular functions such as cell proliferation, adhesion, cycle, growth, 
migration, death, inflammation etc; and 3) scientific evidence of the function of 
selected miRNAs in AV or cardiovascular system.  The miRNAs that met all of 
the above criteria were miR-181 a/b, miR-199a, and miR-214 and thus were 
chosen for further investigation in this specific aim. These four miRNAs are also 




Figure 3.5 Categorization of miRNAs.  
The miRNAs were sorted based on their role in the cellular processes that are 
related to AV disease. 
 
 
Sufficient evidence exists in the current literature that links these four miRNAs to 
cellular processes that are involved in a variety of diseases such as cancer, 
cardiac injury, renal fibrosis, coronary artery disease. Based on their function, 
these miRNAs were categorized and shown in Figure 3.5. Briefly, miR-181a is 
involved in lipid metabolism (125), epithelial-to-mesenchymal transformation 
(126), angiogenesis (127), apoptosis (128), and inflammation (129) and 
calcification (osteopontin) (130). Moreover, miR-181b contributes to inflammation 
(131), growth changes and apoptosis (132) as well. MiR-199a plays a role in 
growth (133), proliferation (134), cell cycle and apoptosis (135), migration (133, 
134), inflammation(136), and calcification (BMP2/SMAD1) (137). MiR-214 plays 
a role in proliferation (138, 139), cell death (136, 140, 141), cell cycle (138), 
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migration (140, 142), and inflammation (136, 139, 141). The low circulating level 
of miR-214 is also a biomarker for coronary artery disease (15).  
 
3.4.4.2 Bioinformatics analysis to identify potential targets of side- and shear- 
dependent miRNA 
It is known that miRNAs control gene expression by inversely regulating the 
expression of mRNA genes. This logic was applied to identify the potential 
mRNA targets of side- and shear- dependent miRNA(s); an in-depth 
bioinformatics analysis was carried out as outlined in the Figure 3.6. Most of the 
sequence-based mRNA target databases are available only for 3 species: 
human, mouse and rat. These two miRNAs, miR-181a, and miR-214 are 
homologous with human miR-181a and miR-214-3p. The experimentally 
validated mRNA target list of human miR-214-3p, miR-181a was obtained from 




Figure 3.6 Bioinformatics analysis and target filtration scheme.  
The targets identified using two programs (MiRWalk and MiRTarBase) were 
filtered using two databases. The filtered targets identified using this scheme 
were 26 for miR-181a and 16 for miR-214. 
 
 
To filter the extensive target list, two additional data sets were used. The first one 
was the validated side-dependent genes from mRNA microarray data of fresh 
porcine AV endothelial cells published by Simmons et al (24). From this data set, 
the list of mRNA genes (299) that had significantly lower expression in the fibrosa 
compared to the ventricularis only was considered. The second data set was the 
mRNA genes list of sheared human AV ECs from our previous experimental data 
(22). Since miR-214 and miR-181a are upregulated in fibrosa exposed to OS vs. 
LS and compared to ventricularis exposed to LS, only mRNA genes that were 
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downregulated in the corresponding data sets were chosen, also shown in the 
Figure 3.6. The number of downregulated genes in these two experimental data 
sets was 302 and 630 respectively with a false discovery rate of < 5%. 
Specifically, the mRNA targets filtered and chosen for further investigation are 
known to play a role in processes such as cell proliferation, apoptosis, 
inflammation, endothelial dysfunction, development, and endothelial-to-
mesenchymal transition that lead to AV calcification. 
 
3.4.5 Statistical analysis 
Data was expressed as mean + standard error. All the statistical analyses were 
done using SPSS Statistics for Mac (Version 20.0, IBM Corp, NY). The normality 
of all the data was tested using the Anderson-Darling method. Student t-test was 
used when only two groups were being compared. Two-way ANOVA was used 
for analyzing independent sample sets with Tukey’s post-hoc test for 
comparisons between multiple groups. If the data was not normally distributed, 
Mann-Whitney and Friedman tests were used in place of the student t-tests and 
ANOVA, respectively. The groups were considered to be significantly different or 
show trends if the p-value was less than or equal to 0.05 and 0.10, respectively. 
 
3.5 Results 
Raw data for all the results are included in Appendix A.18. 
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3.5.1 Effect of idealized shear stresses on AV calcification 
As shown in the Figure 3.7, calcification in the fibrosa was significantly higher 
(p<0.05) when exposed to OS but not steady shear stress of the same 
magnitude. Also, statically incubated tissues did not calcify compared to the fresh 
tissues. This shows that both the low magnitude (5 dyne/cm2) and oscillatory 
nature (+/-) of the shear stress or flow disturbance is needed to trigger 
calcification.  
 
Further, this response proved to be side-dependent, as calcification was 
observed only when the fibrosa was exposed to OS.  This side-dependent 
calcification continued to increase after 7d (p<0.05)  (Figure 3.8A). Consistent 
with this quantitative result, the Von Kossa mineralization stain also showed 
localization of black calcium nodules in the fibrosa side exposed to OS but not 
ventricularis (Figure 3.8B).  
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Figure 3.7 Calcification of AV induced by OS and steady shear.  
A) No calcium levels were observed in fibrosa exposed to steady shear 
compared to OS. n=8, *p<0.05. B) Consistent with the quantitative result, fibrosa 
exposed to a steady shear of 5 dyne/cm2 showed no calcification suggesting that 
calcification is dependent on the oscillatory nature of the shear stress. Calcium 
nodules appeared black (arrows). F: fibrosa, V: ventricularis. n=6. Representative 




   
Figure 3.8 Time course of side-dependent AV calcification induced by OS. 
A) The amount of calcium induced in the fibrosa when exposed to OS is 
significantly higher than that in ventricularis and continued to increase after 7 
days. n=8-10, *p<0.05. B) Consistent with the quantitative result, calcium nodules 
were observed in fibrosa when exposed to OS but not ventricularis, indicating 
that the calcification induced by OS is side-specific. Calcium nodules appeared 
black (arrows). F: fibrosa, V: ventricularis. n=6. Representative scale bar is 
shown only on fresh sample. 
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3.5.2 Effect of realistic shear stresses on AV calcification 
Tissues exposed to shear stress under low CO had significantly higher calcium 
compared to those exposed to the physiological condition (p<0.05), but not 
significantly different compared to the fresh control (Figure 3.9). However, 
qualitatively, calcium nodules were not observed within the tissue (as evident by 
the calcium stains). The fresh samples in this experiment had calcium levels 
higher than that observed in the previous results. This could be due to the 




Figure 3.9 Realistic shear stress and AV calcification.  
A) Calcium content in the fresh tissue tended to be higher than tissues exposed 
to physiological and high HR conditions (n=8, #p<0.1), but not the low CO 
condition. Calcium content in tissue exposed to the low CO condition was 
significantly higher compared to that of the physiological condition. n=8, *p<0.05. 
B) and C) Von Kossa and Alizarin Red stain confirmed that there was no 
calcification in tissues exposed to realistic shear stresses. Fresh AV samples 
were included as controls. F: fibrosa, V: ventricularis. n=4.  Representative scale 
bar is shown only on fresh sample. 
 
3.5.3 Calcification induced by shear stress compared to stretch and pressure 
The extent of AV calcium induced by the low magnitude oscillatory shear stress 
was compared to that of elevated (15%) cyclic stretch or hypertensive (160/100 
mm Hg) pressure (Figure 3.10).  The calcium induced by the hypertensive 
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pressure or elevated stretch was significantly higher than that induced by low 
magnitude shear stress (p<0.05). The calcium induced by the hypertensive 
pressure, however was higher than that of elevated stretch (p<0.1), but did not 
reach statistical significance of 0.05. Significantly higher amount of calcium was 
observed when the AV leaflets were subjected to combined elevated stretch and 




Figure 3.10 AV calcification induced by stretch, pressure and shear stress.  
Calcium levels induced by 15% (elevated) stretch or 160/100 mmHg 
(hypertensive) pressure or combined stretch and pressure was significantly 
higher than that induced by the low oscillatory shear stress. n=4-8, *p<0.05. The 
calcification induced by 160/100 mmHg (hypertensive) pressure tended (#p<0.1) 
to be higher than 15% (elevated) stretch alone. Shear experiments were run for 7 




3.5.4 Cell apoptosis of AV exposed to idealized shear stress  
Apoptosis of cells in tissues cultured in osteogenic media was investigated 
(Figure 3.11). After 3 days in culture, fibrosa or ventricularis exposed to OS 
showed no apoptotic cells. Increased apoptotic cells were observed in fibrosa 
exposed to OS after 7 days of culture.  
 
Figure 3.11 Shear stress and AV apoptosis. 
 Idealized shear stress and apoptosis Positive control for TUNEL showed 
excessive apoptosis (red). Negative control for TUNEL stain showed no signs of 
apoptosis. No apoptotic cells were observed when fibrosa or ventricularis was 
exposed to OS for 3 days in osteogenic media. However, after 7 days, tissues in 
fibrosa when exposed to OS had quite a few apoptotic cells (arrows point to red). 
Fresh sample in included as a control and show no signs of apoptosis. F: fibrosa, 




3.5.5 Effect of idealized shear stress on AV extracellular matrix structure  
The Verhoeff-Van Gieson elastin stain shows that the tri-layered composition of 
the AV extracellular matrix was overall preserved between all culture conditions 
(Figure 3.12A and B). Compared to the fresh AV leaflets, the collagen fiber 
bundles appeared more loosely packed when fibrosa was exposed to OS or LS. 
These collagen bundles were also aligned along the length of the tissue, when 
the fibrosa was exposed to LS.  Quantitatively, the thickness of fibrosa layer 
exposed to OS increased (p=0.0571) compared to that of fresh or statically 
cultured tissue by 15.4% and 17.8% respectively. LS did not change the 
thickness of the fibrosa.  
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Figure 3.12 Shear stress and AV ECM.  
A) Fibrosa or ventricularis side of the AV exposed to OS and LS displayed 
histological changes in collagen and elastin fiber distribution compared to fresh 
and statically cultured tissue samples. The higher magnification images highlight 
these changes. B) Quantification of each of the three layers of AV ECM in 
response to OS and LS. Thickness of the fibrosa increased significantly in fibrosa 
exposed to OS compared to the fresh or static (*p=0.0571), while the thickness of 
ventricularis and spongiosa remained unaltered. (n=4). Representative scale bar 
is shown only on fresh samples. 
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The elastin fibers were aligned along the length of the valve tissue and the 
alignment was preserved when the ventricularis side was exposed to LS. Elastin 
fibers appeared fragmented, and spaced out, when the ventricularis was 
exposed to OS. The thickness of the ventricularis layer, however, remained 
unaffected when exposed to OS or LS, compared to the fresh and statically 
cultured tissue. The spongiosa was preserved in all shear conditions both 
qualitatively and quantitatively. Although, the thickness of all three layers was 
preserved in static culture compared to the fresh tissues, the architecture of the 
layers however, differed slightly.  
 
Picrosirius red collagen stain showed that the percentages of different collagen 
fibers varied in response to different shear stresses (Figure 3.13A and B). As 
indicated earlier, the red/orange, yellow and green fibers represent mature/thick, 
young and nascent collagen fibers respectively. No significant differences were 
observed between the static culture and fresh AV leaflets. Fibrosa exposed to 
OS showed most changes in the maturity of the collagen fibers. Specifically, 
young collagen fiber content increased in fibrosa exposed to OS compared to 
ventricularis exposed to OS (1.95 fold, #p=0.09) and statically cultured AVs (1.04 
fold, *p=0.041). The mature and nascent collagen fiber content was preserved in 
all culture conditions. Thus, overall, OS induced most changes in the collagen 




Figure 3.13 Shear stress and AV collagen distribution.  
A) Picrosirius red staining showed different proportions of collagen fibers (red, 
yellow and green) in AV tissues exposed to different shear conditions. F: fibrosa, 
V: ventricularis. B) Quantification of relative proportions of collagen fibers showed 
that most changes were observed in fibrosa when exposed to OS. Specifically, 
young collagen fiber content increased in fibrosa exposed to OS compared to 
ventricularis exposed to OS (1.95 fold, #p=0.09) and statically cultured AVs (1.04 
fold, *p=0.041). The mature and nascent collagen fiber content was preserved in 
all culture conditions. n=6.  Representative scale bar is shown only on fresh 
sample. 
 
3.5.6 Gene expression changes in AV in response to idealized shear stresses  
The AV cell phenotypic change was assessed with smooth muscle α-actin, Sma.  
The change in ECM was also assessed with collagen type-I (Col1a1). As shown 
in the Figure 3.14A, Col1a1 was upregulated in fibrosa when exposed to OS, but 
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not LS (p=0.1). This increased expression of Col1a1 could possibly be the 
explanation for the previously observed increased thickness of fibrosa in 
response to OS compared to other conditions. As shown in Figure 3.14B, Sma 
was downregulated in a side-dependent manner in the fibrosa compared to the 
ventricularis, when exposed to their respective shear stresses (p=0.1). The 
expression of Sma or Col1a1 did not change in the ventricularis when exposed to 
OS or LS (Figure 3.14C and D).  
 
Figure 3.14 Shear stress and AV phenotype and collagen turnover.  
A) High expression trend of Col1a1 was observed only in fibrosa exposed to OS 
vs. LS. B) Low expression trend of Sma was observed only in fibrosa exposed to 
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OS compared to ventricularis exposed to LS. C) and D) No changes observed in 
Sma and Col1a1. n=3 (pooled 3 samples/isolation), #p< 0.1.  
 
 
3.5.7 Identification of side – and shear – dependent miRNAs in AV 
The expression of miRNAs 181a, 181b, 214 and 199a-5p was determined in AV 
leaflets when exposed to idealized shear stresses ex vivo. As shown in the 
Figure 3.15A the expression of miR-181a and miR-214 was upregulated in 
fibrosa when exposed to OS vs. LS. Interestingly, this OS effect was not 
observed in the ventricularis (Figure 3.15B). When compared to the ventricularis 
samples (LS or OS), fibrosa under OS showed significantly higher miR-214 and 
miR-181a expression (Figure 3.15C and D). This result indicates that miR-214 
and miR-181a are preferentially upregulated in fibrosa, but not in ventricularis, 
consistent with the array data using fresh porcine AV leaflets (124). However, 
only miR-199a-5p showed significantly higher expression in ventricularis, in a 





Figure 3.15 Shear- and side-dependent miRNAs in AV.  
A and B) Two out of four miRNAs, miR-214 and miR-181a were expressed 
significantly higher in fibrosa but not ventricularis when exposed to OS vs. LS. C 
and D) Compared to ventricularis exposed to OS or LS, fibrosa exposed to OS 
showed significantly high expression of miR-214 and miR-181a. n=6 (pooled 3 




The expression of miRNAs (181a, 181b, 199a-5p and 214) in fibrosa when 
exposed to OS was compared to statically cultured and freshly isolated AVs as 
well (Figure 3.16). Only this shear condition was chosen because the expression 
of miRNAs changed the most compared to other shear conditions (Figure 3.15). 
Only miR-199a-5p showed significantly higher expression (p<0.05) in fibrosa 
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exposed to OS compared to static condition. However miRNAs, miR-181a and 
miR-214 showed significantly higher expression in fibrosa exposed to OS 
compared to fresh samples. Between fresh and statically cultured samples, miR-
199a-5p expression decreased in static samples (p<0.1) whereas the expression 
of miR-214 was significantly higher (p<0.05) in static culture.  
 
 
Figure 3.16 Expression of mirNAs in fresh and static AV tissues. 
Only two miRNAs-181a and 214 were significantly higher in fibrosa when 
exposed to OS compared to fresh AV tissues. Only miR-199a-5p showed 
significantly higher expression in fibrosa exposed to OS condition compared to 
static culture. Fibrosa exposed to OS: n=6 (pooled 3 samples/isolation), static 





Thus, overall, miR-181a and miR-214 were expressed significantly higher in 
fibrosa only when exposed to OS compared to all other conditions and fresh 
samples. These two miRNAs thus showed side-dependency (fibrosa exposed to 
OS vs. ventricularis exposed to LS) and shear-dependency in fibrosa side (OS 
vs. LS), but not in ventricularis (OS vs. LS).  Hence miR-181a and miR-214 were 
chosen for further investigation.  
 
3.5.8 Identification of potential mRNA targets of side- and shear-dependent 
miRNAs  
To discover potential, shear-sensitive, side-specific mRNAs that are regulated by 
miR-181a and miR-214, an in-depth bioinformatics analysis was carried out, as 
outlined in the Figure 3.6.  Following this approach, the mRNA targets filtered for 
miR-181a and miR-214 were 26 and 16 respectively and are listed in Table 3-2.  
The miRs-214 and 181a potentially regulate very critical genes that are well 
known to be involved in AV pathophysiology.  As evident from Table 3-2, most of 
the targets of miR-214 are well known and involved in AV cell phenotype, 
apoptosis, development, extracellular matrix regulation, inflammation and 
calcification, the events that are very important in AV disease. Based on this 




































To further understand the function of miR-214 in this side-dependent AV disease, 
six mRNA targets were chosen from its filtered targets. These mRNA targets are 
Sma, Ctnnb1, Enos, Klf4, Bcl2l11, and Col1a1 and the related Kyoto 
Encyclopedia of Genes and Genomes, (KEGG) pathways are listed in Table 3-3.   
 
Table 3-3 KEGG pathways related to selected mRNA targets. 
Gene KEGG Pathway(s) 
NOS3 or 
Enos 
Arginine and proline metabolism, Calcium signaling pathway, VEGF 
signaling pathway 
BCL2L11 




Vascular smooth muscle contraction 
COL1A1 Focal adhesion, ECM-receptor interaction 
KLF4 Signaling pathways regulating pluripotency of stem cells 
CTNNB1 
Wnt signaling pathway, Focal adhesion, Adherens junction, Tight 
junction, Leukocyte transendothelial migration, Melanogenesis, 
Pathogenic Escherichia coli infection, Pathways in cancer, 
Colorectal cancer, Endometrial cancer, Prostate cancer, Thyroid 





These targets are well known for their functional role in AV pathology. Briefly, 
Sma, determines the contractility and phenotype of valvular cells (143). Catenin 
beta-1 or β-catenin (Ctnnb1) is required in embryonic cushion development of the 
AV (144), but its increased expression can induce pathogenesis in adult valves 
(145). A well-known atheroprotective gene, nitric oxide synthase 3 or Enos, is 
anti-inflammatory, and protects the valvular endothelium from calcification (146). 
Apoptosis facilitator, Bim or Bcl2l11 belongs to the family of Bcl2 and activates 
the production of reactive oxygen species (147). Kruppel-like factor 4, Klf4 
regulates the promoter activity of anti-inflammatory and anti-thrombotic factors 
and thus, protects vascular endothelium (148). Flow-dependent differential 
expression of klf4 is also observed in bicuspid compared to tricuspid AV valve 
(149). Finally collagen type I, Col1a1, is predominant in AV matrix and its 
increased expression (observed in calcified AV tissues) indicates high ECM 
turnover (150).  
 
3.6 Discussion 
The major findings of this chapter are 1) Low magnitude oscillatory shear stress 
induced calcification in the fibrosa compared to the ventricularis, but this 
calcification was not as severe as that induced by elevated stretch or 
hypertensive pressure; 2) Most changes in the AV ECM and cell phenotype were 
induced by OS; 3) two out of four miRNAs, miR-214 and miR-181a were highly 
expressed in the fibrosa exposed to OS compared to other shear conditions and 
showed side- and shear-dependency in the fibrosa side; and 4) bioinformatics 
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analysis showed that miR-214 had potential targets that are involved in early 
stages of AV disease progression.  
 
3.6.1 OS induced side-dependent AV calcification 
The aortic valve experiences differing shear stress profiles on either sides of the 
valve that could play a potential role in its side-dependent calcific AV disease. 
Both idealized (or theoretical) and realistic (or experimental) shear stress 
paradigms exist in the literature and have been tested in this chapter to establish 
a calcification model using shear stress ex vivo. The objective of developing this 
model was to be able to induce early and later stages of AV calcification in a 
side-dependent manner. Our results showed that using an established 
osteogenic media, the idealized shear stress paradigm works very well in 
developing calcification preferentially in the fibrosa compared to the ventricularis. 
This preferential calcification in the fibrosa required both low magnitude (5 
dyne/cm2) and oscillatory nature (+/-) of the shear stress, as no calcification was 
observed when the fibrosa was exposed to the steady shear stress alone (5 
dyne/cm2). Increased apoptosis of AV with the increased calcification could be 
mediated by TGF-β1 (present in the osteogenic media), as demonstrated by Jian 
et al (151). However, the hypertensive pressure and elevated stretch can cause 
greater damage to the valve leaflets than the low magnitude oscillatory shear 
stresses. On the contrary, this low magnitude oscillatory shear stress is the 
primary stimuli involved in the atherosclerosis of blood vessels (152).  This is an 
important distinction and further investigation can help us understand the 
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mechanistic differences between the shear stress induced calcification in the AV 
compared to the atherosclerosis in the blood vessels.  
 
On the other hand, the realistic (or experimental) shear stresses did not induce 
any calcification in AV leaflets, which could be attributed to the lack of flow 
reversal in the shear stresses experienced by the fibrosa side. These results also 
suggest that the calcification media used in this specific aim must be 
reformulated in order to develop a side-dependent calcification model using the 
realistic shear stress paradigm.  So, based on the calcification results, idealized 
shear stress profile was chosen for further investigation in this specific aim. 
 
3.6.2 OS Induced most changes in the AV ECM 
Early changes induced in AV leaflets when exposed to the idealized shear stress 
profile were investigated by assessing the changes in the AV extracellular matrix 
and cell phenotype. The components of AV ECM provide much needed 
mechanical strength to maintain the functionality of the valve under rigorous 
conditions of the cardiac cycle. Overall tri-layered structure of the AV tissues was 
preserved in all shear and static conditions; but microscopically, noticeable 
histological changes within these layers were observed.  
 
On the ventricularis side, LS maintained the native structure of elastin fibers 
while OS caused its disruption. Although physiologically, the fibrosa and the 
ventricularis side never experience LS and OS respectively, these results 
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reiterate the sensitivity of the valve extracellular matrix to the changes in its 
mechanical environment.   
 
Low oscillatory shear stress reduced the activation of valvular interstitial cells as 
evident by the low expression of Sma in the fibrosa in a side-dependent manner 
(fibrosa exposed to OS vs ventricularis exposed to LS), consistent with a 
previous study (153). Cyclic pressure also had the same effect as OS, and 
decreased the protein expression of SMA (83), which was restored, only when 
combined with the elevated cyclic stretch. While the valve interstitial cells 
continuously attempt to respond and adapt to its mechanical environment, similar 
to the calcification result observed in Figure 3.10, different mechanical stimuli 
(shear, pressure and stretch) act in synergy to maintain the overall expression of 
Sma.   
 
Thus changes in valve cell phenotype (Sma), collagen fibers, increased collagen 
type-1 (Col1a1), combined with increased thickness of fibrosa (all being the 
indicators of valve ECM remodeling), were noticed only in fibrosa in response to 
OS but not LS. These changes observed in the ECM composition and its related 
genes can also potentially affect the miRNA expression and vice versa (121).  
 
3.6.3 OS induced most changes in miRNA(s) expression in fibrosa  
Native AV leaflets express inflammation and calcification markers on the fibrosa, 
making it predisposed to disease (24). This differential gene expression on either 
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sides of the valve could be in part be regulated by the side-dependent miRNAs, 
identified in a recent study (124). Our results showed that, of the four miRNAs 
tested, two miRNAs, miR-181a and miR-214 showed significant side- and shear-
dependency in the fibrosa but not the ventricularis. Although miR-199a and miR-
214 are clustered(154), it appears that only miR-214 is shear-responsive in AV 
leaflets. Further, these two miRNAs, miR-214 and miR-181a, as discussed 
earlier, are heavily involved in the processes that are relevant to AV disease 
such as inflammation, apoptosis, cell differentiation, migration and calcification 
(12, 13, 125, 126, 129, 141, 142). Their increased expression in the fibrosa side 
in response to OS could either be an adverse or a protective response; 
suggesting their possible involvement in side-dependent AV disease. This idea is 
supported by their lower expression on the ventricularis, which was consistently 
maintained regardless of the shear stress (OS or LS). These two miRNAs are 
perhaps not shear-sensitive in the ventricularis side and support the observation 
that the gene expression of endothelial cells is different on either side of the 
aortic valve (22, 24).  
 
3.6.4 Side- and shear- dependent miRNA, miR-214 is potentially involved in AV 
pathology 
The experimentally validated targets of miR-214 and miR-181a were identified 
and filtered using the existing shear and side-dependent mRNA databases to 
identify one key miRNA for further investigation. Interestingly, miR-214 has 
potential targets such as Ctnnb1, Sma, and Col1a1 that are highly expressed in 
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the calcified AV leaflets (143, 145, 150).  The oscillatory shear stress induced 
changes in the expression of Col1a1 and Sma observed in the previous section 
3.5.6, is probably associated with the changes in the miR-214 expression as well.  
Thus, in the presence of OS, miR-214 can potentially be involved in a feedback 
mechanism with the changes in the ECM structure (Figure 3.13) and its related 
genes. Since miR-214 also inhibits the bone formation (14) and is associated 
with the coronary artery disease (15), it could play a similarly important role in AV 
calcification. All of this evidence allows us to hypothesize that the miR-214 is a 
key side- and shear- dependent miRNA that plays an important role in the fibrosa 
side, by potentially targeting the genes involved in the pathogenesis of side-
dependent AV disease.  
 
3.7 Limitations 
No calcification was observed when the AV leaflets were exposed to altered 
hemodynamics that could be attributed to the lack of flow reversal on the fibrosa 
side. Thus, there is a need to modify the existing osteogenic media to develop a 
side-dependent calcification model using the physiologically relevant realistic 
shear stresses. In this case, culture durations longer than 7 days may be 
necessary to induce calcification (17). Also, the miRNAs identified using the 
idealized shear stress paradigm may behave differently in in vivo scenario, where 
the stretch and pressure are also present. Despite these limitations, our ex vivo 
shear studies provide a critical experimental platform to determine the role of 
shear in regulating gene expression in a side-dependent manner, while excluding 
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numerous other complex systemic changes that occur in vivo such as blood and 
circulating factors.  
3.8 Conclusions 
The results of this study demonstrated that low magnitude oscillatory shear 
stress preferentially alters the extracellular matrix architecture, and cell 
phenotype on the fibrosa. The OS also created a pro-calcific environment that 
predisposed the fibrosa to early onset of disease compared to the ventricularis. 
The impact of low magnitude oscillatory shear stress on AV calcification was not 
as severe as that of pathological stretch or hypertensive pressure.  
 
 




Thus, pathological stretch and pressure can induce even greater damage to AV 
compared to OS. Two miRNAs, miR-214 and 181a were side- and shear-
dependent in the fibrosa side compared to the ventricularis. Based on the targets 
regulated by these miRNAs, the miR-214 could be a key miRNA involved in this 
side-dependent AV disease.  
 95 
CHAPTER 4  DETERMINATION OF THE RELATIONSHIP 
BETWEEN A KEY SIDE- AND SHEAR-DEPENDENT MIRNA 
AND AORTIC VALVE PATHOGENESIS 
 
4.1 Summary 
The oscillatory shear stress can induce the side-specific aortic valve disease via 
microRNA(s) (miRNA) dependent pathway. Identification of these miRNAs and 
its regulated genes could uncover potential mechanisms involved in AV 
inflammation and calcification. A key miRNA, miR-214, that is also both side- 
and shear-dependent in AV (identified in specific aim-1), was selected to 
investigate this possibility. Selected gene targets of miR-214 were tested for 
their side- and shear-dependency as well. Of these 6 potential targets, overall 5 
genes (Klf4, Enos, Ctnnb1, Bcl2l11, Sma) showed a downregulation in fibrosa 
when exposed to OS, also indicative of the pro-inflammatory environment 
induced by OS. These genes also displayed an inverse relationship with miR-
214 in fibrosa exposed to OS. Further, a successful miRNA silencing protocol 
was developed to validate these gene targets and to investigate the functional 
role of miR-214 in AV. Silencing miR-214 in the fibrosa exposed to OS, 
significantly upregulated Klf4 and tended to increase Sma. Further miR-214 in 
fibrosa exposed to OS, also tended to increase VE-Cadherin and significantly 
decreased Tgfβ1, suggesting its role in AV fibrosa and sclerosis. The silencing 
of miR-214, however, did not have a significant effect on AV inflammation and 
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calcification in fibrosa, induced by OS. Thus, miR-214 could play an important 
role in AV fibrosis and sclerosis.  
 
4.2 Introduction 
Calcific AV disease preferentially occurs in the fibrosa and can be attributed to 
the higher expression of pro-inflammatory and pro-calcific genes observed in the 
fibrosa as compared to the ventricularis (24). The oscillatory shear stresses 
observed in the fibrosa, can further enhance the expression of these genes and 
induce inflammation, endothelial-to-mesenchymal transition (Endo-MT), and 
increased oxidative stress (44, 114, 146, 155). However, the mechanisms by 
which the oscillatory shear stress initiates these pathological changes in a side-
dependent manner are not well understood. Lack of therapeutic treatment of AV 
calcification places an increasing demand on uncovering these disease 
mechanisms. 
The miRNAs are master regulators of gene expression and their involvement in 
various cardiovascular diseases is recognized (156, 157). Recent studies have 
reported the contribution of miRNAs in AV disease as well (106). Similar to the 
vascular endothelial cells (157), the AV endothelial cells respond to disturbed or 
uniform flow by varying the expression of miRNAs (124). Although there is a 
growing body of evidence suggesting the involvement of miRNAs in AV 
calcification, the function of these miRNAs remains largely unknown. One such 
key miRNA is miR-214, which was identified in specific aim-1 as shear- and side-
dependent regulator in AV. The expression of miR-214 is significantly increased 
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in fibrosa in response to the oscillatory shear stress; however, the downstream 
mechanisms regulated by miR-214 in AV are unknown. Based on the literature 
evidence, miR-214 is involved in key cellular processes that are very relevant to 
calcific AV disease progression. Briefly, miR-214 plays a role in cell proliferation 
(138, 139), cell death(136, 140, 141), cell cycle (138), cell migration (140, 142), 
and inflammation (136, 139, 141). MiR-214 is also involved in fibrosis (12), 
epithelial-to-mesenchymal transition (158), osteogenic differentiation (14), and is 
correlated to the coronary artery disease (15). Thus, miR-214 may play a 
similarly important role in AV disease. This chapter focuses on investigating the 
cellular processes activated by miR-214 in fibrosa, in response to OS. 
Understanding the function of miR-214 can expose potential molecular 
mechanisms underlying side-dependent AV sclerosis, inflammation, and 
calcification and possibly serve as AV disease biomarker.  
 
4.3 Hypothesis 
The hypothesis of this specific aim is that miR-214 modulates the genes involved 




4.4 Materials and methods 
4.4.1 Overall work flow and experimental plan 
The overall workflow of this specific aim is outlined in Figure 4.1.  The miR-214 is 
a side- and shear-dependent miRNA and is highly expressed in fibrosa when 
exposed to oscillatory shear, compared to all other shear conditions. The side- 
and shear-dependency of selected mRNA targets of this miRNA (filtered and 
identified in specific aim-1) was determined.  The ex vivo cone and plate shear 
bioreactor used for these studies is detailed in section 4.4.3 and the shear 
conditions used are descried in 4.4.4. The general experimental setup is also 
described in 4.4.5 and specific experimental details are detailed in 4.4.6. The 
expression of mRNA targets was assessed using qPCR as detailed in sections 
4.4.11 through 4.4.14. Based on these experiments, the mRNA targets that 
showed an inverse relationship with miR-214 expression (in the fibrosa exposed 
to oscillatory shear) were chosen for further validation.  
 
To assess the functional role of miR-214 in AV pathophysiology, the miR-214 
silencing studies were performed. An anti-miR delivery protocol was developed 
to silence the miRNA ex vivo using statically cultured AV leaflets (4.4.7). The 
delivery efficiency of anti-miR in AV leaflet tissue was assessed using a tagged 
non-targeting (NT) anti-miR and confocal microscopy. TUNEL stain was done to 
ensure that the transfection of anti-miR did not affect the cell viability (4.4.10.2). 
The expression of miR-214 after the silencing experiment was assessed using 
qPCR (4.4.11 through 4.4.14). 
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The same miRNA silencing protocol was adapted to silence the miR-214 in 
fibrosa, when exposed to oscillatory shear (4.4.8), as the miR-214 is upregulated 
in fibrosa exposed to oscillatory shear compared to all other conditions.  Post 
silencing of miR-214 in sheared leaflets (fibrosa exposed to oscillatory shear), 
the miR-214, and the selected mRNA targets were assessed using qPCR as well 
(4.4.11 through 4.4.14). The effect of miR-214 silencing on AV endothelial-to-
mesenchymal transition, inflammation and calcification was assessed to further 






Figure 4.1 Flow chart of overall workflow of specific aim-2.  
 
 
4.4.2 Aortic valve tissue harvest 
Hearts were obtained from healthy, female, non-pregnant pigs (aged 6 to 12 
months) immediately after slaughter from a local abattoir (Holifield Farms, 
Covington, GA). The AV leaflets were immediately excised and thoroughly rinsed 
in sterile nuclease-free Dulbecco’s phosphate buffered solution (dPBS; Sigma-
Aldrich, MO) at 4 oC. Valves were placed in nuclease-free dPBS on ice and 
transported back to the laboratory.  Upon arrival in the laboratory, dissected AVs 
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were transferred to clean, sterile dPBS at 4 oC under the sterile laminar flow 
hood and processed accordingly.  
 
4.4.3 Ex vivo cone and plate shear stress bioreactor 
An ex vivo shear stress bioreactor was used to study the effect of shear stresses 
on the AV leaflets in a side-dependent manner. This bioreactor has been 
designed and extensively validated to expose AV tissues to well-defined shear 
stress profiles (52).  It is a modification of the cone and plate viscometer. Briefly, 
as shown in Figure 4.2, the bioreactor consists of a dish with a plate at the 
bottom, where the valve leaflet tissues are held. In addition, a cone angled at 
0.5o is placed at 200 µm above the plate. A programmable servomotor is coupled 
to this cone and it rotates the cone depending on the specific shear stress 
program. The device can hold 9 tissue samples of diameter 7 mm. The motors 
were programmed by the Motion Planner© software (version 4.3.2.0, Parker 
Hannifin Corp, CA). A perfusion system consisting of a reservoir of media, 
powered by a slow moving peristaltic pump (Model SP202.100, APT Instruments, 





Figure 4.2 Ex vivo shear system for miRNA functional studies.  
A) The cone and plate bioreactor setup. It consists of a rotating cone (via motor) 
on top of a stationary plate (with AV samples). The perfusion system maintains 
constant flow of media in the cone and plate set up. The whole set up is held in a 
bioreactor table and can be placed in an incubator. B) Schematic of the cone and 
plate only. The plate can fit 9 AV samples, all placed at a radial distance of 20 
mm from the center of the cone. C) Samples extracted from AV leaflet tissue. D) 
Plate with 9 samples and the highlighted portion shows agarose filled into the 




The rotating cone rotates the media between the cone and plate and imparts the 
shear stress to the surface of the AV tissues in the circumferential direction. 
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Shear stress on the plate is calculated by the formula, , where  
is the wall shear stress, ρ and ν are the density and the viscosity of the fluid, ω is 
the angular velocity of the cone, and r is the radial coordinate of shear stress 
calculation on the plate, h is the gap between the apex of the cone and the plate, 
and α is the cone taper angle, which is 0.5o. This equation for calculating shear 
stress experienced by the plate has been validated by computational fluid 
dynamics simulations of the cone and plate bioreactor, as well as by Laser 
Doppler Velocimetry measurements of the apparatus (52). Further, the actual 
rotational velocity measured by the tachometer on the motor was shown to match 
the desired velocity programmed into the controller.  The cone was coupled to a 
servomotor (Model SM232AE-NPSN Brushless Servo Motor, Parker Hannifin 
Corp., Rohnert Park, CA), which was controlled by a servo drive (Model GV6K 
Gemini Servo, Parker Hannifin Corp., Rohnert Park, CA).  Additional details of 
this bioreactor are explained in-depth in appendices A.1 and A.2. 
 
4.4.4 Shear stress conditions 
The most commonly used idealized shear stress paradigm was used in this 
specific aim (48, 102, 112). The ventricularis side experiences pulsatile 
unidirectional shear stress (LS) of 0-79 dyne/cm2, with a peak magnitude 79 
dyne/cm2. An oscillatory shear stress of ± 5 dyne/cm2 at 1 Hz (OS) was chosen 
to study the mechanobiology in the fibrosa. As detailed in specific aim-1, this OS 
induced side-specific calcification in fibrosa but not ventricularis. 
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4.4.5 Experimental setup 
In the laboratory, circular 7-mm radius samples were cut aseptically from the 
basal region of each leaflet under the sterile laminar flow hood. As detailed by 
Sucosky et al (52), each well of the shear stress bioreactor was filled with 
approximately 750 µL of 1.2% agarose (Agarose, Thermo Fisher Scientific, NJ), 
which acted as a tissue holder, and the circularly cut tissue samples were placed 
on top of the agarose bed (Figure 3.2C, D). Since the thickness of the AV tissue 
slightly varies from pig to pig, the height of this agarose bed must be adjusted 
based on the thickness of the tissue. This is to ensure that the tissue samples 
are flush mounted, i.e., are placed at the same level as the plate that holds all the 
tissues in place. To verify this, a micro-cover-slide can be slided from the center 
of the plate to the top of the tissue. If the micro-cover-slide does not move 
smoothly over the tissue (which happens when the tissues are not flush 
mounted), the height of the agarose bed must be re-adjusted. These steps are 
crucial because if the level of the tissue increases relative to the plate (e.g. by 0.1 
mm), it decreases the height between the cone and the plate. This variation of 
the tissue height significantly increases the shear stress experienced by the 
tissues (1.36 times). This calculation is based on the fact that there are no 
secondary flows in this cone and plate system and that the velocity profile is 
linear as detailed by Sucosky et al (52). Additional details are also available in 
Appendix: Cone and Plate manual A.2.  
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To investigate the changes in expression of miRNA and mRNAs, leaflets were 
cultured for 48 h using regular DMEM media (118). A 48 h culture duration was 
chosen, as it is well known that this culture duration is sufficient to induce 
changes in gene expression and makes it possible to investigate the early onset 
of AV disease (102).   
 
For calcification-related studies, 72 h experiments were performed. To accelerate 
the calcification process that occurs over decades in vivo, an osteogenic media 
was used. This osteogenic media contained normal DMEM supplemented with 1 
mmol/L glycerophosphate, 10µmol/L dexamethasone, 3.8 mmol/L PO43-, and 1 
ng/ml TGF-β1. This media has been previously validated to accelerate the 
calcification of the porcine AV leaflets in the presence of cyclic stretch (17). 
Media (regular or osteogenic) was changed every 48 h to replenish the nutrients. 
The entire setup was placed in a 5% CO2 incubator at 37 °C. Post-culture, the 
portion of the tissue unexposed to shear stress was carefully excised (without 
touching the exposed tissue) using sterile tools under the sterile laminar flow 
hood. Tissues were briefly rinsed in multiple changes of sterile nuclease-free 
dPBS maintained at 4 oC until the media was completely removed.  
 
4.4.6 Shear- and side-dependency of filtered targets of miR-214  
In specific aim-1, the potential mRNA targets of miR-214 were filtered. To further 
understand the function of miR-214 in this side-dependent AV disease, six 
mRNA targets were chosen from its filtered targets, based on their known 
 106 
functional role in AV pathology. These mRNA targets are Sma, Ctnnb1, Enos, 
Klf4, Bcl2l11, and Col1a1. Briefly, Sma, determines the contractility and 
phenotype of valvular cells (143). Catenin beta-1 or β-catenin (Ctnnb1) is 
required in embryonic cushion development of the AV (144), but its increased 
expression can induce pathogenesis in adult valves (145). A well-known 
atheroprotective gene, nitric oxide synthase 3 or Enos, is anti-inflammatory, and 
protects the valvular endothelium from calcification (146). Apoptosis facilitator, 
Bim or Bcl2l11 belongs to the family of Bcl2 and activates the production of 
reactive oxygen species (147). Kruppel-like factor 4, Klf4 is a well known 
atheroprotective gene (148). Flow-dependent differential expression of klf4 is 
also observed in bicuspid compared to tricuspid AV valve (149). Finally collagen 
type I, Col1a1, is predominant in AV matrix and its increased expression 
(observed in calcified AV tissues) indicates high ECM turnover (150).  
 
As one can see, these targets are very relevant to AV disease. However, as 
described earlier, their shear- and side-dependency in AV needs to be 
determined before proceeding with the miR-214 modulation studies. For this 
purpose, fibrosa or ventricularis of AV leaflets were exposed to OS or LS for 48h 
and four conditions were investigated: 1) fibrosa exposed to OS, 2) fibrosa 
exposed to LS, 3) ventricularis exposed to OS, and 4) ventricularis exposed to 
LS. Fibrosa exposed to OS and ventricularis exposed to LS are physiologically 
relevant as the sides’ fibrosa/ventricularis are exposed to their respective shear 
stresses. Thus the fibrosa exposed to OS vs. ventricularis exposed to LS 
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comparison indicates side-dependency. Fibrosa exposed to LS and ventricularis 
exposed to OS are referred to as altered conditions as the physiological shear 
stress profiles are switched between the two sides. Fibrosa exposed to OS vs. 
LS and ventricularis exposed to OS vs. LS comparisons were used to compare 
the shear dependency of the fibrosa and the ventricularis, respectively. From 
specific aim-1, we know that miR-214 showed an increased expression in the 
fibrosa exposed to OS vs. LS and compared to ventricularis exposed to OS or 
LS. Based on these experiments, the mRNA targets that showed an inverse 
relationship with the miR-214 expression were chosen for further functional 
investigation.  
 
4.4.7 Development of miRNA silencing protocol ex vivo 
Since there is no well-established protocol to deliver anti-miR in an ex vivo 
culture, a protocol was developed. This protocol is a modified version of the 
existing in vitro miRNA silencing protocol (124). Statically cultured AV tissues 
were used to optimize the delivery of anti-miR to the tissues. The workflow of this 
protocol is shown in the Figure 4.3. A fluorescently tagged non-targeting (NT) 
anti-miR (Exiqon, Denmark) was used to optimize the transfection protocol and 
also to visualize the extent of transfection. AV leaflets samples were cut as 
previously described in 4.4.5 and passively transfected with 400 nM tagged NT 
anti-miR. The samples were then incubated in OptiMEM for 4 h (Life 
Technologies, NY). After this, the leaflets were quenched with regular DMEM and 
cultured under static conditions for 48 h. Statically cultured leaflets with no anti-
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miR were used as a negative control. After 48 h, each tissue was washed well in 
nuclease-free sterile dPBS and was cut into two halves for both RNA isolation 
and imaging. The tissue sections used for imaging were counterstained with 
DAPI and imaged en face to determine the transfection efficiency of tagged NT 
anti-miR. Total RNA was isolated from the other half of each tissue section and 
qPCR analysis was done to determine the expression of miR-214 was affected 
by the NT anti-miR transfection. After which, the same protocol was used to 
verify the silencing of miR-214 in statically cultured AV leaflets. An in vivo grade 
non-tagged anti-miR-214 was used for this purpose (Exiqon, Denmark). 





Figure 4.3 Work flow of anti-miR delivery protocol in statically cultured AV.  
Samples were passively transfected with anti-miR (NT anti-miR or anti-miR-214) 
for 4 hours. The samples were statically cultured for 48 h. The samples were 
then imaged to check for transfection efficiency of NT anti-miR and analyzed to 
check for the expression of miR-214 (qPCR). 
 
 
4.4.8 Effect of miR-214 silencing on its target mRNAs  
It is known from specific aim-1 that the miR-214 is highly expressed when fibrosa 
is exposed to OS compared to all other shear conditions. Hence, the miR-214 
silencing studies were carried out in this shear condition only. The protocol 
developed using statically cultured tissues (4.4.7) was adapted for use with the 
shear system. The workflow for silencing the miRNA in sheared samples is 
shown in the Figure 4.4. Following this protocol, the tissues were then treated 
with 400 nM of anti-miR-214 or tagged NT anti-miR and then the fibrosa was 
exposed to OS, for 48 h. To ensure that the anti-miR was retained within the 
tissue even after shearing, a cross section of the tissue was imaged. The 
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expression of miR-214 and its target mRNAs (identified from 4.4.6) was then 




Figure 4.4 Work flow of miR-silencing study in sheared AV.  
Samples are passively transfected with anti-miR (tagged NT anti-miR or anti-
miR-214) for 4 hours. Fibrosa side of AV are then exposed to OS and cultured for 
48 or 72 h. The samples were then assessed for: transfection efficiency, 
expression of miR-214, mRNA targets, Endo-MT markers, inflammation markers 
and calcium levels. 
 
 
4.4.9 Functional role of miR-214 in porcine AV leaflets ex vivo 
In addition to identifying the potential targets regulated by miR-214 in AV, the 
functional role of miR-214 in early (Endo-MT and inflammation) and late 
(calcification) stages of calcific AV disease was also determined (Figure 4.4).  
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4.4.9.1 Early stage: endo-MT and inflammation 
The role of miR-214 in AV Endo-MT, and inflammation was investigated. 
Silencing studies with anti-miR-214 were carried out for 48 h when fibrosa was 
exposed to OS. The gene expression was assessed via qPCR (4.4.11 through 
4.4.14). The Endo-MT markers (159) such as vascular endothelial cadherin (VE-
Cadherin), and monocyte chemoattractant protein-1 (Mcp1/Ccl2) were tested. To 
investigate the role of miR-214 in AV inflammation, the inflammation markers 
tested included intercellular adhesion molecule 1 (Icam1), vascular cell adhesion 
molecule 1(Vcam1), and bone morphogenetic protein (Bmp4) (56, 160).  A well-
known transcription regulator, transforming growth factor beta 1 (Tgfβ1) is highly 
expressed in calcified AVs (151) and is known to mediate phenotypic switch 
(fibroblast to myofibroblast), fibrosis, apoptosis, inflammation and calcification 
(145, 159, 161). So the possible regulation and activation of Tgfβ1 by miR-214 
was also tested. Samples sheared with NT anti-miR (Exiqon, Denmark) were 
used as a control. 
 
4.4.9.2 Late stage: calcification 
The role of miR-214 in AV calcification was investigated. Since OS also induced 
relatively higher calcium on fibrosa compared to ventricularis, the miR-214 
silencing experiments were performed only when fibrosa exposed to OS. The 
culture duration was 72 h (media changed after 48 h) with osteogenic media. 
Calcium assay was performed to assess the calcium levels induced (4.4.15). 
Samples sheared with NT anti-miR were used as a control.  
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4.4.10 Histology 
4.4.10.1 Preparation of frozen sections 
The cryopreserved tissue blocks were prepared by embedding the tissue in OCT 
medium (Electron Microscopy Sciences, PA) and frozen using liquid nitrogen. 
Sections with thicknesses ranging between 5 to 7 µm were cut. The blocks and 
tissue sections were stored at -80 oC. For en face, the tissues were directly 
placed on a tissue slide and imaged.  
 
4.4.10.2 Cell apoptosis stain 
A cell apoptosis stain was performed to assess the cell death induced by the 
transfection of tagged NT anti-miR to statically cultured AV leaflets. A freshly 
isolated AV leaflet sample was included as a control. This staining was done 
using the In Situ Cell Death Detection Kit; TMR red, TUNEL kit (Roche 
Diagnostics, Germany). Cryopreserved tissue sections were fixed with 4% 
paraformaldehyde (Sigma-Aldrich, MO) in dPBS (pH 7.4) for 20 min, rinsed with 
dPBS for 30 min, permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, MO) in 
dPBS (2 min at 4 oC), and rinsed twice with dPBS. Staining was performed by 
incubating tissue sections for 1 h at 37 °C in a humidified chamber in the dark in 
50 µL of TUNEL reaction mixture followed by counterstaining with DAPI for 5 
min. A positive control was prepared by incubating the fixed and permeabilized 
tissue section with DNAse-I solution (3-3000U/ml RNAse free DNAse-I (Qiagen, 
CA) in 50mM TrisCl (Sigma-Aldrich, MO), pH 7.5, 1mg/mL BSA (Fisher Scientific, 
PA) for 10 min prior to labeling with TUNEL reaction mixture. A negative control 
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was prepared by incubating fixed and permeabilized tissue sections in 50 µl of 
TUNEL label solution (without terminal transferase). Apoptotic cells appeared red 
and nuclei appeared blue under fluorescence microscopy.  
 
4.4.10.3 Imaging and analysis 
A laser-scanning microscope (710 NLO, Zeiss, Germany) was used for confocal 
microscopy.  The transfection of tagged NT anti-miR was visualized (both en face 
and cross-section) using a confocal microscope. The apoptotic cells within the 
tissue after the TUNEL stain was also visualized using a confocal microscope. 
The apoptotic cells in the tissue were counted using ImageJ software (162). 
 
4.4.11 RNA isolation 
From 48 h shear experiments, total RNA was isolated from whole tissue (both 
endothelial and interstitial tissue) using the miRNeasy kit (Qiagen, CA). It was not 
feasible to isolate endothelial-enriched RNA from the sheared AV samples and it 
was more practical to isolate total RNA from entire tissue (interstitial and 
endothelial cells). To achieve sufficient RNA yield for qPCR, three sheared 
tissues were pooled per isolation.  In the case of static culture, it was sufficient to 
pool just two tissue samples. 
 
Post experiment, media from the tissues was completely removed using sterile 
dPBS, as mentioned earlier. The tissues were then incubated in 700 µL of Qiazol 
for about 5 min at room temperature. The phenol-chloroform extraction was done 
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and subsequent purification steps were performed as per the manufacturer’s 
protocol. The concentration and the purity of the samples were measured using 
the Take 3 plate attachment of Synergy H4 Hybrid Reader (Biotek, VT). Samples 
showed 260/280 and 260/320 ratios in the range 1.2 to 1.8 and had 
concentrations ranging from 10-30 ng/ µL (sheared samples) and 200-500 ng/ µL 
(statically cultured samples). 
 
4.4.12 Preparation of mRNA and miRNA cDNA 
To prepare cDNA for mRNA, High-Capacity cDNA Reverse Transcription kit with 
RNAse inhibitor kit (Life Technologies, NY) was used. To prepare cDNA for 
miRNA, miScript II RT kit (Qiagen, CA) was used.  
 
4.4.13 Real-time qPCR 
Real time qPCR was used to assess the expression miR-214 and mRNA genes 
(targets, Endo-MT markers, and inflammation markers). The primers for mRNA 
genes were designed and ordered from Integrated DNA Technologies (IA). The 
primer sequences for all the genes tested including the endogenous control, 18S, 
are listed in the Table 4-1. The expression of mRNA targets and functional genes 
was also assessed via qPCR using the VeriQuest Fast SYBR Green (Affymetrix, 
CA). The primer for miRNA-214 was purchased from Qiagen (CA) and its level 
was assessed using qPCR with miScript SYBR Green PCR kit (Qiagen, CA). 
RNU6B included in this PCR kit was used as the endogenous control.  
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Table 4-1 Primer sequences of all mRNA genes tested in this specific aim. 
 
 
4.4.14 Analysis of qPCR data 
A sample size of at least 3 to a maximum of 9 was used for data analysis. As 
mentioned earlier, each sample infact represents 2 (for static) or 3 (for sheared) 
tissue samples (due pooling of tissues). To analyze qPCR data, ΔCT method 
was used and fold changes (2^(-ΔCT)) were calculated. When comparing two 
groups, eg. fibrosa exposed to OS vs. LS, the fold changes were normalized to 
the mean of the second group (here fibrosa exposed to LS which was set as the 
baseline) (14). 
Gene Forward Primer Reverse Primer 
Enos 5- GAG ACT GGC CTT ATT CCT GGG -3  5- CTC CGG AAT ACC ACT GCT GG -3  
Bcl2l11 5-TGA GTC GGA TCG CAA CTT GG-3 5-ATC GGT TGA AGC GTT CCT GG-3 
Ctnnb1 5-GGA CAT CAC TGA ACC TGC CA-3 5-GGT AGT CCG TAG TGA AGG CG-3 
Col1a1 5-GGC CAA GAA GAA GAC ATC CCA-3 5-ACA ACA CAT TGC CGT TGT CG-3 
Klf4 5-CTA AGC AGC AGG GAC TGT CA-3 
5-GTG GCA TGA GCT CTT GGT AAT 
G-3 
Sma 
5- GGT GGG AAT GGG ACA AAA AGA C 
-3  
5- TGG TGA TGA TGC CGT GTT CTA 
TT -3 
18S 
5-CCC CAA CTT CTT AGA GGG ACA 
AG-3 
5-AGG GCA TCA CAG ACC TGT TAT 
TG-3 
Vcam1 5- AGT TGC TCC CAG GGA TAC GA -3  5- GGA GCT GGA AAG CCA TCA CT -3  
Bmp4 5-CGT CAT CCC AGA TTA CAT -3 5-GAG TCG AAG CTC TGC GGA T-3 
Tgfβ1 
5-CAA CTA CTG CTT CAG CTC CAC 
GGA GAA GAA-3 
5-GAA CAT CGA TGA CAA GCT TAG 
GTA TCG ATA-3 
Icam1 5-GTC CCC CTC AAA AGT CAT CC-3 5-AAC CCC ATT CAG CGT CAC CT-3 
Mcp1 
5-TGT CCT AAA GAA GCA GTG ATC 
TTC-3 5-AGT CAG GCT TCA AGG CTT CG-3 
VE-
Cadherin 5-AAG AAC ATC GCC CGT GTC AT-3 5-CAC TGA GCC GAT CCA AGG TT-3 
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4.4.15 Calcium assessment 
The calcium levels were measured in tissues after the miR-214 silencing was 
carried out in osteogenic media. The tissues were pulverized by mortar and 
pestle in liquid nitrogen, and collected in pre-weighed vials. After sample 
collection, the vials were re-weighed before and after drying the samples 
overnight at 37 oC. The dry weights of the tissue were then computed. 
Subsequently, the ground samples were incubated in 1 M acetic acid at 4 oC for 
24 h, to solubilize calcium. The samples were then centrifuged at 15,000 rpm for 
9 min, and the supernatant was collected. The supernatant as well as calcium 
standards were assayed for calcium content by using a calcium specific 
Arsenazo dye reagent (Fisher-Scientific, MA): 25 µL of the supernatant or the 
calcium standard was mixed with 300 µL of Arsenazo solution in a 96 well plate. 
The absorbance of the various samples at a wavelength of 650 nm was 
measured through spectrophotometry, using a 96 well plate reader (BioTek, VT). 
The absorption calibration curve was established with the calcium standard 
spectrophotometry readings, and was thereafter applied to readings from the 
samples. The amount of calcium per dry weight of sample tissue was then 
calculated. 
 
4.4.16 Statistical analysis 
Data was expressed as mean + standard error. All the statistical analyses were 
done using SPSS Statistics for Mac (Version 20.0, IBM Corp, NY). The normality 
of all the data was tested using the Anderson-Darling method. Student t-test was 
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used when only two groups were being compared. Two-way ANOVA was used 
for analyzing independent sample sets with Tukey’s post-hoc test for 
comparisons between multiple groups. If the data was not normally distributed, 
Mann-Whitney and Friedman tests were used in place of the student t-tests and 
ANOVA, respectively. The groups were considered to be significantly different or 
show trends if the p-value was less than or equal to 0.05 and 0.10, respectively. 
 
4.5 Results 
The raw data of all these results is available in Appendix A.19. 
 
4.5.1 Side- and shear-dependent expression of potential mRNA targets of miR-
214 in AV leaflets 
Of the 6 potential targets tested, four (Klf4, Enos, Ctnnb1, Bcl2l1) showed a 
downregulation in fibrosa when exposed to OS, but not LS (p=0.1,Figure 4.5A). 
In contrast, Col1a1 expression showed an upregulation in fibrosa, suggesting 
that this gene is unlikely to be a target of miR-214 in AV.  However, this 
increased expression of Col1a1 could possibly be the explanation for the 
previously observed increased thickness of fibrosa in response to OS, compared 
to other conditions. The expression of any of these targets did not change in the 
ventricularis regardless of the shear stress (OS or LS), suggesting that the gene 
expression was preserved in ventricularis (Figure 4.5B). When exposed to OS, 
the expression of Enos decreased in fibrosa but not in ventricularis (p=0.1, Figure 
4.6A). On the other hand, only Sma and Ctnnb1 showed a downregulation in 
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fibrosa exposed to OS compared to ventricularis exposed to LS, in a side-
dependent manner (p=0.1, Figure 4.6B). Thus, overall 5 out of 6 potential targets 
showed side- and shear-dependency in fibrosa and displayed an inverse 
relationship with miR-214 expression. These 5 were further investigated in the 








Figure 4.5 Shear-dependency of selected target genes.  
A) Four genes: Klf4, Enos, Ctnnb1, and Bcl2l11 showed a lower expression in 
fibrosa in a shear-dependent manner (OS vs. LS). B) No changes were observed 
in gene expression in ventricularis in a shear-dependent manner (OS vs. LS).  




Figure 4.6 Side-dependency of selected gene targets.  
A) Only Enos showed a lower expression in fibrosa compared to ventricularis, 
when exposed to OS. B) Two genes: Sma and Ctnnb1 showed a lower 
expression in fibrosa in a side-dependent manner (fibrosa exposed to OS vs. 
ventricularis exposed to LS). n=3 (pooled 3 samples/isolation), #p< 0.1. 
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4.5.2 Delivery of anti-miR to AV leaflets ex vivo 
Modulation studies on miR-214 are needed to confirm its potential gene targets 
identified in the previous section. For this, a protocol was developed to deliver 
anti-miR to AV leaflets ex vivo (Figure 4.3). The transfection of a tagged NT anti-
miR in static cultures compared to the no anti-miR control group was observed 
not only to endothelial cells, but also to interstitial cells, as shown in Figure 4.7B. 
Also, this transfection is observed in the entire tissue Figure 4.7B. The TUNEL 
stain was performed to assess if the transfection of tagged NT anti-miR affected 
the cell viability. As shown in the Figure 4.8, leaflets transfected with tagged NT-
anti-miR showed a few apoptotic cells (fewer than 100 apoptotic cells/1700 total 
cells, <6%) and thus did not have a significant effect on cell viability. Further, the 
anti-miR-214 significantly silenced miR-214 in statically cultured AV leaflets 
(p=0.05), compared to the tagged NT-anti-miR, as shown in the Figure 4.9. Thus, 
a protocol was developed to successfully deliver anti-miR to the AV leaflets ex 






Figure 4.7 Delivery of anti-miR to statically cultured AV leaflets ex vivo.  
A) The anti-miR control with no anti-miR showed nuclei counterstained with 
DAPI. B) Tagged NT anti-miR (red) showed transfection in both endothelial and 
interstitial cells of the statically cultured AV (48 h), also showing nuclei 







Figure 4.8 Positive control for TUNEL showed excessive apoptosis (red).  
Negative control for TUNEL stain showed no signs of apoptosis. As expected no 
apoptotic cells were observed in freshly isolated AV.  However, a few apoptotic 
cells were observed (arrows point to red tagged nuclei) in statically cultured 







Figure 4.9 Silencing of miR-214 in AV static culture.  
Successful silencing of miR-214 in statically cultured AV leaflets by anti-miR-214 
compared to NT anti-miR. *p=0.05. n=6 (pooled 2 samples /isolation). 
 
 
4.5.3 Silencing of miR-214 in sheared AV leaflets ex vivo 
The miR-214 silencing was carried out (Figure 4.4) in fibrosa when exposed to 
OS.  As shown in the Figure 4.10A, the transfection of a tagged NT-anti-miR in 
sheared leaflets was successful and was retained even after 48 h of shear. The 
miR-214 was also significantly silenced in fibrosa exposed to OS (p=0.004), also 




Figure 4.10 Silencing of miR-214 in fibrosa exposed to OS.  
A) The cross section image of sheared AV tissue (fibrosa exposed to OS) 
showed successful transfection and retention of the NT-anti-miR throughout the 
tissue. B) Successful silencing of miR-214 in fibrosa exposed to OS at 400nM of 




4.5.4 Validation of miR-214 targets by silencing miR-214 
Following the silencing of miR-214 in fibrosa exposed to OS, the expression of 
mRNA targets (identified in the earlier section, 4.5.1) was determined. Out of 5 
mRNA targets that showed an inverse relationship with miR-214; upon miR-214 
silencing, only Klf4 was significantly upregulated (p=0.05) while Sma trend did 
not reach statistical significance (p=0.11) (Figure 4.11). This confirms that klf4 is 





Figure 4.11 Validation of mRNA targets by silencing miR-214 in fibrosa  
exposed to OS. Out of 5 mRNA targets tested, silencing of miR-214 in fibrosa 
when exposed to OS, significantly upregulated Klf4 (p=0.05) and tended to 
increase Sma (p=0.11). n=6-8 (pooled 3 samples/isolation). 
 
 
4.5.5 OS dependent functional role of miR-214 in AV Endo-MT and inflammation 
The functional relevance of silencing miR-214 in fibrosa when exposed to OS 
was investigated. As shown in Figure 4.12A, silencing of miR-214 tended to 
restore the expression of VE-Cadherin (p=0.1) but not Mcp1, in fibrosa exposed 
to OS.  Out of 4 inflammation markers tested, silencing of miR-214 significantly 
decreased Tgfβ1 (p=0.03) while moderately decreasing Icam1 (p=0.08) (Figure 
4.12B). Since the miR-214 silencing did not affect the other inflammatory 
markers Vcam1, and Bmp4, the miR-214 may be targeting the various other 




Figure 4.12 miR-214 silencing and AV endo-MT and inflammation. 
 A) Silencing of miR-214 in fibrosa when exposed to OS tended to increase VE-
Cadherin but not Mcp1. B) Silencing of miR-214 in fibrosa when exposed to OS 
significantly downregulated the Tgfβ1 and decreased Icam1. n=6-8 (pooled 3 
samples/isolation). *p≤0.05 and #p≤0.1. 
 
 
4.5.6 OS dependent functional role of miR-214 in AV calcification 
The effect of miR-214 silencing on AV calcification was also investigated. The 
miR-214 silencing did not alter the calcium levels induced by the OS in the 
fibrosa compared to the NT anti-miR control group (Figure 4.13). This suggests 
that miR-214 may not play a direct role in shear–mediated calcification or may 
require longer culture duration to have a detectable effect on AV calcification. 
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Figure 4.13 The effect of miR-214 silencing on AV calcification.  
The silencing of miR-214 did not change the calcium levels in fibrosa induced by 




This chapter focused on understanding the role of a key shear- and side-
dependent miRNA, miR-214 in AV pathophysiology. The major findings of this 
chapter are: 1) 5 out of 6 potential targets of miR-214 showed an inverse 
relationship with miR-214 in a side- and shear-dependent manner, 2) silencing of 
miR-214 in fibrosa exposed to OS significantly increased klf4, confirming Klf4 as 
a target and 3) shear-dependent functional role of miR-214 in AV 
pathophysiology by knocking down its expression. 
 
The calcific AV disease is a side-dependent disease preferentially occurring in 
the fibrosa and we have previously shown that the low magnitude oscillatory 
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shear stress can possibly contribute to this side-dependency. The OS also 
altered the AV ECM by increasing the thickness of the fibrosa but not the 
ventricularis, also observed in sclerotic valves (9). However, to understand the 
mechanism by which the OS contributes to these pathological changes that lead 
to AV disease, the functional role of a key side- and shear- dependent miRNA, 
miR-214 was investigated. It is well known that the miRNAs are critical regulators 
of gene expression and their involvement in cardiovascular diseases and 
congenital AV diseases have been recently recognized (94, 106). Hence, 
understanding the OS dependent regulation of miR-214 and its functional 
relevance in AV pathophysiology, will improve our current knowledge of shear-
dependent mechanisms that lead to AV disease.  
 
4.6.1 OS significantly increased miR-214 while decreasing its potential targets in 
the fibrosa 
As mentioned previously, the miR-214 is a key side- and shear-dependent 
miRNA as its expression was significantly increased in the fibrosa when exposed 
to OS but not LS. The expression of miR-214 is also not shear-dependent in the 
ventricularis side. A detailed bioinformatics analysis showed that miR-214 
potentially regulates the genes that play an important role in AV pathogenesis. 
Interestingly, the expression of 5 of 6 potential mRNA targets of miR-214 (except 
for Col1a1) was downregulated in fibrosa when exposed to OS, and thus, 
inversely correlated with the increased expression of miR-214. Nevertheless, the 
downregulation of anti-inflammatory genes: Enos, and Klf4, and upregulation of 
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Col1a1 (collagen turnover) in the fibrosa, are pathological and make the fibrosa 
more susceptible to disease. Thus, OS creates a pro-inflammatory environment, 
preferentially in the fibrosa side (48, 56, 102), that may be correlated with the 
higher expression of miR-214 observed in fibrosa.  
 
4.6.2 Increased expression of miR-214 in fibrosa in response to OS can activate 
the Klf4 and Tgfβ1 dependent pathways 
Successful transfection of anti-miR to AV endothelial and interstitial cells in 
sheared AV leaflets was demonstrated without compromising the cell viability. 
The increased expression of miR-214 in response to OS in the fibrosa was also 
successfully silenced using anti-miR-214. Out of 5 potential targets tested, one 
anti-inflammatory gene, Klf4 was confirmed as a potential target of miR-214. As 
mentioned earlier, Klf4 is an atheroprotective gene, and protects vascular 
endothelium by regulating the promoter activity of anti-inflammatory and anti-
thrombotic factors (148). The disturbed shear stresses are known to decrease 
Klf4 and therefore induce a pro-atherogenic environment in arterial bifurcations 
(163).  Since the role of kfl4 is not well defined in AV, a similar mechanism can 
be speculated that miR-214 regulates Klf4, and is involved in the OS dependent 
inflammation (155, 164) induced in fibrosa. Thus, the oscillatory shear stress can 
potentially induce inflammation in fibrosa by decreasing the expression of Klf4 via 
increase in miR-214.  
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Since silencing of miR-214 did not significantly affect the expression of Icam1, 
Vcam1, and Bmp4, miR-214 may not be directly involved in AV inflammation. 
However, miR-214 silencing significantly decreased Tgfβ1 indicating that miR-
214 may be involved in pathways regulated by Tgfβ1 such as fibrosis, EndoMT, 
apoptosis, etc. (143, 145, 151, 159, 161).  The increased expression of VE-
Cadherin in response to miR-214 silencing in fibrosa exposed to OS, raised this 
possibility.  
 
On the other hand, in vasculature, the increased expression of klf4 inhibits the 
epithelial-to-mesenchymal transition by targeting the expression of Tgfβ1 (165, 
166). However, the exact mechanism as to how klf4 regulates the expression of 
Tgfβ1 (and vice versa) in AV pathogenesis is unknown. One hypothesis could be 
that Tgfβ1 can accelerate the AV fibrosis, by activating the differentiation of 
quiescent valvular interstitial cells into osteoblast like phenotype (145), and this 
activation may require the downregulation of klf4 (167). Also, TGF-β1 has been 
shown to regulate the expression of miR-214 in renal injury and fibrosis (12). 
Thus, the increased expression of Tgfβ1 in response to OS can further increase 
the miR-214 and decrease Klf4, and this process can form a feedback loop. This 
feedback effect can increase the tendency of trans-differentiation of valvular cells 
in the fibrosa. Although the downregulation of Tgfβ1 observed here is significant, 
but not severe (less than 2 fold) in response to miR-214 silencing, it is likely that 
this effect will be more pronounced with longer culture durations. Thus, the 
possibility of this feedback response cannot be denied and must be investigated 
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in future studies. On the contrary, miR-214 did not seem to have a direct effect 
on OS induced AV calcification. As discussed earlier, by silencing miR-214 with 
anti-miR-214, we rescued one of the important anti-inflammatory genes, Klf4 
while also potentially inducing pro-calcific genes such as Vcam1 and Bmp4 (high 
fold changes, Figure 4.12, although not statistically significant). It is possible that 
this increased expression of pro-inflammatory and pro-calcific markers competed 
with the anti-inflammatory marker, to slow down the overall anti-calcific effect of 
anti-miR-214. It is also possible that miR-214 may regulate calcification via a 
different mechanism or there might be other miRNAs involved.  
 
Also as observed in specific aim-1, in addition to side-dependent calcification in 
fibrosa, the OS induced changes in ECM (collagen and elastin), increased 
thickness of fibrosa as well as increased the expression of Col1a1, all showing 
the signs of altered ECM remodeling.  
 
Thus, based on all of our results, a side- and shear- dependent role of miR-214 
in the AV endothelium is proposed (Figure 4.14): the oscillatory shear stress 
increases the thickness of the fibrosa, alters the ECM, and creates a pro-fibrotic 
environment via a miR-214 - Klf4 - Tgfβ1 dependent pathway. This activation 
likely results in AV fibrosis, Endo-MT and eventually sclerosis. Thus miR-214 is a 





Figure 4.14 The proposed mechanism of action of miR-214 in AV. 
 Fibrosa exposed to OS increases expression of miR-214 that targets klf4 and 
activates Tgfβ1. This activation likely results in AV fibrosis, EndoMT and thus 
sclerosis. The dashed lines show the possible mechanisms and a possible 




4.7 Limitations  
An idealized shear stress paradigm as opposed to realistic shear stresses was 
used. In the presence of altered hemodynamics such as low heart rate and 
cardiac output, the magnitude of shear stress experienced by the fibrosa side 
can decrease to about 3 dyne/cm2 from 13 dyne/cm2, indicating that the valve 
does experience low magnitude shear stress (111). However, the lack of flow 
reversal on the fibrosa side according to this paradigm may change the response 
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of miR-214. The mRNA targets of miR-214 identified in this study were not 
validated at the protein level. It is because it was challenging to isolate good 
quality protein from the sheared tissue, post inhibition. This would not have been 
a problem in in vitro cell culture studies. This limitation was addressed by picking 
experimentally validated targets of miR-214 instead of predicted targets. The 
experiments were also repeated atleast 3 times to make sure the results are 
repeatable - both with and without the inhibitor experiments. 
  
Additionally, to gain more insight into the mechanisms regulated by miR-214, the 
modulation studies should be carried out with pre-miR-214 as well. The 
upregulation of miR-214 due to pre-miR-214 may have had an effect on AV 
calcification, which was not observed when anti-miR-214 was used. However, 
longer culture durations (7 to 14 days) may also be necessary to observe the 
effect of anti-miR-214 on AV calcification. Finally, the differential gene expression 
pattern observed in this study may differ in humans due to the species (pig vs. 
human). Since the side-dependent miRNAs identified in this study are conserved 
in humans, investigating the functional role of these miRNAs in porcine AV 
leaflets will still provide us clues about their role in AV pathogenesis. Thus, 
despite these limitations, our data shows a possibility of the involvement in miR-






The oscillatory shear stress predisposes the fibrosa to the early onset of disease 
by decreasing the expression of anti-inflammatory markers (Enos, and Klf4) and 
increasing the turnover of collagen (Col1a1). This OS induced pathology in the 
fibrosa is mediated via miR-214, klf4 and Tgfβ1 dependent pathway that can lead 
to AV fibrosis, Endo-MT and eventually sclerosis. Thus, miR-214 plays a key role 
in the early onset of side- and shear- dependent AV disease and has a potential 




CHAPTER 5  INVESTIGATION OF THE ROLE OF INORGANIC 
PYROPHOSPHATE IN AORTIC VALVE CALCIFICATION 
 
5.1 Summary 
Aortic valve calcification is a major cause of morbidity and mortality but the 
underlying molecular mechanisms are poorly understood. In this specific aim, an 
ex vivo model of calcification in intact AVs has been developed in order to 
investigate the role of PPi in AV ectopic calcification. Porcine AV leaflets were 
cultured in serum-free medium under static conditions for 8 days, over which time 
architecture and viability were preserved. Calcification occurred predominantly on 
the fibrosa side, and required both a high phosphate concentration (3.8 mM) and 
removal of PPi with alkaline phosphatase (ALP) or inorganic pyrophosphatase 
(IP). Calcification was arrested by the bisphosphonate etidronate, a non-
hydrolyzable analog of PPi. Leaflets actively released PPi into the medium and 
this was enhanced by MLS38949, a specific inhibitor of tissue non-specific 
alkaline phosphatase (TNAP). Furthermore, leaflets synthesized PPi from 
extracellular ATP, which was reduced by β, γ-methylene-ATP, an inhibitor of 
ENPP1. Thus extracellular PPi is a key endogenous inhibitor of calcification and 
its levels appear to be controlled through synthesis by ENPP1 and hydrolysis by 
TNAP.  Future preventative therapeutics to treat AV disease could be similarly 




Aortic valve disease is a common condition and a strong risk factor for 
cardiovascular deaths (16). Unfortunately at present, the only therapeutic option 
is repair or replacement of diseased valves; to avoid surgery, there is a need for 
preventative strategies. While the initial events in valvular disease are poorly 
understood and may be multifactorial, calcification is a common endpoint that 
leads to valve failure (168). Thus targeting the calcification may be a useful 
therapeutic strategy. Calcification likely results from an imbalance between 
promoters and inhibitors of mineralization; understanding these mechanisms is a 
crucial step in developing medical therapies and tissue-engineering applications.  
 
Mineralization in other soft tissues such as arteries is controlled in large part by 
the concentrations of calcium and phosphate and by endogenous inhibitors of 
hydroxyapatite formation. Foremost among these inhibitors is PPi, which is 
present in bodily fluids at concentrations sufficient to prevent hydroxyapatite 
crystal formation (169). Removal of PPi induces vascular calcification ex vivo 
(170). Direct administration of PPi can prevent calcification in vascular system ex 
vivo and in vivo (42), and in AV interstitial cells in vitro(171).  
 
PPi is produced extracellularly from ATP through ENPP1 (172) and absence of 
this enzyme results in fatal arterial calcification (173). PPi may also be 
transported out of cells via the membrane protein ANK, absence of which also 
causes ectopic calcification (174). A key determinant of extracellular PPi levels 
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and mineralization is TNAP, an ecto-enzyme that hydrolyzes PPi. It is the robust 
expression of TNAP by osteoblasts that lowers local PPi levels and enables bone 
formation to occur (175). However, increased activity of TNAP in vascular 
smooth muscle may contribute to the vascular calcification that occurs in renal 
failure (176). This mechanism is illustrated in Figure 5.1. 
 
Figure 5.1 Tissue non-specific alkaline phosphatase and pyrophosphate  
induce and inhibit mineralization respectively, in vascular smooth muscle cells 





It is hypothesized that PPi has a similarly important role in preventing AV 
calcification. While pyrophosphate was found to inhibit calcification in interstitial 
cells cultured from AV leaflets (171), cell culture does not reflect events and 
metabolism in intact tissues. Therefore, an ex vivo calcification model was 
developed as part of this work using cultured porcine AV leaflets and used to 
examine PPi metabolism and its effect on calcification.  
 
5.4 Materials and methods 
5.4.1 Tissue harvest and preparation 
Hearts were obtained from healthy, female pigs immediately after slaughter from 
a local abattoir (Holifield Farms, Covington, GA). The AV leaflets were 
immediately excised, thoroughly rinsed, and stored in sterile Dulbecco’s 
phosphate buffered solution (dPBS; Sigma-Aldrich, MO) at 4 oC for transport to 
the laboratory. Upon arrival in the laboratory, five pieces (5 mm square) were cut 
aseptically from the basal region of each leaflet in a laminar flow hood. Each 
leaflet sample was placed in a separate well of a 12-well tissue culture plate with 
2.4 mL of DMEM (Mediatech, VA) containing penicillin and streptomycin. These 
tissues were statically cultured for 8 days in a 5% CO2 incubator at 37 °C with 
media changes every 2 days. The DMEM contains 1.8 mM calcium and 0.8 mM 
phosphate, and the phosphate concentration was increased by adding NaH2PO4. 
For use as a positive control for the calcification model, the valves were 
devitalized prior to culture by repetitive freezing and thawing (5 to 6 cycles) or 
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injured by rubbing the tissues with a cotton swab. The following additives were 
used when indicated: 1) inorganic pyrophosphatase (from Bakers’ yeast; Sigma-
Aldrich, MO), 1000 units/mL stock solution in Hanks buffered salt solution; 2) calf 
intestinal alkaline phosphatase (Promega, WI), 1000 units/mL suspension; 3) 
etidronic acid (TCI America, OR), 1 mM stock solution in distilled water; 4) 
Transforming Growth Factor-beta1 (TGF-β1) (Sigma-Aldrich, MO), 1ng/mL of 
culture media; 5) dexamethasone (Sigma-Aldrich, MO), 100 µM; 6) fetal bovine 
serum (Fisher Scientific, GA), 10% of culture media; and 7) warfarin (Sigma-
Aldrich, MO), 6.7mM stock solution in 0.5 M NaOH, pH adjusted to 7.5 to 8.0.  
 
5.4.2 Calcium incorporation 
The assay to quantify calcium incorporation was performed as previously 
described (170). Approximately 0.3 µCi/mL of 45CaCl2 (DuPont-NEN, MA) was 
added to the culture medium. At the end of the culture, the tissues were washed 
briefly twice to completely remove the culture media. The tissues were then 
incubated for an hour in a physiologic salt solution such as Hank’s balanced salt 
solution (HBSS) at room temperature to remove any soluble tissue calcium. The 
samples were then dried in an oven, weighed; and then extracted overnight in 
500 µL of 1N HCl to remove incorporated 45Ca for measurement by liquid 
scintillation. Results are expressed as nanomoles of calcium per mg, calculated 
from the specific activity of 45Ca in the medium. 
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5.4.3 Histological assessment 
5.4.3.1 Preparation of paraffin or frozen sections 
To prepare paraffin sections, the tissues were fixed in 10% neutral buffered 
formalin (Fisher Scientific, PA) for at least 24 h, then saturated in 70% ethanol 
(VWR, GA), processed in ascending grades of ethanol, embedded in paraffin, 
and cut into 5 µm sections. The blocks and the tissue sections were stored at 
room temperature. Paraffin sections were deparaffinized in xylene and then in 
descending grades of ethanol before they were used for staining.  The 
cryopreserved tissue blocks were prepared by embedding the tissue in OCT 
medium (Electron Microscopy Sciences, PA) and were frozen using liquid 
nitrogen. 5 to 7 µm sections were cut. The blocks and tissue sections were 
stored at -80 oC. These cryo sections were warmed to room temperature before 
use.  
 
5.4.3.2 Alizarin Red stain 
 Alizarin Red staining was performed with to visualize the calcification within the 
tissue. Briefly, deparaffinized paraffin sections were incubated with a 2% Alizarin 
Red (Sigma-Aldrich, MO) solution in distilled water at pH 4.1 to 4.3 for up to 5 
min. The sections were then rinsed in acetone-xylene solution and coverslipped.  
Calcium deposits appeared red when viewed under normal bright field 
microscope.  
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5.4.3.3 Verhoeff-Van Gieson elastin stain 
To visualize the overall architecture of the AV leaflet tissue a Verhoeff-Van 
Gieson elastin stain was performed.  AV leaflet samples stained with this elastin 
stain distinctly show the tri-layered components of AV ECM, fibrosa, spongiosa 
and ventricularis layers.  Elastin fibers stain blue-black to black, nuclei stains blue 
to black, collagen stains red, and muscle and other matrix components stain 
yellow. ACCUSTAIN Elastic kit (Sigma-Aldrich, MO) was used according to the 
manufacturer’s directions.  
 
5.4.3.4 Cell viability and apoptosis stains 
 Cell viability staining was performed by incubating tissues with 0.5 mg/mL 
methylthiazoletetrazolium (MTT, Sigma-Aldrich, MO) in DMEM at the end of the 
culture period for 3 h at 37 °C. The tissues were then washed with PBS 3 times 
and embedded for cryopreservation. Tissue sections of 5 to 7 µm were cut and 
then coverslipped. Viable cells appeared blue-brown when viewed under normal 
bright field microscopy. Dead cells, on the other hand, appeared colorless.  
 
Cell apoptosis stain was performed to assess the cell death of cultured AV leaflet 
tissues. This staining was done using the In Situ Cell Death Detection Kit; TMR 
red, TUNEL kit (Roche Diagnostics, Germany). Cryopreserved tissue sections 
were fixed with 4% paraformaldehyde (Sigma-Aldrich, MO) in dPBS (pH 7.4) for 
20 min, rinsed with dPBS for 30 min, permeabilized with 0.1% Triton X-100 
(Sigma-Aldrich, MO) in dPBS (2 min at 4 oC), and rinsed twice with dPBS. 
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Staining was performed by incubating tissue sections for 1 h at 37 °C in a 
humidified chamber in the dark in 50 µL of TUNEL reaction mixture followed by 
counterstaining with DAPI for 5 min. Positive control was prepared by incubating 
the fixed and permeabilized tissue section with DNAse-I solution (3-3000U/ml 
RNAse free DNAse-I (Qiagen, CA) in 50mM TrisCl (Sigma-Aldrich, MO), pH 7.5, 
1mg/mL BSA (Fisher Scientific, PA) for 10 min prior to labeling with TUNEL 
reaction mixture. A negative control was prepared by incubating fixed and 
permeabilized tissue sections in 50 µL of TUNEL label solution (without terminal 
transferase). Apoptotic cells appeared red and nuclei appeared blue under 
fluorescence microscopy.  
 
5.4.4 Imaging 
A Nikon E600 microscope (Nikon Inc., NY) coupled to a Retiga 1300C camera (I-
Cube, MD) and its bundled software Q-Capture Pro were used to acquire 
images.  
 
5.4.5 Pyrophosphate production 
Fresh AV leaflets were incubated in DMEM (3 leaflets in 1 mL) in a 5% CO2 
incubator at 37 °C with or without 30 µM MLS38949 a specific inhibitor of TNAP 
(178) (PubChem ID 2931238, kindly provided by Dr. Jose Luis Millan, Sanford-
Burnham Biomedical Research Institute, La Jolla, CA, USA). PPi content in the 
medium was measured enzymatically using uridinediphospho (UDP) glucose 
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pyrophosphorylase and UDP[14C]glucose as substrate as previously described 
(179). Synthesis of PPi from ATP was measured by incubating fresh leaflets in 
physiologic salt solution (2 leaflets in 1 mL) containing 3 nM ATP and tracer [γ 
32P] ATP with or without 300 µM β, γ-methylene ATP (an inhibitor of ENPP1) or 
30 µM MLS38949. Samples of the medium were spotted on polyethyleneimine 
cellulose plates (Sigma-Aldrich, MO) followed by development with 650 mM 
KH2PO4 (pH 3). Spots identified by autoradiography were scraped into distilled 
water and counted as Cerenkov radiation by liquid scintillation.  PPi production 
was normalized to the dry weight of the leaflets.  
 
5.4.6 Statistical analysis  
Data were expressed as mean + standard error of at least 6 samples. Normality 
of all the data was tested using the Anderson-Darling method. Student’s t-test 
was used for comparison of two groups and one-way ANOVA with Tukey’s post-
hoc test was used for comparisons between multiple groups. If not normally 
distributed, the data were analyzed by the Mann-Whitney or Kruskal-Wallis tests. 
Differences between samples were considered significant when the p-value was 
< 0.05.  
 
5.5 Results 
Raw data for all the results are included in Appendix A.20. 
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5.5.1 Effect of phosphate and phosphatase on AV calcification ex vivo 
A dose-response study (0.1, 0.2, 0.4, 0.8 units/mL) demonstrated that 0.4 
units/mL of IP resulted in calcification that is detectable both quantitatively and 
qualitatively, as shown in Figure 5.2. The incorporation of 45Ca into AV leaflets 
cultured with different phosphate concentrations for 8 days is shown in Figure 
5.3. A small uptake of 45Ca occurred without added phosphate that probably 
represents equilibration with cellular stores as previously described for cultured 
aortas (170). Incorporation of 45Ca increased at 3.2 mM phosphate and became 
significant at 3.8 mM (p<0.05 vs. 0.8 mM) but no staining was apparent with 
Alizarin Red. Incorporation of 45Ca was markedly increased by the addition of 0.4 
units/mL of inorganic pyrophosphatase (171) to the medium and resulted in 




Figure 5.2 Effect of pyrophosphatase on AV calcification: dose response.  
A) Incorporation of 45Ca in valve tissues over 8 days at different phosphate 
concentrations of inorganic pyrophosphatase at 3.8 mM phosphate. Control 
refers to leaflets cultured in 3.8 mM phosphate alone. *p<0.05 vs. any dose of 
IP., n=6-8. B) Corresponding Alizarin Red stains. F: fibrosa; V: ventricularis. 




Time course study showed that the increased 45Ca incorporation was apparent 
by 2 days (Figure 5.4) and visible by Alizarin Red staining by 4 days. Staining 
occurred predominantly on the fibrosa side of the leaflet with occasional minor 
staining of the ventricularis.  
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Figure 5.3 Effect of phosphate and pyrophosphatase on AV calcification.  
A) Incorporation of 45Ca in valve tissues over 8 days at different phosphate 
concentrations with or without inorganic pyrophosphatase. #p<0.05 vs. 0.8mM 
phosphate alone, *p<0.05 vs. 3.8 mM phosphate alone., n=6-8. B) 
Corresponding Alizarin Red stains for valves cultured in IP. A freshly isolated 
leaflet is included as a negative control (far left). F: fibrosa; V: ventricularis. 





Figure 5.4 Time course of AV calcification.  
A) 45Ca incorporation in valve tissues cultured with or without IP and 3.8 mM 
phosphate in 2, 4, 6 and 8 days. *p<0.05 vs. 2, 4 days, &p<0.1 vs. 4 days, 
#p<0.05 vs. 4, 6, 8 days; n=16. B) Corresponding Alizarin Red stains. F: fibrosa, 
V: ventricularis. Arrows point to calcified areas. 
 
 
Similar results were obtained when ALP was added to the cultures as shown in 
Figure 5.5. ALP also hydrolyzes PPi but is less specific and hydrolyzes other 
phosphorylated compounds as well (3). ALP + IP did not produce any further 
calcification beyond IP alone, indicating that this effect was solely through 
removal of PPi. Addition of TGF-β1, dexamethasone and serum to the culture 
media along with ALP also did not produce additional calcification beyond ALP 
alone or IP alone. However, the regions of calcification differed as evident in 
Alizarin Red staining. Finally, devitalization of the leaflets by repetitive freezing 




Figure 5.5 Effect of alkaline phosphatase, TGF-β1, serum, dexamethasone,  
and devitalization on AV calcification. A) Incorporation of 45Ca into AV leaflets 
cultured in different conditions as indicated. Control refers to leaflets cultured in 
3.8 mM phosphate alone. Leaflets were devitalized by freezing and thawing 
several times. *p<0.05 vs. all groups, and &p<0.05 vs. all groups; n=6-8. B) 




Warfarin was also added to the culture with or without IP and as shown in the 
Figure 5.6, warfarin induced significant calcification only when combined with IP. 
However, the extent of calcification in the leaflets was intense in the presence of 
both warfarin and IP compared to either warfarin or IP alone, as seen in the 




Figure 5.6 Effect of warfarin on AV calcification. 
A) Incorporation of 45Ca into AV leaflets cultured in the presence of warfarin with 
and without the inorganic pyrophosphatase. Control refers to leaflets cultured 
with 3.8 mM phosphates only. *p<0.05 vs. control; n =16. B) Corresponding 
Alizarin Red stains. F: fibrosa; V: ventricularis. Arrows point to calcified areas. 
 
 
5.5.2 Effect of etidronate on AV calcification ex vivo 
To confirm that the effect of IP was indeed due to removal of PPi, the 
bisphosphonate etidronate, a non-hydrolyzable analog of PPi (180) was added to 
the culture medium. As shown in Figure 5.7, etidronate completely prevented AV 




Figure 5.7 Effect of Etidronate on calcification of AV leaflets. 
A) Incorporation of 45Ca in valve leaflets over 8 days at different concentrations of 
etidronate with inorganic pyrophosphate. *p<0.05 vs. all other groups, #p<0.05 
vs. 3.8 mM phosphates only and other concentrations of etidronate. B) 




5.5.3 AV structure and cell viability ex vivo 
There were no apparent histologic changes in the leaflets after culture for 8 days 
as revealed by staining with Verhoeff-Van Gieson staining for elastin (Figure 5.8). 
Staining with methylthiazoletetrazolium, MTT (Figure 5.9) indicated that cell 
viability of AV tissues was maintained during culture. As expected there was no 
staining in devitalized leaflets. Consistent with MTT staining results, TUNEL 
staining did not reveal any apoptotic cells (Figure 5.10). Addition of phosphate, 
IP, ALP or etidronate did not alter histology or viability. However, cell viability or 
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apoptosis in the presence of TGF-β1, dexamethasone, serum and warfarin was 
not tested.  
 
 
Figure 5.8 Verhoeff-Van Gieson elastin stain shows preserved AV structure 
under various culture conditions. Arrows point to elastin fibers oriented along the 
length of the tissue. F: fibrosa, V: ventricularis. A freshly isolated AV is included 




Figure 5.9 MTT stain shows preserved viability of AV tissue 
under various culture conditions. Leaflets devitalized (positive control) by freezing 
and thawing several times show no staining. F: fibrosa, V: ventricularis. A freshly 




Figure 5.10 TUNEL stain for apoptosis. 
Apoptotic nuclei stain red superimposed on the blue DAPI counterstain. Positive 
control: after treatment with DNase; negative control: without TMR red stain. 
Arrows point to apoptotic cells.  Fresh and cultured leaflets each had less than 
0.2% positive cells (out of >500 counted). F: fibrosa, V: ventricularis. 
 
 
5.5.4 Synthesis of Pyrophosphate from AV Leaflets 
Leaflets were capable of producing PPi, as shown by the appearance of PPi 
(measured by enzyme assay) in the medium (Figure 5.11A). MLS38949, an 
inhibitor of TNAP, was added to prevent hydrolysis of PPi. There was rapid 
appearance of PPi within the first hour and, in the presence of MLS38949, this 
continued to increase. 
 155 
 
Figure 5.11 Synthesis of pyrophosphate from AV leaflets. 
A) Quantification of PPi released into the medium from AV leaflets incubated with 
or without 30uM MLS38949 (an inhibitor of TNAP as a function of time). *p<0.05 
vs. no MLS38949 at 5 h. n=4. B) Autoradiogram of a representative thin-layer 
chromatogram after incubation of valve leaflets with [γ32P] ATP in 3 nM ATP with 
or without 30 µM MLS38949, an inhibitor of TNAP or 300 µM β,γ-methylene ATP, 
an inhibitor of ENPP1. All the exogenous ATP was consumed in 5 min. Control 
leaflets were incubated without any inhibitors. C) Quantification of PPi production 
by AV tissue from ATP. *p<0.05 vs. control. 
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ENPP1 is the sole enzymatic source of extracellular PPi. To determine whether it 
is active in valve tissue, freshly isolated leaflets were incubated with [γ32P] ATP. 
Disappearance of ATP was rapid and complete by 5 min, with most of the ATP 
hydrolyzed to orthophosphate (Figure 5.11B, and C). However, a small amount 
of 32PPi was apparent and this was reduced upon addition of β, γ-methylene 
ATP, an inhibitor of ENPP1 (181), indicating that 32PPi was being synthesized by 
the leaflets and was not merely a contaminant of the [γ32P]ATP. The amount of 
32PPi was significantly increased when the TNAP inhibitor MLS38949 was added. 
 
5.6 Discussion 
Valve leaflets cultured under serum-free conditions maintained viability and 
normal morphology for at least 8 days. Under these conditions, calcification 
required an elevated phosphate concentration and the addition of inorganic 
pyrophosphatase. This calcification occurred mostly in the fibrosa as seen in 
humans in vivo, although there was occasional calcification of the ventricularis 
side. This is consistent with previous clinical and experimental findings that have 
shown that fibrosa is more prone to mineralization compared to ventricularis (1).  
In AVs from patients with end-stage renal disease, a hyperphosphatemic, low 
pyrophosphate condition (182), calcification is also primarily within the fibrosa 
with occasional involvement of the ventricularis (O’Neill, W.C., unpublished data).     
 
The effect of phosphate is likely due to promotion of CaH2PO4 crystallization and 
subsequent hydroxyapatite formation (169) but phosphate may also induce 
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cellular changes including osteogenic differentiation that may promote 
mineralization (38). Serum phosphate is a known risk factor for valvular 
calcification in CKD (27, 37). The requirement of IP is probably related to removal 
of PPi, a critical endogenous inhibitor of calcification. Inhibition of calcification by 
etidronate, a non-hydrolyzable PPi analog is consistent with this. Unlike IP, which 
selectively hydrolyzes PPi, ALP can hydrolyze other phosphorylated compounds 
as well such as osteopontin, another endogenous inhibitor of calcification (3). 
The fact that ALP did not produce additional calcification when added with IP 
suggests that other phosphorylated inhibitors are not active in cultured AV 
leaflets.  
 
TGF-β1, dexamethasone and serum are commonly used additives in osteogenic 
media to induce calcification in AV leaflets (17, 102, 151, 183) were added to the 
culture medium to determine their calcification potential independent of each 
other. Although the addition of neither of these compounds induced higher 
calcification compared to that of ALP or IP alone, the distribution of calcification 
nodules within the AV leaflet tissue differed. This suggests that the underlying 
mechanisms by which these compounds induce calcification might be different. 
However, no further experiments were carried out to understand these different 
mechanisms, as the focus of this aim is to specifically understand the role of 
pyrophosphate in AV calcification. As expected, the significant calcification after 
devitalization is consistent with loss of calcification inhibitors although cell 
necrosis could become a nidus for dystrophic calcification (5). 
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Warfarin is a commonly administered anti-coagulant to patients receiving 
vascular devices or grafts. Warfarin, a vitamin K antagonist can induce arterial 
and valvular calcification by potentially inhibiting MGP, an endogenous inhibitor 
of calcification (184, 185). This process inactivates the putative calcification-
inhibitory activity of MGP.  Although addition of warfarin did not induce further 
calcification quantitatively, the amount of calcification within the tissue was 
severe compared to the control group or IP alone, as seen in the Alizarin Red 
staining. The investigation on warfarin induced AV calcification in this study is 
only to demonstrate a possibility, and a proof of concept.  Further in-depth 
studies are warranted to understand this response and specifically the role of 
warfarin, and its possible interactions with PPi or TNAP or other regulators of 
calcification.  
 
Thus, the role of PPi in inhibiting AV calcification observed in this study is 
consistent with a previous study in cultured valvular interstitial cells and with the 
known inhibitory role of PPi in vascular calcification. Similar effects of IP and ALP 
were observed in cultured aortas (170, 176). Bisphosphonates, which are non-
hydrolyzable analogs of PPi, also prevent vascular calcification in culture and in 
vivo (186, 187). Although PPi is present in the circulation at concentrations that 
can inhibit calcification (169), it is clear from the results that valve tissue can 
synthesize PPi that could act locally. Valve leaflets generated PPi from added 
ATP, which significantly decreased in the presence of β, γ methylene ATP, an 
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inhibitor of ENPP1. This enzyme is a major source of extracellular PPi and 
deficiency of ENPP1 results in severe arterial calcification in humans (188) and 
mice (173). Since β,γ methylene ATP interferes with the assay of PPi, it is not 
possible to determine the contribution of ENPP1 to net PPi synthesis by the 
leaflets. Another potential source of extracellular PPi is the putative membrane 
transporter ANK but since there are no known inhibitors, its contribution cannot 
be determined.    
 
Paradoxically, ENPP1 expression is increased in calcified valves (189)  and has 
been proposed to promote calcification by reducing extracellular ATP levels 
(thereby promoting apoptosis) and increasing phosphate levels. However, the 
studies supporting this were performed in cultured cells and the amount of 
phosphate that could be generated from extracellular ATP is minimal compared 
to ambient phosphate levels. While this remains a possible mechanism, the 
current results demonstrate that simple removal of PPi without altering ENPP1 is 
sufficient to produce calcification, indicating that ENPP1 activity is required to 
prevent calcification. It is possible that the increased ENPP1 expression in 
calcified valves is a compensatory response to the calcification or a local 
deficiency of PPi. 
 
TNAP hydrolyzes PPi and also regulates the availability of PPi in the vascular 
tissues (175), being responsible for almost 50% of the PPi hydrolysis in vascular 
smooth muscle. Inhibition of TNAP significantly increased the production of PPi 
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by AV leaflets, indicating that this enzyme also influences the levels of PPi in the 
AV. Consistent with this, elevated ALP activity has also been reported in calcified 
valves (190).  
 
This tissue-based model offers substantial advantages over cultured cells 
because a normal extracellular matrix and both valve interstitial and endothelial 
cells are present. In addition, the serum-free culture medium avoids potential 
problems related to the myriad of growth factors, cytokines, and compounds 
present in serum. The absence of serum did not affect cell viability (Figure 5.9 
MTT stain shows preserved viability of AV tissue).  
 
5.7 Limitations 
In this study, the cultures were performed under static conditions, which do not 
reflect the dynamic mechanical environment in vivo that differs on either side of 
the leaflets. Even in static cultures, our results show that AV leaflets are capable 
of producing PPi, the levels of which are intricately regulated by the expression of 
ENPP1 and TNAP. Since mechanical stimuli have significant effects on cell 
metabolism in valve tissue (10), the metabolism of PPi is likely to be affected as 




The results of this study demonstrate a critical role for pyrophosphate in AV 
calcification and suggest important roles for ENPP1 and TNAP in controlling PPi 
levels in valvular tissue.  
 
Figure 5.12 Schematic showing the conclusions of specific aim 3. 
 
Thus agents that enhance ENPP1 activity or inhibit TNAP could be potential 
therapies. Although PPi could be administered to treat AV calcification, it is 
subject to rapid hydrolysis in vivo (42). Bisphosphonates, which are non-
hydrolyzable analogs of pyrophosphate, have been shown to inhibit vascular 
calcification in animal models. These are a potential alternative, but could have 
unknown effects on bone metabolism. 
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CHAPTER 6  DISCUSSION 
 
Calcific aortic valve disease is a multifactorial disease and a major risk factor for 
cardiovascular related deaths in elderly population (16, 168). Calcified AV leaflets 
show signs of endothelial damage, inflammation, macrophage infiltration, and 
bone formation preferentially in the fibrosa compared to ventricularis (9). The 
focus of this thesis was to improve our current understanding of the molecular 
mechanisms involved in this preferential pathogenesis in the fibrosa. The overall 
hypothesis of this work was “sclerosis, inflammation, and calcification 
preferentially occur in the fibrosa compared to the ventricularis due to differential 
gene expression and oscillatory shear stress”. This hypothesis is represented in 
a schematic (Figure 6.1) and was tested by three specific aims using porcine AV 
leaflets with an ex vivo approach: 1) identification of the side- and shear-
dependent miRNAs (miR-181a, and miR-214) involved in AV sclerosis, 
inflammation and calcification, 2) determination of the relationship between a key 
side- and shear-dependent miRNA, miR-214 and AV pathogenesis, and 3) 
investigation of the role of pyrophosphate in AV calcification. This chapter 
discusses the key findings of these specific aims in the context of the overall 




Figure 6.1 Schematic showing the overall hypothesis of this dissertation. 
 
6.1 Low magnitude oscillatory shear stress induced a pro-sclerotic, -
inflammatory and -calcific environment in the fibrosa compared to the 
ventricularis  
The oscillatory shear stress (OS) induced calcification in the fibrosa compared to 
the ventricularis, similar to the calcified valves (9). The OS also changed the 
collagen composition (decreased mature, and increased young, nascent collagen 
fibers), increased collagen turnover (Col1a1) in the fibrosa compared to the 
ventricularis exposed to OS or LS. These changes constitute active remodeling 
in the fibrosa and can explain the observed OS induced increase in thickness of 
the fibrosa. Further, OS also decreased the atheroprotective markers (Enos, 
Klf4) in the fibrosa creating a pro-inflammatory environment. Selective ECM 
remodeling and loss of anti-inflammatory markers in the fibrosa are also 
observed in sclerotic valves (1). These findings suggest that OS promoted 
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calcification in the fibrosa by altering the ECM and inducing a pro-inflammatory 
environment.  
 
6.2 Side-and shear-dependent miRNA, miR-214 is potentially involved in 
AV sclerosis but not inflammation and calcification 
As the miRNAs are recognized as key regulators of gene expression in both 
cardiovascular and valvular diseases (22, 156), their involvement in OS induced 
AV pathogenesis was investigated. Further, the active ECM remodeling observed 
in the fibrosa exposed to OS, can also affect the miRNA expression (121), gene 
expression changes and vice versa (25, 145). In response to OS, two miRNAs 
(miR-181a and 214) showed side-dependency as they were highly expressed in 
the fibrosa but not ventricularis. The side- and shear-dependency of these two 
miRNAs corroborate the previous observation that the miRNAs are differentially 
expressed on either side of the valve and are mechanosensitive (22).  
 
Of the 5 potential mRNA targets tested, only Klf4 was significantly upregulated 
upon silencing miR-214. It can be speculated that miR-214 regulates Klf4, and is 
involved in the OS dependent inflammation (155, 164) induced in the fibrosa. 
Since silencing of miR-214 did not significantly affect the expression of Icam1, 
Vcam1, and Bmp4, or calcium levels, miR-214 may not be directly involved in AV 
inflammation and calcification. However, miR-214 silencing significantly 
decreased Tgfβ1 indicating that miR-214 may be involved in pathways regulated 
by Tgfβ1 such as fibrosis and EndoMT (143, 145, 151, 159, 161). It is interesting 
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to note that anti-miR-214 inhibited some markers of EndoMT inducers such as 
Tgfβ1 while rescuing expression of anti-Endo-MT markers (VE-Cadherin and 
Klf4), supporting the potential role of miR-214 in Endo-MT pathway. However, 
anti-miR-214 showed no effect on Sma, another key EndoMT marker.  These 
results suggest the complex role of miR-214 and that it may work in concert with 
other miRNAs to regulate the AV pathophysiology. 
 
Thus, the miR-214 can mediate OS induced fibrosis and Endo-MT (changes in 
Tgfβ1, Klf4, VE-Cadherin, Col1a1, and ECM architecture and fibrosa thickening) 
(Figure 6.2). Also, the increased expression of miR-214 in response to OS may 
be indicative of the early stages of AV pathogenesis. Given the critical role for 
Tgfβ1 and Klf4 in cardiovascular pathophysiology, we propose that miR-214 is a 
key miRNA involved in early AV pathogenesis in a side- and shear- dependent 
manner. Further research is warranted to understand the complex functional role 
of miR-214 in mediating AV inflammation and calcification. 
 
6.3 Cyclic stretch and hypertensive pressure can cause greater damage to 
AV compared to the OS 
As discussed previously (section 6.1), the OS initiated calcification in the AV 
leaflets, preferentially in the fibrosa compared to the ventricularis. Under similar 
culture conditions (media: osteogenic, culture duration: 7 or 8 days), the extent of 
calcification in AV leaflets as a result of elevated cyclic stretch (15%) and severe 
hypertension (160/100 mmHg) alone was remarkably higher than that induced by 
the OS. It is well known that hypertension and elevated leaflet stretch are 
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associated with the calcific AV disease (17, 78). It appears that the increased 
strain of the leaflets as a result of hypertension (64) can possibly induce more 
damage to the AV leaflets than the OS. This is an interesting result from this 
dissertation and warrants further investigation.  
 
6.4 Inorganic pyrophosphate prevents the AV ectopic calcification  
Inorganic pyrophosphate is well known to inhibit the ectopic calcification of blood 
vessels (170).  Pyrophosphate appeared to play a similarly important role in AV 
as its removal lead to calcification in AV leaflets. The specificity of PPi was 
demonstrated when etidronate (a synthetic non-hydrolyzable analog of PPi) 
prevented this calcification induced by the removal of PPi. Similar to the 
vasculature (170), the levels of PPi in AV leaflets seemed to be regulated by the 
TNAP as the production of PPi increased markedly when TNAP was inhibited. 
Moreover, a significant amount of PPi came from ATP in AV leaflets via the 
action of an enzyme, ENPP1. Based on these findings, the increased expression 
of ENPP1 observed in calcified AVs (171) could be a compensatory response to 
the calcification or a local deficiency of PPi induced by the high expression of 
TNAP (190). The pyrophosphate thus, protects the valve from calcification and its 
expression is likely regulated through the synthesis by ENPP1 and hydrolysis by 
TNAP. Furthermore, the synthetic analogs of PPi or inhibitors of TNAP could be 
good candidates as therapeutics to prevent AV calcification.  
 
6.5 Proposed AV disease mechanisms  
We believe that AV calcification is a multifactorial disease and thus, based on our 
findings, two distinct, yet plausible mechanisms are proposed as shown in the 
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Figure 6.2. The dashed lines in the schematic show the possible feedback 
mechanisms as previously explained in section 6.2.  
 
Figure 6.2 The proposed pathways that lead to calcific AV disease.  
The dashed lines show the possible mechanisms and feedback loop. 
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CHAPTER 7  CONCLUSIONS  
 
The focus of this thesis was to understand the basis for this increased 
susceptibility of the fibrosa to sclerosis, inflammation, and calcification. The 
calcification model developed by Balachandran et.al (17) was used in conjunction 
with the ex vivo shear system to induce side-dependent calcification.  
The oscillatory nature of the shear stress at a low magnitude induced calcification 
preferentially in the fibrosa compared to the ventricularis, in a manner consistent 
with the calcification patterns observed in diseased human AVs (1, 9). The low 
magnitude oscillatory shear stress (OS) possibly predisposed fibrosa to side-
dependent calcification via increasing collagen turnover (Col1a1), and thickening 
of the ECM (fibrosis) and decreasing the expression of genes that protect 
endothelial function (Klf4 and Enos). The unidirectional pulsatile shear, LS, 
however, preserved the ECM and gene expression in the ventricularis.  
The involvement of miRNAs in OS mediated AV pathogenesis was also 
investigated.  Several groups have investigated the function of miRNAs in an in 
vitro setting (22, 107, 191, 192); however, the cell culture does not reflect events 
and metabolism in intact tissues. In this work, we are the first to investigate the 
role of a miRNA in AV pathogenesis in an ex vivo setting in a shear-dependent 
manner. The miR-214 was found to play a role in this OS induced pathogenesis 
in fibrosa but not ventricularis. An ex vivo miR silencing protocol was also 
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developed to perform the miRNA functional studies. The anti-miR was 
successfully delivered to both endothelial and interstitial cells of the AV tissue 
without compromising the cell viability. The miR-214 silencing studies showed 
that this OS induced pathology in the fibrosa is likely to be mediated via miR-214, 
klf4 and Tgfβ1 dependent pathway that can lead to AV fibrosis, Endothelial-to-
mesenchymal transition and eventually sclerosis. The miR-214, however, did not 
play a role in shear-induced inflammation and calcification. The miR-214, as 
such, is likely to play a key role in the early onset of side- and shear- dependent 
AV disease and has a potential to serve as a disease biomarker.  
This dissertation also focused on understanding the role of pyrophosphate in 
inhibiting AV calcification. The protective role of PPi is well known in vascular 
calcification (4, 170), and in calcified AVs (171). For the first time, this work 
showed that AV leaflets actively synthesize PPi from ATP through an enzyme, 
ENPP1. The PPi in turn protects AV leaflets from calcification. Calcified AVs 
contain elevated levels of tissue non-specific ALP (190), TNAP that hydrolyzes 
PPi and decreases its protective action. The PPi is rapidly hydrolyzed in vivo as 
such, PPi cannot be administered directly to treat AV calcification (42). The 
synthetic non-hydrolyzable analogs of PPi such as Etidronate can be used to 
treat or slow down AV calcification, as shown in our study. Thus, the agents that 
inhibit TNAP activity or increase the ENPP1 activity could be potential therapies. 
 
To conclude, the role of miRNA(s) in OS mediated side-dependent AV 
pathogenesis was studied in this work.  This thesis provided preliminary evidence 
 170 
that stretch and hypertension may be the major players inducing calcification in 
AV compared to the OS. The potential of synthetic analogs of PPi for use as a 
drug to inhibit AV calcification was also demonstrated. These findings add more 
knowledge to the existing information on the molecular mechanisms involved in 
AV calcification. Furthermore, the findings from this thesis can be used as a 







CHAPTER 8  RECOMMENDATIONS AND FUTURE WORK 
 
This chapter details the recommended future work – both short tem and long 
term, based on the findings in this dissertation.  
 
8.1 Short term projects 
8.1.1 Role of miRNAs in pathogenesis of AV calcification 
The miRNAs are key regulators of gene expression and serve as biomarkers for 
cardiovascular diseases. Our findings corroborate recent evidence that miRNAs 
also play an important role in AV pathogenesis (22, 106). Further, the findings 
and methods developed in this dissertation opened several new avenues for this 
exciting new area of research. Of the two side- and shear-sensitive miRNAs 
(miR-181a and miR-214) identified in this thesis, only miR-214 was further 
investigated as part of this dissertation. Interestingly, miR-214 seemed to be 
involved in oscillatory shear stress, OS mediated AV sclerosis but not 
inflammation and calcification. However, shear studies should be carried out for 
longer culture durations in both regular and calcification media (at least 7 days) 
to confirm this observation. Alternatively a pre-miR-214 can also be transfected 
in fibrosa exposed to OS to determine if the overexpression of miR-214 
aggravates inflammation and calcification of AV. One of the challenges of this 
work was that the size of the sheared tissue was not large enough to isolate 
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good quality and quantity of protein. This is the major reason why the targets 
were only validated at the mRNA level but not at protein level. In future studies, 
the ex vivo cone and plate shear system should be modified to accommodate an 
AV tissue size greater than 7 mm dia (current size).  
 
In addition, it would also be interesting to see how miR-214 behaves in elevated 
stretch and hypertension mediated AV inflammation and calcification Also, since 
miR-181ais strongly involved in inflammation and lipid metabolism in vasculature 
(125, 126, 129), future studies can also focus on understanding the role of miR-
181a in AV inflammation and calcification. 
 
8.1.2 Synthesis and regulation of pyrophosphate by the dynamic mechanical 
environment experienced by the AV  
AV leaflets actively synthesize PPi, which inhibits calcification. The PPi levels are 
regulated by the TNAP. We also showed that AV leaflets synthesize PPi from 
ATP through the enzymatic action of ENPP1. A transmembrane protein, ANK, 
maintains the circulating levels of PPi and the absence of ANK results in ectopic 
calcification (174). The function of ANK and its regulation of PPi in AV leaflets 
were not verified in this dissertation and should be pursued in future studies.  
 
This dissertation is the first to report a systematic investigation of the role of PPi 
in healthy porcine AV leaflets. These studies were carried out using freshly 
isolated and statically cultured AVs. However, the AV experiences a dynamic 
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mechanical environment, which likely changes the mechanism by which the PPi 
and TNAP are regulated. Since ANK and ENPP1 are mechanosensitive (193), 
their enzymatic activity will also possibly change in the presence of physiological 
and altered mechanical stimuli.  As synthetic analogs of PPi offer great potential 
to treat or slow down AV calcification, understanding how PPi is regulated in a 
mechanical environment, will aid in developing therapeutics to treat AV 
calcification.  
 
8.1.3 Warfarin and AV calcification  
Warfarin (common name: Coumadin) is a widely used anti-coagulant in patients 
receiving cardiovascular or valvular devices. However, warfarin administration is 
associated with several side effects and has been shown to interfere with the 
calcification process (185). It is a vitamin K antagonist that can induce arterial 
and valvular calcification by potentially inhibiting gamma-carboxylation of matrix 
Gla protein, an endogenous inhibitor of calcification (184, 185). This dissertation 
presented some evidence that use of warfarin can increase the tendency of AV 
leaflets to calcify. Further in-depth studies are warranted to understand this 
response. Specifically the role of warfarin or any vitamin K antagonist drug and 
that drug’s possible interactions with PPi, TNAP, or other regulators of 




8.2 Long term projects 
 
 
Figure 8.1 Understanding the miRNAs involved in side-dependent AV  
disease will aid in identification of biomarkers for early AV disease  
detetction and therapies. 
8.2.1 Effect of combined mechanical stimuli: stretch, pressure and shear in 
mediating aortic valve pathogenesis 
Independent reports on isolated effects of elevated stretch, pressure and shear 
stress on AV are available (17, 22, 83, 84, 102). However, different culture 
conditions prevent us from making a holistic comparison. This dissertation 
showed preliminary evidence that under similar culture conditions (media: 
osteogenic media, duration: 7 or 8 days), elevated stretch and hypertensive 
pressure induced significantly higher calcification in AV leaflets compared to the 
OS. However, supplementary studies need to be performed to understand if 
elevated stretch and hypertension activated additional mechanisms that resulted 
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in this increased calcification compared to the OS.  For these purposes, future 
studies could start by looking at the extracellular matrix characterization and 
remodeling, activation of valvular interstitial cells, and expression of pro- and 
anti- inflammatory markers in response to each of these mechanical stimuli.  
 
Additionally, future studies can also focus on developing a tissue bioreactor that 
can expose the entire valve and its aortic root to its native and altered dynamic 
mechanical environment. This enables us to look at the combined effect of each 
of the stimuli (stretch, pressure and shear) and to understand how these stimuli 
act in synergy. For instance, a recent study showed that isolated stretch 
increased the expression of α-SMA in AV leaflets, whereas pressure decreased it 
(83). When both stretch and pressure were combined, the expression of α-SMA 
was comparable to that of freshly isolated AV leaflets. Thus, these studies 
definitely provide us additional cues on AV calcification mechanisms.  
 
8.2.2 miRNA based biomarkers and therapies for AV calcification  
The regulation of gene expression by miRNAs is complex and is cell, tissue, 
mechanics and time dependent. The expression of miRNAs is precisely 
controlled in physiological state, and is sensitive to changes such as 
development, environment changes, diseases, and therapies. As such, the 
miRNAs have great potential to serve, as biomarkers for early identification of 
pathogenesis for a variety of cardiovascular diseases (88). For example, based 
on the findings in this dissertation, miR-214 can be potentially linked to the early 
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shear-dependent AV pathogenesis. Since calcific AV disease is a multifactorial 
disease, further investigations as to how this miRNA is regulated in conjunction 
with other miRNAs and cytokines in vivo are warranted. Thus, a complete 
understanding of the regulatory mechanisms of miRNAs and the gene 
expression is the most important issue at present as this knowledge is essential 
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A.2.1 System description 
Ex vivo tissue studies require the maintenance of mechanical and biochemical 
environments close to physiologic conditions. The present cone-and-plate tissue 
culture system has been designed to expose tissue samples to well-defined 
shear stress conditions. The design consists of a servo motor coupled to a cone 
placed on top of a stationary dish. The motor is controlled by a servo drive 
programmed via a computer. Fluid flows within the gap between the cone and 
the plate. In the present design, the cone features an angle of 0.5° and is located 
200 microns above the surface of the plate.  
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Figure A. 2. 1 Cone and plate shear stress bioreactor set up. 
 
 
This particular geometry allows for the production of a nearly-uniform shear 
stress environment in the flow, and more particularly at the surface of the plate. 
Since the shear stress level is directly related to the cone angular velocity, 
desired temporal shear stress variations can be imposed by rotating the cone at 
specific angular velocity waveforms. The production of a desired angular velocity 
waveform can be monitored in real time via a digital/analog acquisition card 
interfacing between the computer and the servo motor. 
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Although similar devices have already been used extensively in biomedical 
research to subject cells to uniform shear stress environments, they have not 
been adapted to accommodate whole pieces of tissue. The present novel design 
can accommodate circular tissue samples (7 mm diameter) flush mounted in the 
bottom plate to avoid any perturbation to the surrounding flow, and thus, to the 
uniformity of the surrounding shear stress environment. Nine equi-angularly 
spaced cylindrical wells are machined in the plate, each accommodating a 
sample holder. The tissue sample placed at the top of the holder is clamped in 
position by a plate cover such that the top surface of the sample coincides with 
that of the plate cover. The particular geometry of the plate cover exposes a 
circular sample region of 5 mm in diameter. The system can be used to expose 
various types of tissues to steady, pulsatile or oscillatory shear stress. A picture 
of the complete apparatus is shown in Figure A. 2. 1.  
 
A.2.2 Cone assembly 
As shown in the Figure A. 2. 2, the cone assembly consists of a cone attached to 
a shaft. The cone is made of Delrin plastic while the shaft is made of stainless 
steel. The cone is coupled to the shaft via three screws. The cone features an 




Figure A. 2. 2 Cone assembly: top view (A) and front view (B) 




The plate (Figure A. 2. 3) is machined in a cylindrical rod of polycarbonate. Nine 
equi-angularly spaced cylindrical wells (7-mm diameter) are located at a radius r 
= 20 mm from the center. The internal and external lateral surfaces can be 
polished to enhance optical access, if needed. Each well can accommodate a 
tissue sample holder.  
 




A.2.4 Plate cover 
The function of the plate cover is two-fold: to expose a smooth flat piece of tissue 
to the flow, and to clamp the tissue samples in position on top of the holders. The 
plate cover is a thin circular plate of polycarbonate screwed on top of the tissue 
wells located in the plate. Nine equi-angularly spaced holes are machined in the 
plate cover, aligned with the wells of the plate.  
 
 
Figure A. 2. 4 Plate cover with nine equi-angularly spaced holes 




The holes are chamfered at an angle of 45° such that the hole diameter on the 
lower surface of the plate cover is equal to the diameter of the well machined in 
the plate, and the hole diameter on the upper surface of the plate cover is equal 
to the diameter of the circular surface at the top of the holder (i.e., 5 mm) (Figure 
A. 2. 4). The chamfered surface presses on the tissue sample to maintain it in 
position on top of the holder. 
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A.2.5 Agarose bed within tissue wells 
The function of the agarose bed is to position the circular tissue samples at the 
center of the wells and to maintain them at a certain distance from the plate 
surface. 1.2% agarose was found to be well suited for this purpose. The agarose 
can be autoclaved to ensure sterility. Thereafter, they should be stored in a 4oC 
refrigerator until use. Before insertion into the cone and plate, the bottle of 
agarose is first microwaved to liquefy the agarose for manipulation. To ensure 
the agarose bed had the suitable shape within the well, the plate cover is first 
coupled with the plate, such that the wells are empty spaces accessible through 
holes in the plate cover. About 715-800 µL of agarose is then pipetted into each 
well, and allowed to solidify for atleast 15 min. The plate cover is then removed, 
leaving the agarose in the required shape within the wells. However, care must 
be taken to minimize breakage of the agarose pieces during removal of the plate 
cover. To achieve this, a curved tweezer can be gently inserted between the 
plate cover and the agarose to loosen the contact before removing the plate 
cover. At this stage, however, the agarose has a meniscus to its top surface. 2 
drops of agarose can be placed into this meniscus to flatten it after removing the 
place cover. Once the additional agarose solidifies, trimmed valve leaflets can be 
placed on the agarose, and the plate cover can be re-attached to the plate. The 
agarose height may have to be adjusted depending on the thickness of the 








The flange closes the system to ensure sterility and accommodates the two ball 
bearings driving the cone and shaft assembly in rotation. The lip machined on the 
edge ensures a correct centering of the flange with respect to the plate and the 
rest of the system. The flange is made of polycarbonate. A shaft collar placed on 
the cone shaft allows the adjustment of the vertical distance between the cone 
apex and the surface of the plate cover. The collar is maintained in position via a 
setscrew. The first prototype is shown in Figure A. 2. 6A. A new flange has been 
designed. In this new design, nine holes are machined around the perimeter of 
the flange and intersect with a groove machined in the flat circular surface 
located at the bottom of the flange. The function of those channels is to ensure 
proper gas exchange by bringing air from the surroundings into the device. The 
axes of the holes machined on the perimeter of the flange are horizontal to 




Figure A. 2. 6 Flange design: A) picture of the prototype 
(no gas exchange capability); and B) clipped CAD rendering of the newly 
designed flange (with gas exchange capability). 
 
 
A.2.7 The perfusion system 
Since the cone and plate system has orifices to allow gas exchange, the small 
amount of media fluid within the bioreactor can easily dry out. To prevent this, a 
reservoir is attached to the system, allowing at least 50 ml of media to be stored, 
and a slow peristaltic pump (SP200FO, APT Instruments, Rochester, IL) is used 
to circulate the media into and out of the cone and plate system. Threaded luer 
lock fittings were installed on the plate portion of the bioreactor, and the 
reservoir, such that small diameter (1/8” ID) tygon® tubing (B-44-3, McMaster 
Carr, Atlanta, GA) can be used to connect the reservoir to the pump, from the 
pump to the plate portion of the bioreactor, and from the plate back to the 




Figure A. 2. 7 Schematic of the perfusion system. 
 
 
A.2.8 Suction table, suction lid and motor table 
A suction table has been designed to maintain the system in position while the 
cone is rotating. The table is made of polycarbonate and can accommodate four 
cone-and-plate systems. Four sets of concentric suction channels are machined 
in the table. Those channels are connected by two transversal channels and a 
central channel with inlet located at the front of the suction table. Four 
polycarbonate rods are screwed in at the corners of the suction table to support 
the motor table (Figure A. 2. 8). The diameter of the rods (19 mm) is large 
enough to stabilize the entire assembly even in presence of the inherent 
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vibrations produced by the servo motor. Figure A. 2. 9 shows the different 
elements assembled and mounted on the motor and suction tables. 
 
 
Figure A. 2. 8 Design of the suction table. 
A) suction table and motor table; B) detail of the concentric channels; and C) 




Figure A. 2. 9 Complete system. 
 A) different elements assembled and mounted on the motor and suction tables; 
B) details of the cone-and-plate assembly mounted on the suction lid; and C) 
clipped CAD rendering of the whole assembly. 
 
 
A.2.9 Driving system 
The driving system used to rotate the cone at the desired angular velocity 
waveforms consists of a rotary servo motor and a servo drive/controller. The 
single-axis controller/drive used in the present setup (Figure A. 2. 10) offers 
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complex program and I/O capabilities. The servo drive/controller powered by a 
DC power block can be programmed using a commercial software package 
supplied with the product. The rotary servo motor chosen in the current setup 
was dimensioned to provide the necessary torque and velocity to subject the 
tissue samples to a maximum shear stress of 100 dyn/cm2.  
 
 
Figure A. 2. 10 Driving system set up. 
 
 
A.2.10 Programming the servo drive 
We use the compiled waveform method to program all of our shear stress 
waveforms. This involves the sectioning off of the waveform into hundreds of 
small segments. For each segment, the velocity and the distance traversed 
under that velocity are programmed into the drive. A second program will then 
need to be created to compile the first program and then loop it.  
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 Program 1 
del name  ---> This deletes anything stored under this program name.  
def name  ---> This assigns the program the new name 
mc01       
A400      ---> Defines acceleration at which motor switches between velocities 
V0.82133  ---> Velocity in RPS 
D28       ---> Distance traversed at this velocity (note: 4000 units per rotation, 
               double check that this is the setting for your specific motor) 
GOBUF1    ---> Command to complete segment 










The distance D has to be a whole number. To rotate in the opposite direction, 
enter a negative distance. Once the maximum desired velocity is reached, you 
will need to enter a deceleration command (ad instead of A as we did in line 4) 
right after the last GOBUF1 command of the accelerating segment and before 
 198 
inserting the new decelerating segments. This must be done every time the 
acceleration changes from positive to negative or vice versa.   
 
 Program 2 
del rname  
DEF rname  
 
PCOMP name  ---> compiles the segments of program “name” 
L0          ---> begin loop 
PRUN tauh   ---> run program  
T0.31       ---> inserts a time delay of .31 seconds. Insert delay as needed. 
LN          ---> defines the infinite loop 
END 
 
Write these programs in the program editor and download to the servo drive. 
Once downloaded, you will only need to run the second program (type rname in 
the terminal). You will need to read the manual or contact tech support to learn 
the basic operations of the servo drive and motor (how to turn on and off and 
how to activate the motor). 
 
A.2.11 Analog monitoring 
To monitor the waveform in real time, you will need to connect two sets of cables 
to the Data acquisition card. This is not being actively carried out all the time, 
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since this shear system and its servo motor components have been well 
established over years. However, in case there is a need to troubleshoot and 
monitor the output of the motor, follow this protocol. The analog cable which will 
output a voltage is connected from pin 21 and 25 (ground). Refer to page 75 of 
the hardware installation manual for a schematic. The digital output will be used 
as a trigger. This trigger will be programmed to function when the motor stops 
and starts running. Refer to page 73 of the hardware installation guide for a 
schematic of the digital outputs. 
 
A.2.12 Analog outputs 
There are a few commands to activate the analog output. Analog output A is on 
pin 21 and analog output B is on pin 22. They both do the same thing. Ground is 
on pin 25. A cable should connect these pins to the Analog In connections on the 
DAQ card (Figures 1 and 2 of the hardware installation guide). 
The commands are: 
DMONAV 5 – programs output A to velocity.  
DMONBV 5- same as above but for output B 
DMONAS- scaling factor 2000 corresponds to 1rps=.975V;  
1000 corresponds to 1rps=.487 
  
Determining the scaling is a bit tricky since it is drive specific. The easiest thing to 
do is run the motor at 1 rps and connect the probes of a voltage meter directly to 
pins 21 and 25 and measure the voltage. Alter the ratio of voltage/velocity with 
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the DMONAS command. Remember, your max and min voltage has to be within 
-10 to +10 so scale in a manner such that you're max and min velocities are 
included. 
 
DMONAV 24- This command will allow you to test if the outputs are functioning 
properly. Enter this command and rotate the shaft with your hand. You should 
notice voltage fluctuation on the instrument being used to measure (make sure 
you enter the drive0 command to deactivate the drive otherwise the shaft won’t 
turn) 
 
DMONBV 24- same as above but for output B. 
Now you should have your analog outputs activated and should know the ratio of 
velocity to output voltage.  
 
A.2.13 Digital outputs 
You will need to connect two cables from pin 41 and 42 of the servo drive to the 
digital and timing I/O connections of the DAQ BNC block (Figures II.1 and II.2). 
42 is the ground. Once connected, use the following command:  
outfnc1-B  
The 1 corresponds to pin 41 and the B defines the motion trigger. This trigger is 
initiated when the motor starts moving after a halt. When reading the waveform in 
LabView, we can use this trigger such that collection of data will begin only when 
the motor starts moving. This is appropriate for our purposes because it 
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guarantees that our data corresponds to the beginning of the waveform. You do 
not need the trigger for continuous waveforms that have no halts. 
 
A.2.14 Feedback 
We are using LabView 8 to carry out feedback. Open LabView and in the 
“Getting Started” section choose “vi from template”. Then under “DAQ”, choose 
“Data Acquisition with NI-DAQ.mx”. 
 
Follow the given instructions. On the screen for Analog data acquisition, you will 
see the trigger tab by double clicking on the DAQ block. Set it to digital and 
choose the appropriate inputs from the card. Be sure to program the appropriate 
slope under “custom scaling” in the configuration window. The slope should have 
been determined when running the DMONAS command as described above. 
Finally, make sure the timing settings are set so as to read at least one period of 
the waveform. 
 
When back on the DAQ block, right click on the data tab and choose “create” and 
“graph indicator”. Then right click on the white region, choose “File I/O” under 
programming and then choose “write spreadsheet file”. Drag and place this next 
to the graph indicator and connect the two. (Note: You may want to wait to add 
the spreadsheet writing function until you have properly configured the feedback 
mechanism and can clearly see the graph in LabView) 
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Now, when you open the graph indicator and hit the arrow tab, the waveform will 
be read and you will be prompted to save the information immediately (assuming 
you created the spreadsheet write function as described above). Once saved, 
you will have to rename the file with the .txt extension. You will be given a series 
of velocity measurements. The number of measurements given will correspond 




Tuning can be very tedious since it must be carried out manually. Once you 
obtain a set of data from LabView, plot in Excel and compare with the original 
programmed waveform. Make adjustments to the Program as necessary. It is 
very common for the output velocity to come out one or two units lower than the 
programmed velocity. Keep in mind that when raising the velocity of a segment in 
the program, you must also increase the distance D for that segment by the 
appropriate distance. Not doing so will result in the shortening of the period of the 
waveform (Increasing V but not D will decreased the time).   
 
A.2.16 Servo drive codes 
One can use RS232 cable and a USB connector to upload the servo drive codes 
in the motor. Alternatively, IP address mapping of the motors can be done. For 
this, a batch file is required to activate the connection between the laptop and the 
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servo-motor controllers (connected through the LAN cables). This batch file’s 
contents are as follows: 
Filename:6KARP.bat 
Contents: 
arp -s 192.168.10.30 00-90-55-00-56-E6 192.168.10.31 
arp -s 192.168.10.29 00-90-55-00-56-E7 192.168.10.31 
 
A.2.17 Motor reset and installation protocol 
Typically, before running the programs, it is recommended to reset the servo 
motors.  This is done in order to clear the memory of the motor and ensure there 
are no memory related errors that can sometimes cause the motor to fail. Start 
the servo motor controller program, “Motion Planner, version 4.3 and make sure 
the servo motor is connected to the system and is communicating.  Then open a 
new terminal window (small blue square icon on upper left of the tabs of motion 
planner). Type RFS in the command line and press enter.  RFS means Restore 
Factory Settings. After a short time (approx. half a minute) the terminal will output 
several lines of code (shown right below RFS command) once it is done as 




Figure A. 2. 11 Instructions to reset the servo motor to factory settings. 
 
 
The servo motor has now been restored to factory settings and must be installed 
to be able to use it. Click file and select new.  Then among the options, select the 
program editor (left image) and press OK. Then select the Gemini tab and install 
the motor by following the instructions in Figure A. 2. 12 and Figure A. 2. 13. 
Enter the series, frame, and part for the motors we use.  For our motors this is 
SM232AE.  This code can be found written on each of the motor heads.  Press 
“Yes” when asked to require DRESET to be activated.  Now, if you open a new 
terminal and enter TDIR to the command line, you should find that there are no 



















A.2.18 System operation 
Connect the cone and plate apparatus (Figure A. 2. 7) to the servomotor, and 
plug in the peristaltic perfusion pump. Turn on the laptop; plug in the RS232 
cable between the laptop and the servo motor controller. Allow some time for the 
laptop to detect the connection. Start the servo motor controller program, “Motion 
Planner, version 4.3. You can now upload / download shear stress waveforms 
through the laptop program. To run the waveforms, enter command: “drive1” to 
engage the motor, and then enter the command to run the waveform, which 
would be the name of the waveform file. Usually cyclic programs start with a “r”. 
To stop the program, press Ctrl-K, and then enter command “drive0” to dis-
engage the motor.  
 
Now that the motor memory has been wiped, you can go ahead and download 
the program to the servo motor.   Next, you have to download the programs to 
the motor for either oscillatory (sin5, rsin5) or pulsatile shear (tauh, rtauh), 
depending on the experiment you are running.   
 
Hit the “download file” icon (left image).  Download the two programs required for 
the experiments that will be run on that motor.  Here sin5 is downloaded.  You 
can also find the programs required on the yellow post-it notes above the motor. 
To trace the program running on the motor, type command trace1 (to turn the 
trace on) and trace0 (to turn the trace off) while programming the code to the 
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motor.  Always disable the limits using command lh0. Typically the commands 














A.2.19 List of parts and supplies  
Cone and Plate apparatus (please see Appendix A.1 for mechanical drawings) is 
custom machined by the ChBE machine shop or GTRI. The parts needed to 
machine this bioreactor as well as the motors, and pump part numbers are listed 
in the tables below.   Other than the parts listed, we also need the following:  
a. Incubator: Model 3110 CO2 water Jacketed Incubator, Forma 
Scientific, Marrietta, OH. 
b. Laptop: Dell Inspiron 710m, Dell, Round rock, TX. 
Table A. 2. 1 Motor and controller – assemble and set up 
 
Part Description Company Part number Price per Unit 
Cover - Bottom Plate Newark 05M4430 $31.23  
AC Power Cord Newark 98K6011 $4.34  
Fuse Holder Newark 84K0273 $2.11  
Power Entry Module Newark 48M7013 $10.69  
AC Power Cord to Drive Newark 17B6600 $5.15  
AC Input Fuse Newark 26K7958 $1.34  
24V Power Supply Digikey T1206-P5P-N $21.76  
Fuse Block Digikey F4928-ND $3.07  
2.5A Fuse Digikey 507-1631-ND $0.29  
6.0 A Fuse Digikey 507-1636-ND $0.29  
Rubber Feet (Bag of 64) Digikey SJ5508-0-ND $3.92  




Table A. 2. 2 Peristaltic pump 
 




Fixed-Flow Cased Peristaltic PumpTubing 
size ID: 3mm, Material: Viton, gen purpose,  
motor: 3 rpm synchronous, continuous  
Standard enclosure with on/off switch 
APT 
Instruments 
SP200 $135  
  
Table A. 2. 3 Materials for 2 sets of cone and plate set up 
 
Part Description Company Part number Price per 
Unit 
O rings - AS568A Dash Number 
031 
Mcmaster 9396K111 $4.92  
Scratch and UV resistant poly 
carbonate sheet 
Mcmaster 8707K112 $35.19  
Impact Resistant Polycarbonate 
Rod, 4" Diameter, Semi-Clear 
Gray - 1 ft 
Mcmaster 8571K41 $107  
white delrin rod (3-1/2" Dia, 
Length 12") 
Mcmaster 8572K35 $60  
Polycarbonate rod (2.1/2 " Dia, 
Length 12") 
Mcmaster 8571K39 $48.81  
Steel ball bearing Mcmaster 6138K66 $13.27  
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Laboratory clear Tygon PVC 
tubing-10ft-4 
Mcmaster 5155T17 $28  
Clear polycarbonate barbed 
fitting 
Mcmaster 5117K83 $4.96  
18-8 stainless steel 82degree flat 
head philips machine screw 
Mcmaster 96877A121 $7.72  
1808 Stainless steel knurl grip 
cup point set screw 
Mcmaster 93445A170 $10.92  
316/316L Stainless Steel Rod, 
5/8" Diameter-1' 
McMaster 89325K83 $9.68  
316/316L Stainless Steel Rod, 2" 
Diameter-1' 
Mcmaster 89325K63 $58.04  
Acetal Helical Flexible Shaft 
Coupling, 3/8" x 3/8" Diameter 
Shaft, 1-1/4" Length, 1" OD 
McMaster 2505K133 $43.17  
Optically Clear Cast Acrylic 
Sheet, 1/2" Thick, 12" x 24" 
McMaster 8560K266 $52.58  
Miscellaneous Screws and Parts 
(for buffer) 
McMaster   $100  
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A.3. Sterilization techniques 
 
All materials for the experiments (including surgical tools, bottles, bioreactors etc) 
were sterilized by one or more of the following methods. 
 
A.3.1 Autoclaving at 120°C for 30 min 
Gravity cycle was chosen for autoclaving metallic surgical tools, pipette tips, 
glassware and plastics (autoclavable only). All the contents were placed in 
autoclavable pouches (VWR #11213-038, #11213-025) and taped with autoclave 
indicator tape (VWR #58752-781). Liquid cycle was chosen for autoclaving 
liquids only. Liquids such as DI water, DPBS, and agarose were autoclaved 
using this method. 
 
A.3.2 Ethylene oxide (EtOH) sterilization for 24 hrs 
This method was employed for sterilizing materials that are not autoclavable. All 
the plastic parts of the shear stress bioreactor parts, including the reservoir 
pumps and the tools that are not autoclavable were packed in gas sterilization 
pouches (VWR #11213-226) and sterilized using this method. EtOH ampoules 
and bags were purchased from Anderson sterilizers (AN #79). 
A.3.3 Sterile filtering using 0.1 µm filter 
 Media and other solutions are filtered using media filters (Corning) or 
syringe filters (VWR). 
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A.4. Post experiment tissue handling 
A.4.1 Supplies 
• 6 well plate (1) (Fisher #08-772-1B) 
• Ice Pack (pre-frozen at -20oC) 
• Scalpel handle (1) and sterile scalpel (1) 
• Sterile ice cold DPBS (Sigma #D5773) 
• Sterile ice cold DEPC (Sigma # D5758-25ML) treated DPBS (for RNA 
analysis) – Prepared by adding 0.1% v/V DEPC to DPBS, vortex at 
medium heat for atleast 12 hrs and sterilize using autoclave liquid cycle for 
atleast 30 minutes.  
A.4.2 Procedure 
• Autoclave surgical tools and DPBS** well in advance. Refrigerate dPBS**. 
• Fill the wells of 6 well plate or petri dishes with ice cold DPBS** and place 
them on ice pack to ensure that DPBS remains cold. This will ensure that 
the gene expression pattern in the cells is preserved.  
• Use motion planner to stop the motors and take only one cone and plate 
system out at a time and return to the sterile laminar flow hood. Handle 
tissues from one set up at a time. Please refer to the cone and plate 
system operation protocol for more details on operating the motors. 
• Remove the tissues from the base plate of the cone and plate system, 
using forceps. Place them on the petri dish cover/6-well plate and cut the 
excess tissue, ensuring the portion of the tissue that is exposed to shear is 
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untouched (this portion of the tissue has a faint circular mark from the 
cover plate). 
• Quickly rinse the tissues in 2 to 3 changes of ice cold DPBS** (step 2) 
until the tissue loses most of the pink color from the media before 
proceeding to next steps of the appropriate tissue saving protocol. Media 
contains ascorbic acid so it is important to ensure that the media is 
completely removed from the tissue, as it may interfere with some of the 
assays (protein, calcium, MMP assays, etc.).  
• Typically for RNA and protein isolation, the tissues are ground and 
homogenized before adding the appropriate lysis buffer. However, if the 
RNA content of the tissue is very low, the grinding and homogenization 
step can be skipped. Add lysis buffer directly to the tissue, incubate for 5 
min at room temperature and then proceed with the miRNeasy kit 
(Qiagen) isolation procedure. This will not improve the RNA concentration, 
however, the degradation of the RNA due to handling can be minimized.  
A.5. Cryopreservation of tissues 
Cryopreservation of tissues is recommended only for immunohistochemistry 
analysis, as the antibody binding sites are well preserved. However, tissue 
structure is not very well preserved.  
 
A.5.1 Supplies 
• Plastic molds (Electron microscopy sciences #EMS 70182) 
• OCT compound (Electron microscopy sciences #EMS 62550-01) 
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• Long hemostat 
• Vacuum flask (TEP core lab) 
• Liquid Nitrogen (TEP Biohazard Room/Core lab)  
• Methanol (BDH1135-19L) 
• Plastic weighing boats 
• Small styrofoam box 
 
A.5.2 Procedure 
• Have the liquid nitrogen ready in the vacuum flask. Pour sufficient amount 
of liquid nitrogen in a small styrofoam box (make sure the opening of the 
box is proportionate with the plastic weighing boats).   
• Pour methanol in the plastic weighing boats (after which technically it 
should float on liquid nitrogen, but just in case, it is better to ensure that 
the opening of the styrofoam box is just enough to fit the weighing boat). 
• Label plastic molds with the experimental details and sides that face the 
fibrosa/ventricularis. Put the label at the top of the sides of the plastic mold 
so that the methanol does not remove the ink.  This way, it is much easier 
to identify the sides during imaging. Fill plastic mold with OCT compound 
and allow the air bubbles to settle down, for about 5 minutes. 
• Arrange tissue samples at the base of plastic mold in appropriate 
orientation. For aortic valve tissues, the collagen and elastin fibers (or the 
ridges on the fibrosa side) should always be parallel to the base of the 
plastic molds. Also ensure that the fibrosa of the tissue faces the label 
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fibrosa on the mold. Allow the tissues to “sit” in OCT compound for at least 
5 to 10 minutes, to make sure all the water in the tissue is replaced with 
OCT compound. If not, the water within the valve tissue freezes creating 
lots of gaps within the tissue.  
• Using forceps ensure that the tissues “stand” in the OCT compound while 
keeping track of the tissue orientation. Place the mold (with the tissue) on 
a weighing boat containing methanol. Take a small styrofoam box with the 
opening that is just enough to fit the weighing boat. Fill the styrofoam box 
with liquid nitrogen up to the brim (use extreme caution and wear thermal 
gloves, safety glasses and a lab coat) and place the weighing boat in 
liquid nitrogen (flask/Styrofoam box). The methanol will be cold enough to 
freeze the mold. This ensures slow and uniform freezing of the tissue 
sections and at the same time, the liquid nitrogen does not get into the 
mold, which can crack it. Store the frozen molds in -80°C freezer. 
 
A.6. Tissue paraffin embedding 
Paraffin embedding of tissues is recommended for tissue structure visualization 
stains.  Antibody retrieval must be done on paraffin embedded slides, if these 
were to be used for immunohistochemistry analysis.  
 
A.6.1 Supplies 
• Paraffin embedding cassettes (IBB histology core) 
• Microcentrifuge vials or 15mL falcon tubes  
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• 10% neutral buffered formalin (IBB histology core) 
• Straight forceps (1) 
• 70% Reagent Alcohol (IBB histology core) 
 
A.6.2 Procedure 
• Have 10% formalin ready in micro centrifuge vials or 15mL falcon tubes 
depending on the size of the tissue. Typically, the volume of the formalin 
used should be atleast 20 times more than the volume of the sample.  
• Leave the samples in formalin for at least 24 hours before further 
processing.  
• When ready, transfer the samples in the paraffin embedding cassettes 
(one per cassette) and label the cassettes accordingly with a pencil only!!! 
(Because the ink from the pen will be erased due to the heavy alcohol 
related processing).  
• Transfer all the cassettes (with tissue) in a container with 70% reagent 
alcohol, label the container with PI, name of the user and the date and 
leave it in 4oC fridge in Histology core lab in IBB.  
• Sign up for paraffin processing on the sign up sheet (typically found on the 
same fridge where the container with the tissue cassettes is stored) and 
let Aqua Asberry know about this.  
• Once processed, please pick up the samples promptly and embed the 
tissues in paraffin blocks. This step requires prior training and approval 
from Aqua Asberry in IBB.  
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• After embedding, leave the samples on ice block for at least 6 hours 
before beginning the slicing using a microtome either in IBB or in TEP. 
 
A.7. Pulverization of heart valve tissue 
A.7.1 Supplies 
• Long hemostat (1).  
• Vacuum flask (TEP Core lab).  
• Liquid nitrogen (TEP Biohazard Room/Core lab). 
• Lysis buffer (RIPA buffer or Qiazol lysis buffer). 
• Homogenization vials/Cryovials. 
• Small funnel with a hole big enough to insert into homogenization or 
cryovials. 
• Mortar and pestle – the size of a Chinese tea cup. 
• Thermal gloves. 
• 70% reagent alcohol. 
• Small plastic cup.  
 
A.7.2 Procedure 
• Have the liquid nitrogen ready in the vacuum flask. Wear thermal gloves to 
avoid contact with liquid nitrogen.  A small plastic cup can be used to 
transfer the liquid nitrogen.  
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• Thoroughly clean mortar and pestle, funnel and the bench with 100% 
alcohol (histology reagent alcohol can be used) and then with autoclaved 
DI water. This is to ensure that the samples do not get contaminated.  
• Place the funnel on the pre-labeled cryovial into which the ground tissue 
will be transferred. Add a small amount of liquid nitrogen to the cryovial as 
well to maintain the same temperature as the ground tissue.  
• Place the tissue in the mortar and add liquid nitrogen to immerse the 
tissue completely for at least a minute. Leave the pestle in the mortar to 
keep it at the same temperature as the tissue.  
• Using the pestle and a twisting and pulsating downwards motion, push 
down the tissue and grind it until it is a very fine granular powder. Never 
let the tissue thaw and keep adding liquid nitrogen while grinding.  
• Don’t push the tissue too hard because there is a chance that the liquid 
nitrogen will spill along with some of the sample.  
• Add enough liquid nitrogen to make tissue slurry and quickly pour it in the 
pre-cooled cryovial via funnel. If there is any left over tissue, repeat this 
step until all the ground tissue is transferred. However, ensure that excess 
liquid nitrogen is not added to the cryovial while transferring the tissue, 
because the liquid nitrogen might pop out along with some tissue.  
• At this point, the tissue can be further homogenized for protein or RNA 
isolation or can be used directly for various quantitative assays.  
• If RNA/protein is not isolated immediately, add appropriate lysis buffer 
(RIPA or Qiazol) and save the cryovial with ground tissue in -80°C freezer. 
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RIPA buffer must contain protease and phosphatase inhibitors (add the 
product number).  
• Ground tissues should never be allowed to thaw!!! Only take them out 
when it is ready to be ground and homogenized for protein isolation. For 
use, thaw the vial only on ice (Very Important!!) and use the same vial to 
hold the ground tissue and add additional buffer for homogenization and 
sonication.  
• For western blots, gently tap/scoop out about 0.1g of ground tissue (more 
than 0.3g is overkill) and homogenize it. 
 
A.8. Primer design protocol 
Primers for miRNA qPCR must be ordered from Qiagen as these work best 
compared to the primers designed using this protocol. For mRNA qPCR primers, 
follow this protocol.  
A.8.1 Get mRNA transcript 
• Go to NCBI and under the drop down search menu select gene. Search 
for the gene of interest, for example eNPP1.  
• From the results, select the one that is specific to the species of interest, 
sus scrofa (pig). 
• Go all the way down to the mRNA and proteins and get the NM or XM 
accession number for mRNA.  
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• The XM corresponds to the gene data obtained from predictive models. 
This could be due the fact that not all genes in pig are validated. In 
general, validated genes are labeled as NM. Since we only have this 
option, we will use the XM sequence.  In case, if both the NM and XM 
sequence are available, always use NM as the website provides the 
information on predictive models as well (if available).  Copy this 
sequence number, here XM_001925476.3. 
 
A.8.2 Design primers 
• To design the primer, use the free tool from NCBI: 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/ and use the NM or XM 
number to search for specific primers. 
 
A.8.3 Selection criteria 
• Adjust other parameters in this tool to make the search more stringent.  
• PCR primer length or product size: 100 to 200 (<100 –cannot be purified, 
>100-cycle wont be efficient); PCR melting temperature: Min: 58, Opt: 60, 
Max: 62; max Tm difference is 2 degrees. This is specific to this tool, and 
can change depending on the software or specific equipment we use.  
 223 
• Choose the Refseq database. Exon junction span: Select the exon-exon 
mapping, but if it does not produce any result, select no-preference. For 
some of the reference genes, for example, 18S is a ribosomal RNA so it 
has no exon junctions, so no preference must be chosen.  
• Select the organism: Sus scrofa (if looking in pig).  
• Click the advance parameters and check the primer size, min: 18, max: 
24, opt: 20.  
• GC content min: 30, max: 80.  
• Something else to keep in mind: Make the lengths and compositions of the 
primers designed for all the genes as similar as possible.  This will help in 
running multiple genes in the same plate.  
• Search will yield primers and also indicate its specificity for the gene of 
interest. Choose 3 to 4 primers from the list.  Make sure that when you 
input the primers, only your mRNA of interest comes up.  If others come 
up, redesign primers. 
A.8.4 Verification of the primers 
• To ensure that the primers designed here work as expected, they need to 
be verified.  To double check if we got the proper gene expression 
amplified, we can predict the amplicon temperature at oligo calc: 
http://www.basic.northwestern.edu/biotools/oligocalc.html 
• Primer can also be designed to go over an intron/exon border so that the 
genomic DNA is not amplified.  This is generally not done because it is 
assumed that all the genomic DNA is eliminated with a separate DNase I 
 224 
treatment (available through Qiagen used in conjunction with the 
miRNeasy kit). 
• GC Clamp: The presence of G or C bases within the last five bases from 
the 3' end of primers (GC clamp) helps promote specific binding at the 3' 
end due to the stronger bonding of G and C bases. More than 3 G's or C's 
should be avoided in the last 5 bases at the 3' end of the primer. 
• Repeats: A repeat is a di-nucleotide occurring many times consecutively 
and should be avoided because they can misprime. For example: 
ATATATAT. A maximum number of di-nucleotide repeats acceptable in an 
oligo is 4 di-nucleotides. 
• Runs: Primers with long runs of a single base should generally be avoided 
as they can misprime. For example, AGCGGGGGATGGGG has runs of 
base 'G' of value 5 and 4. A maximum number of runs accepted is 4bp. 
• 3' End Stability: It is the maximum ΔG value of the five bases from the 3' 
end. An unstable 3' end (less negative ΔG) will result in less false priming. 
• Avoid Template Secondary Structure: A single stranded nucleic acid 
sequence is highly unstable and fold into conformations (secondary 
structures). The stability of these template secondary structures depends 
largely on their free energy and melting temperatures(Tm). Consideration 
of template secondary structures is important in designing primers, 
especially in qPCR. If primers are designed on a secondary structure 
which is stable even above the annealing temperatures, the primers are 
unable to bind to the template and the yield of PCR product is significantly 
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affected. Hence, it is important to design primers in the regions of the 
templates that do not form stable secondary structures during the PCR 
reaction. Our products determine the secondary structures of the template 
and design primers avoiding them. 
• Avoid Cross Homology: To improve specificity of the primers it is 
necessary to avoid regions of homology. Primers designed for a sequence 
must not amplify other genes in the mixture.  
• Primer Secondary Structures: Presence of the primer secondary 
structures produced by intermolecular or intramolecular interactions can 
lead to poor or no yield of the product. They adversely affect primer 
template annealing and thus the amplification. They greatly reduce the 
availability of primers to the reaction. 
• Hairpins: It is formed by intramolecular interaction within the primer and 
should be avoided. Optimally a 3' end hairpin with a ΔG of -2 kcal/mol and 
an internal hairpin with a ΔG of -3 kcal/mol is tolerated generally. 
 
• ΔG definition: The Gibbs Free Energy G is the measure of the amount of 
work that can be extracted from a process operating at a constant 
pressure. It is the measure of the spontaneity of the reaction. The stability 
of hairpin is commonly represented by its ΔG value, the energy required to 
break the secondary structure. Larger negative value for ΔG indicates 
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stable, undesirable hairpins. Presence of hairpins at the 3' end most 
adversely affects the reaction. 
• ΔG = ΔH – TΔS 
• Self Dimer: A primer self-dimer is formed by intermolecular interactions 
between the two (same sense) primers, where the primer is homologous 
to itself. Generally a large amount of primers are used in PCR compared 
to the amount of target gene. When primers form intermolecular dimers 
much more readily than hybridizing to target DNA, they reduce the product 
yield. Optimally a 3' end self dimer with a ΔG of -5 kcal/mol and an internal 
self dimer with a ΔG of -6 kcal/mol is tolerated generally. 
• Cross Dimer: Primer cross dimers are formed by intermolecular interaction 
between sense and antisense primers, where they are homologous. 
Optimally a 3' end cross dimer with a ΔG of -5 kcal/mol and an internal 




• The smallest quantity can be ordered from either Invitrogen or Integrated 
DNA Technologies and use standard desalting. 
•  Order forward and reverse primer as separate primers. They can be 
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prepared for qPCR later. The primers will be shipped in its lyophilized 
(powdered) form. 
•  As soon as the primers arrive, proceed with the reconstitution steps.  
 
A.8.6 Reconstitution of primers for real-time qPCR 
• Spin the lyophilized primers at room temperature using mini centrifuge. 
Only spin briefly a few times to collect the sample at the bottom of the 
tube. 
• Add water based on the yield of the primer. For example, if the yield is 
32.3 nm, then add 323 µL of nuclease free water. Note: Always use 
nuclease free water only!.  
• The stock primers can be aliquoted to minimize the free thaw cycles.  
 
A.8.7 Preparation of primer aliquots for real-time qPCR 
Total Volume of Primer Aliquot: 200µL 
• Add 10 µL of forward primer.  
• Add 10 µL of reverse primer. 
• Add 180 µL of nuclease free water to bring volume to 200 µL.  
• Vortex briefly and spin using the microcentrifuge.  
• Note: Primer Aliquots can be stored at 4oC for a month. 
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A.9. MTT Cell viability stain 
A.9.1 Supplies 
• Thiazolyl Blue Tetrazolium Bromide (MTT) (Sigma #M5655). 
• DPBS or PBS or Hanks Buffered Saline solution. 
• Media (ascorbic acid free)  
• Syringe filters. 
• Mounting media  
• Cover slips. 
• Tissue Cryopreservation supplies. 
 
A.9.2 Procedure 
• Prepare the MTT stock solution (5mg/mL) in PBS or Hanks Balanced Salt 
Solution. Solution must be sterilized by filtering after adding MTT. Stock 
solution can be stored in fridge (4oC) for up to a month and must be 
protected from light.  
• For positive controls, dead porcine AV tissues were used. To obtain these 
dead tissues, healthy porcine AVs were cut and left under UV for about 3 
days and were subjected to 3 to 4 freeze-thaw cycles using liquid nitrogen.  
• In a 6 well plate, place either fresh, cultured tissues or dead tissues in 
each well. Two tissues per well were used.  
• Add at least 3mL of media per well and add 0.5mg/mL of MTT.  
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• The culture was incubated at 37oC for 3 hrs in a CO2 incubator. Always 
use a CO2 incubator to maintain sterility and the pH of the media. 
• After the culture, rinse the tissues in dPBS for up to 2 to 3 minutes to 
remove the media. If the cells are viable, the tissues look purple in color 
and no color if the tissues are dead (positive). It is important to use 
ascorbic acid free media because the ascorbic acid can reduce MTT and 
can give a false positive result.  
• Cryopreserve the blocks in OCT following the cryopreservation protocol.  
• Slice and coverslip using the water based medium and allow to dry before 
imaging.  
 
A.10. TUNEL apoptosis stain 
A.10.1 Supplies 
• In Situ Cell Death Detection Kit, Fluorescein (Roche). 
• Permeabilization Solution (0.1% Triton-X100) (Dilute 10% Triton-X100 
solution 1:100 in PBS (10% Solution: 1mL of Triton X in 9mL of PBS).  
Make enough for slide holder (200mL). 
• DNase Solution  (3-3000U/ml of DNAse (from miRNeasy kit, Qiagen) in 
50mM TrisCl, pH 7.5, 1mg/mL BSA). 
• 1X PBS. 
• 4 % Paraformaldehyde (pH 7.4). 




• Section frozen slides (7um). Circle the tissue sections with a PAP pen. 
The contents of PAP pen are hydrophilic and will help hold the reaction 
mixture on tissue sections.  
• Wash with 1x PBS for 5min. 
• Fix slides with 4% PFA for 10min at room temperature. 
• Three times - Wash with 1x PBS for 5 min each.  
• Permeabilize with permeabilization solution for 2 min in fridge at 4oC. 
• Three times - Wash with 1x PBS for 5 min each.  
• Prepare positive control by incubating slide with DNase for 10min at RT. 
• Prepare negative control by incubating a tissue section with 50uL labeling 
solution without enzyme solution. 
• For rest of samples, scale appropriately: add total 50uL of enzyme 
solution to 450uL of labeling solution (totaling 500uL TUNEL reaction 
mixture). 
• Add 50uL of TUNEL reaction mixture to each slide. 
• Include in a humidifying chamber at 37°C for 60 min. 
• Rinse with 1x PBS (3 times for 5 min each). 
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• Stain with DAPI (1:2000 for 8 min). 
• Rinse with 1x PBS (3 times for 5 min each). 
• Mount and image for fluorescein using traditional microscopy.  
• Save the slides in 4oC, protected from light and air (can seal the slides 
with nail polish) if imaging later. 
 
A.11. Von Kossa Stain 
A.11.1 Supplies 
• Add 5% silver nitrate solution (add 25 g of Silver nitrate (Sigma #S8157) to 
500 mL of dH2O. Mix well and pour into clean brown bottle and store in 
refrigerator at 4°C. Stable for 1 year). 
• 5% sodium thiosulfate solution (add 5 g of sodium thiosulfate (Sigma 
#S7026) to 100 mL of dH2O. Make fresh). 
• Nuclear fast red (Kemechtrot) solution (dissolve 5 g of aluminum sulfate 
(Sigma #368458) in 100 mL of dH2O. Add 0.1 g nuclear fast red (Sigma 
#229113) and slowly heat to boil and cool. Filter and add a grain of thymol 
(Sigma #T0501) as a preservative.  
 
A.11.2 Procedure 
• Slice paraffin sections at 5-7 um. Deparaffinize slides and rehydrate to 
dH2O at RT.    
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• Circle the tissue sections with a PAP pen. The contents of PAP pen are 
hydrophilic and will help hold the reaction mixture on tissue sections. 
• Incubate slides in 5% silver nitrate solution placed under bright sunlight or 
under a  60W lamp. It is wise to add 100ul of this silver nitrate solution to 
the tissue sections encircled with PAP pen.  
• Place foil or mirror behind the jar/tray to reflect the light. Leave for 1  hour 
or until calcium turns black. For best results use UV lamp. 
• Wash 3x dH2O for 5 min at RT.   
• Wash 1x in 5% sodium thiosulfate for 5 min at RT.   
• Wash 1x in tap water, 1x in dH2O.   
• Incubate slides in Nuclear Fast Red for 5 min at RT.   
• Wash briefly in dH2O.   
• Dehydrate and clear.   
• Coverslip and store at RT.   
 
A.12.  Alizarin Red stain 
A.12.1 Supplies 
• 1 % Alizarin Red S (Sigma-Aldrich, Cat. No.A5533), pH 4.2 with 
ammonium hydroxide. Lasts for approx. 1 month. 
• Xylene (VWR, histology grade) 
• Acetone (VWR, histology grade) 




• Warm slides to room temperature for 10 minutes. 
• Wash 3 min in dH2O. 
• Stain sections in 1% Alizarin Red for 5 minutes. Calcium deposits should 
turn orange-red in color. 
• Rinse in acetone 1 minute with dipping. 
• Rinse in acetone-xylene for 3 minutes. 
• Clear in xylene for 3 minutes. 
• Coverslip and store at RT. 
A.13. Silencing of miRNA in AV leaflets ex vivo 
This protocol was primarily developed primarily to silence miR-214 in AV leaflets 
ex vivo. This protocol can be adapted to transfect any anti-miR or pre-miR to AV 
leaflets. However, transfection of pre-miR might require some troubleshooting.  
These experiments must be performed in a sterile laminar flow hood and if 
using the tagged anti-miR (either anti-miR-214 or NT anti-miR), all the steps 
must be carried out in DARK!!. 
 
A.13.1 Resuspension calculations for anti-miR-214 
• Yield of anti-miR 214 oligo: 5 nmol (in vivo grade power inhibitor, Exiqon, 
Germany).  
• To obtain stock Concentration: 20 µM, add 250 µL of Tris EDTA 7.5-8 buffer 
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(Sigma) to the anti-miR. 
• Aiquot 50 µL of re-suspended anti-miR-214 and store in -20 °C for upto 6 
months without loss in activity.  
 
A.13.2 Resuspension calculations for scrambled anti-miR 
• Yield of scrambled or NT tagged anti-miR oligo: 238.2 nmol (in vivo grade 
power inhibitor, Exiqon, Germany). Here TEX615 (texas red) was used as 
the fluorescent tag.  
• To obtain stock Concentration: 100 µM, add 2338.2 µL of Tris EDTA 7.5-8 
buffer (Sigma) to the anti-miR.  
• Aliquot 100 µL of re-suspended and store in -20 °C for upto 6 months 
without loss in activity. 
• Tagged anti-miRs are light sensitive and must be protected from light.  
 
A.13.3 Dilution of anti-miR for transfection 
• For anti-miR-214, the concentration that worked well is 400 nM. So the 
same concentration of tagged NT-anti-miR was used. 
• Minimum amount of OptiMEM (Life Technologies, NY) needed to transfect 
anti-miR to a 7mm dia. AV tissue sample is 600 µL without causing 
appreciable hypoxia. This is the size of the tissue used in the cone and 
plate shear bioreactor.  
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• Work out the volume of anti-miR-214 and tagged NT-anti-miR needed to 
transfect to achieve a final concentration of 400nM based on the amount 
of OptiMEM used. Remember, the amount of anti-miR-214 and tagged 
NT-anti-miR added will differ since the stock concentrations are different. 
 
A.13.4 Passive transfection of anti-miR to AV leaflets ex vivo 
• Incubate the tissues with OptiMEM + anti-miR (anti-miR-214 or tagged 
NT-anti-miR) for 4 hours.  
• After 4 hours incubation, quench the samples with regular media (atleast 4 
mL/ tissue sample).  
• Load the samples in the shear system with fibrosa facing up. Expose 
fibrosa to OS for 2 days.  
• Post shear, save samples in Qiazol for RNA isolation. Pool atleast 3 
samples or more for better yield of RNA.  
• Each time the silencing of miR-214 in both groups (anti-miR-214 and 
tagged NT-anti-miR) must be verified before proceeding to further target 
investigation.  
• Additionally, two to three tissues from tagged NT-anti-miR shear group 
must be cryopreserved. Frozen sections can be prepared to check for 
transfection efficiency and apoptosis (using TUNEL stain).  
 
A.14. Quantification of ECM layers from elastin stain 
Prepared by Kartik Balachandran in 2010.  
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Refined by Pouria Hosseini in 2015.  
 
A.14.1 Procedure 
• Turn on microscope and computer, start up ZEN Software, click on live, 
place the slide under 10x lens.  
• Focus the image. 
• Adjust exposure and white balance as necessary. The image should look 
like those shown above. You may change these values for each image as 
you see fit. 
• Snap the picture.  
• Open the image with imageJ (an opensource software) or your favorite 
image processing software. 
• Make note of the resolution of the image. 
• Open one or more images with imageJ to make sure the dimensions are 
consistent.  
• Use the line tool to measure the length of each of the three layers of the 
tissue 
o Fibrosa layer: the fibrosa layer is defined as the collagen rich layer 
closest to the aorta. It is characterized by red squiggly lines on the 
image. Measure the thickness from the edge of the tissue to where 
the collagen ends. Measure the collagen layer at its thickest and 
thinnest in each image and then average the two values.  
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o Ventricularis layer: the ventricularis layer is defined as the elastin 
rich layer closest to the left ventricle. Black vertical lines on the 
image characterize it. Measure the thickness from the start of the 
black elastin lines to the edge of the tissue. Measure the 
ventricularis layer at its thickest and thinnest in each image and 
then average the two values.  
o Spongiosa layer: the spongiosa layer is defined as the water rich 
region composed of sulfated glycosaminoglycans and 
proteoglycans in between the two other layers. It is characterized 
by the lightest colors in the tissue and appears between the edge of 
the collagen and the elastin lines.  
o An example is shown below: 
 
 




• If many images are averaged, be sure to normalize the data with respect 
to itself by dividing the average percent thickness of each layer by the sum 
of the average percent thicknesses of all three layers so that the percent 





A.15. Matlab Codes 
 
A Matlab R2009 b (The Mathworks, Natick, MA) was used to run these codes. 
  
A.16. Matlab code to program the servo with desired shear stress 
File name: writeprgfile.m 
This code was written by Philip Sucosky and Kartik Balachandran. This matlab 
code converts the shear stress vs. time data into a format that is readable by the 
servo motor. Additional details on how to load this program on the servo are 







A=dlmread('/Users/Swetha/Cone and Plate experiments/ Fibrosa Shear 
stress/OS.txt');  %Input file is the text file containing shear stress vs. time (0.860 


















    count=count+1; 
    if abs(D(i))>2 
        w2(count)=w(i); 
        D2(count)=D(i); 
        i=i+1; 
    else 
        DD=D(i); 
        WW=w(i); 
        count2=0; 
        while abs(DD)<2 
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            count2=count2+1; 
            i=i+1; 
            DD=DD+D(i); 
            WW=WW+w(i); 
        end 
        if i<length(A(:,1)) 
            w2(count)=WW/count2; 
            D2(count)=DD; 
        end 





    if A(i,2)~=0 & A(i+1,2)==0 
        tpt=[tpt; i+1]; 
    elseif A(i,2)==0 & A(i+1,2)~=0 
        tpt2=[tpt2;i]; 
    end 
end 
tpt2=[tpt2;length(A(:,2))]; 
if sum(D2./w2/4000) < cycletime %change this if needed...!! this is cycle time 
    addtime=cycletime-sum(D2./w2/4000); 
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    D2(end)=D2(end)+w2(end)*addtime*4000; 
end 
%D(find(D>0 & D<2))=2; 




fid=fopen('/Users/Swetha/Cone and Plate experiments/ Fibrosa Shear 
stress/OS.prg','wt'); %This is the folder where the programmable code that is 
generated by this matlab code is saved.  
fprintf(fid,'del sin5\n'); %This is the name of the user defined program name and 




    fprintf(fid,'A400 \n'); 
    sign=1; 
else 
    fprintf(fid,'AD400 \n'); 
    sign=-1; 
end 
for i=1:length(w) 
    %[w(i) sign  w(i)*sign] 
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    if sign*w(i) >0 
        if i>1 
            fprintf(fid,'GOBUF1\n'); 
        end 
        fprintf(fid,'V%f\n',abs(w(i))); 
        fprintf(fid,'D%d\n',D(i)); 
    elseif w(i)>0 
        fprintf(fid,'VF0 \n'); 
        if i>1 
            fprintf(fid,'GOBUF1\n'); 
        end 
        fprintf(fid,'A400 \n'); 
        sign=1; 
        fprintf(fid,'V%f\n',abs(w(i))); 
        fprintf(fid,'D%d\n',D(i)); 
    elseif w(i)<0 
        fprintf(fid,'VF0 \n'); 
        if i>1 
            fprintf(fid,'GOBUF1\n'); 
        end 
        fprintf(fid,'AD400 \n'); 
        sign=-1; 
        fprintf(fid,'V%f\n',abs(w(i))); 
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        fprintf(fid,'D%d\n',D(i)); 







A.17. Analysis of picrosirius red images 
File name: picrosirius_analysis-modified.m  
This code was written by Kartik Balachandran and modified by Pouria Hosseini.  
 
% % This program reads in picrosirius red image files and calculates 
     % percentage of red, orange, yellow and green fibers in the 
     % image. 
     function 
[redpercent,orangepercent,yellowpercent,greenpercent,num_red,num_orange,nu
m_yellow,num_green] = picrosirius_analysis(filename) 
     [stain,map]=imread(filename); %Image file name 
     stain = stain(:,:,1:3); 
     stain_cropped=imcrop(stain); 
     figure; 
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% Magnifies image to simplify the selection of area of intest 
     imshow(stain_cropped) 
     stain_cropped=double(stain_cropped); 
     stain_cropped_norm = stain_cropped./255; % We get 3 images - R,B,G -- 
Each image is a gray scale representing the intensity of color in the respective 
channels 
     stain_cropped_thres= stain_cropped_norm > 0.1; % check this value..!1 
     stain_cropped_thres=double(stain_cropped_thres); 
     stain1=stain_cropped_norm.*stain_cropped_thres; % To get the image with 
intensities greater than the threshold value 
     stain_hsv=rgb2hsv(stain1);% convert rgb image to hsv image 
     hue_mat=stain_hsv(:,:,1); % get only the hue matrix (the true color) 
     hue_mat1= hue_mat .* 255; 
     [height width]=size(hue_mat1); 
% Defines the hue values for a particular color 
H1=double(hue_mat1 > 2 & hue_mat1 < 9) + double(hue_mat1 >230 & 
hue_mat1 <256); 
     H2=double(hue_mat1 > 10 & hue_mat1 < 38); % figure out the hue and color 
range !! 
     H3= double(hue_mat1 > 39 & hue_mat1 < 51); 
     H4= double(hue_mat1 > 52 & hue_mat1 < 128); 
     figure; 
% Shows the individual red, orange, yellow, green images based on the above 
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mentioned criteria 
     imshow(H1) 
     figure; 
     imshow (H2) 
     figure; 
     imshow (H3) 
     figure; 
     imshow (H4) 
     num_red=0; 
     num_orange=0; 
     num_yellow=0; 
     num_green=0; 
     num_total = height .* width; 
     for i=1:height % counting the number of non-zero entries in each matrix 
         for j=1:width 
             if(hue_mat1(i,j) > 2) && (hue_mat1(i,j) < 9) 
num_red = num_red + 1; 
             elseif(hue_mat1(i,j)  >  230)  &&  (hue_mat1(i,j)  < 256) 
                 num_red = num_red + 1; 
             elseif(hue_mat1(i,j) > 10) && (hue_mat1(i,j) < 38) 
                 num_orange = num_orange + 1; 
             elseif(hue_mat1(i,j) > 39) && (hue_mat1(i,j) < 51) 
                 num_yellow = num_yellow + 1; 
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             elseif(hue_mat1(i,j) > 52) && (hue_mat1(i,j) < 128) 
                 num_green = num_green + 1; 
             end 
         end 
end 
% Displays the percentage of fibers that are red, orange, yellow, or green 
     redpercent = (num_red/num_total).*100; 
     orangepercent = (num_orange/num_total).*100; 
     yellowpercent = (num_yellow/num_total).*100; 
     greenpercent = (num_green/num_total).*100; 
      
     data = {'','Raw 
Value','Percent';'Red',num_red,redpercent;'orange',num_orange,orangepercent;'
Yellow',num_yellow,yellowpercent;'Green',num_green,greenpercent}; 










A.18. Raw Data for specific aim1 




Fibrosa exposed  
to OS 
Fibrosa exposed 
to steady shear  Static 
0.74 3.79 1.81 1.25 
0.31 1.45 0.50 2.21 
1.14 1.73 0.55 1.14 
0.36 2.99 0.54 1.31 
2.24 3.69 0.88 1.12 
0.63 0.74 0.22 0.80 
1.53 0.75 0.15 1.31 
1.05 0.77 0.39 1.24 
 
2.55 0.44 1.35 
 
A.18.2 Time course of AV calcification induced by OS (Figure 3.8A) 
 














0.74 3.79 0.30 9.18 2.60 
0.31 1.45 0.49 3.41 2.28 
1.14 1.73 0.34 3.99 2.85 
0.36 2.99 0.55 7.02 3.37 
2.24 3.69 0.31 3.46 3.39 
0.63 0.74 0.36 3.77 3.18 
1.53 0.75 2.08 3.72 4.96 
1.05 0.77 0.49 5.72 2.24 
 
2.55 0.60 3.92 3.22 
  
1.76 




A.18.3 Realistic shear stress and AV calcification (Figure 3.9A) 
 
7 days 
Fresh Normal Low CO High HR 
0.66 0.62 0.79 0.29 
0.97 0.71 0.75 1.27 
0.58 0.89 0.83 0.60 
1.57 0.88 0.93 0.62 
0.64 0.62 0.99 0.43 
0.64 0.46 0.91 0.37 
1.38 0.81 0.82 1.02 
1.20 0.56 0.84 0.75 
1.37 
    
A.18.4 AV calcification due to different mechanical stimuli (Figure 3.10) 
















0.74 9.18 2.60 25.91 32.56 138.57 
0.31 3.41 2.28 32.16 41.41 88.47 
1.14 3.99 2.85 15.44 23.66 73.99 
0.36 7.02 3.37 1.00 33.25 79.53 
2.24 3.46 3.39 13.02 32.40 
 0.63 3.77 3.18 31.80 67.08 
 1.53 3.72 4.96 57.48 37.38 


























0.393 0.347 0.465 0.388 0.434 0.501 
0.452 0.452 0.461 0.432 0.401 0.386 
0.405 0.448 0.502 0.444 0.370 0.404 















0.177 0.322 0.315 0.362 0.239 0.262 
0.175 0.261 0.346 0.271 0.403 0.279 
0.218 0.307 0.312 0.215 0.363 0.269 















0.389 0.296 0.186 0.221 0.277 0.187 
0.346 0.243 0.186 0.295 0.164 0.283 
0.401 0.219 0.179 0.287 0.240 0.302 
0.363 0.242 0.150 0.306 0.225 0.222 
 
A.18.6 Relative proportion of collagen fibers (Figure 3.13B) 
 Condition/Fiber Red/Orange Yellow Green 
Fresh 0.749 0.027 0.224 
Fibrosa exposed to OS 0.761 0.047 0.193 
Ventricularis exposed to OS 0.721 0.016 0.263 
Fibrosa exposed to OS 0.764 0.030 0.206 
Ventricularis exposed to OS 0.699 0.024 0.277 



















0.023 1.693 4.789 0.795 
0.012 1.302 2.820 1.898 

















0.845 0.490 1.374 0.962 
0.434 0.018 0.809 0.115 















0.141 0.547 1.234 1.070 
0.005 1.611 0.453 2.138 


















0.243 0.547 1.528 1.234 
0.125 1.611 0.900 0.453 
0.391 0.842 1.362 1.313 
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A.18.8 Side- and shear-dependent expression of miRNAs (Figure 3.15)  









OS LS OS LS 
37.93 0.01 7.39 0.00 
79.83 1.13 366.43 1.87 
8.61 1.86 2.00 1.13 
4.85 1.05 3.55 0.97 
8.79 0.78 221.47 0.60 
2.89 1.17 4.47 1.43 
2.12   0.44   
2.58   0.76   
3.74   0.85   
 









OS LS OS LS 
6.79 0.06 1.75 0.04 
6.43 0.84 3.32 1.76 
2.92 2.10 0.17 1.21 
0.20 1.09 6.54 1.25 
2.42 0.92 52.14 0.52 
0.31 0.99 8.40 1.23 
0.77   2.21   
0.28   3.46   
1.06   0.02   
  
6.07   
  
4.90   
  

















OS LS OS LS 
6.73 1.09 5.45 1.01 
5.75 0.96 5.79 0.93 
19.89 0.95 46.36 1.06 
0.14 2.07 0.07 1.57 
0.15 0.65 0.14 0.57 
0.18 0.28 0.13 0.86 
0.63   0.15   
0.60   0.09   
0.38   0.14   
 









OS LS OS LS 
101.77 1.01 0.82 0.90 
49.19 0.93 0.09 1.00 
20.63 1.06 1.73 1.10 
76.71 1.57 4.01 1.01 
34.81 0.57 6.17 0.98 











miR -181a miR -181b 
OS OS 
Fibrosa Ventricularis Fibrosa Ventricularis 
4.55 0.62 1.59 0.28 
9.58 0.53 78.88 0.30 
1.03 1.84 0.43 2.41 




12.12 1.13 11.24 1.17 
1.66 1.17 1.01 1.20 
2.40 1.12 1.73 0.71 
1.81 0.71 1.94 1.09 
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miR -199a-5p miR -214 
OS OS 
Fibrosa Ventricularis Fibrosa Ventricularis 
4.08 1.78 2.02 0.41 
3.86 0.86 3.82 0.64 
1.75 0.36 0.19 1.95 
0.21 1.47 19.87 0.78 
2.59 0.67 158.36 0.93 
0.33 0.86 25.51 1.29 
2.99 0.97 6.70 
 1.10 0.91 10.50 
 4.10 1.12 
   









OS LS OS LS 
49.13 1.09 30.56 1.01 
103.38 0.96 1514.57 0.93 
11.16 0.95 8.26 1.06 
1.68 2.07 1.03 1.57 
3.04 0.65 64.20 0.57 
1.00 0.28 1.30 0.86 
0.73   0.13   
0.89   0.22   




















OS LS OS LS 
6.77 0.89 19.58 1.01 
6.40 0.85 37.01 0.98 
2.91 1.26 1.88 1.00 
0.29 1.00 6.76 1.19 
3.57 1.39 53.88 0.81 
0.45 0.61 8.68 1.00 
1.14   2.28   
0.42   3.57   
1.56       
 
A.18.9 Expression of miRNAs in fresh and static conditions (Figure 3.16) 
miR -181a miR -181b 
Fibrosa 
exposed to 
OS Fresh Static 
Fibrosa 
exposed to 
OS Fresh Static 
26.64 0.79 2.02 25.13 0.90 14.34 
56.05 1.13 241.89 1245.58 1.21 357.88 




  7.14 
  
302.89 
  2.35 
  
6.11 
  1.72 
  
0.61 
  2.10 
  
1.04 
  3.04 
  
1.17 









miR -199a-5p miR -214 
Fibrosa 
exposed to 
OS Fresh Static 
Fibrosa 
exposed to 
OS Fresh Static 
1.46 1.12 0.27 7.56 0.72 7.86 
1.38 0.91 0.37 14.30 1.19 17.01 




  4.82 
  
39.50 
  0.61 
  
6.36 
  1.53 
  
1.67 
  0.57 
  
2.62 
  2.10 
      
 257 
 
A.19. Raw data for specific aim 2 
A.19.1 Shear-dependency of selected target genes (Figure 4.5) 
Condition/ 
Gene 




0.006 0.004 0.023 0.006 0.000 4.789 
0.003 0.009 0.012 0.009 0.001 2.820 




2.133 0.046 1.693 1.054 1.939 0.795 
0.736 1.648 1.302 1.191 0.282 1.898 








0.257 0.477 0.547 0.203 0.005 1.234 
2.603 1.934 1.611 2.514 2.851 0.453 




0.317 5.056 0.141 0.095 0.036 1.070 
0.163 1.159 0.005 0.022 0.036 2.138 
0.167 2.564 0.717 1.367 0.036 0.128 
 
A.19.2 Side-dependency of selected targets genes (Figure 4.6) 
Condition/Gene Klf4 Enos Sma Ctnnb1 Bcl2l11 Col1a1 
Fibrosa  
exposed to OS 
1.458 0.117 0.845 0.121 0.279 1.374 
0.693 0.178 0.434 0.170 0.551 0.809 
1.127 0.389 1.361 0.258 0.971 1.225 
Ventricularis 
exposed to OS 
1.470 1.728 0.490 0.192 1.000 0.962 
0.757 0.396 0.018 0.045 1.000 0.115 


















A.19.4 Silencing of miR-214 in fibrosa exposed to OS (Figure 4.10B) 











Condition/Gene Klf4 Enos Sma Ctnnb1 Bcl2l11 Col1a1 
Fibrosa  
exposed to OS 
0.314 0.341 0.243 0.060 0.010 1.528 
0.149 0.521 0.125 0.084 0.020 0.900 
0.243 1.139 0.391 0.128 0.035 1.362 
Ventricularis 
exposed to LS 
0.257 0.477 0.547 0.203 0.005 1.234 
2.603 1.934 1.611 2.514 2.851 0.453 
0.140 0.589 0.842 0.282 0.144 1.313 
 259 
A.19.5 Validation of mRNA targets using anti-miR-214 (Figure 4.11) 
Conditio
n/Gene 






2.097 0.269 1.383 1.630 0.556 
0.035 0.850 0.591  1.474 
0.868 1.880 1.025 0.370 0.970 
2.093 0.001 1.155 0.800 0.782 
0.246 2.997 1.036 1.172 1.043 
0.661 0.001 0.809 1.028 1.175 
1.194  0.573 1.000  
0.806  1.199  0.012 






116.024 89.295 2.957 3.675 5.801 
8.769 573.779 0.652 13.118 1.082 
2.065 238.842 0.824 0.628 0.527 
0.000 0.038 0.902 0.707 0.518 
0.004 0.058 0.758 1.350 6.918 
0.001 0.000 0.841 13.773 2.932 
200.014  0.707 3.564 2.051 
1.825   6.832  






































Condition/Gene Icam1 Vcam1 Tgfβ1 Bmp4 
Fibrosa 
exposed to OS: 
NT anti-miR 
1.215 0.297 1.337 0.284 
1.168 2.611 1.170 1.055 











exposed to OS: 
anti-miR-214 
0.435 23.532 0.416 28.543 
0.588 37.398 0.605 20.549 












A.19.7 Role of miR-214 in AV calcification (Figure 4.13) 
Fibrosa exposed to OS 






















A.20. Raw data for specific aim 3 
A.20.1 Pyrophosphatase and AV calcification (Figure 5.2A) 
Control 0.1U/mL 0.2U/mL 0.4U/mL 0.8U/mL 
12.36 1280.60 403.54 3370.09 670.44 
94.32 621.27 117.43 526.44 174.57 
95.67 31.05 1204.41 266.62 288.16 
91.35 46.09 396.39 1077.63 1021.61 
164.76 1260.74 295.60 432.31 1024.07 
224.71 602.81 500.08 234.17 355.26 
104.49 1008.94 667.88 373.59 175.97 
26.08 267.01 1074.21 328.24 1887.25 
 
A.20.2 Phosphate, pyrophosphatase and AV calcification (Figure 5.3A) 
Without Inorganic 
Pyrophosphatase (IP) 
With Inorganic Pyrophosphatase 
(IP) 
0.8mM 2.6mM 3.2mM 3.8mM 0.8mM 2.6mM 3.2mM 3.8mM 
6.30 4.91 9.73 5.66 5.27 6.41 7.60 1002.28 
5.83 8.83 6.51 212.25 3.07 5.02 7.17 280.81 
8.95 24.66 8.31 10.86 3.12 24.18 251.36 42.82 
9.40 20.40 6.07 7.66 3.10 3.71 110.38 888.66 
4.98 6.71 11.96 22.59 1.93 3.94 0.37 1691.43 
4.72 7.75 79.97 187.50 3.24 3.36 68.42 1195.99 
6.34 14.69   274.52 2.39 4.78 68.98 222.76 









A.20.3 Time course of AV calcification (Figure 5.4A) 
With Inorganic Pyrophosphatase (IP) Control 
2 days 4 days 6 days 8 days  8 days 
288.72 1211.73 518.00 3370.09 8.77 
490.97 476.78 1087.07 526.44 8.19 
370.29 74.45 373.25 266.62 10.15 
490.31 528.37 93.31 1077.63 5.51 
36.32 536.21 40.23 432.31 4.73 
575.76 1395.85 676.08 234.17 9.53 
21.49 37.95 246.34 373.59 10.44 
684.28 296.32 162.74 328.24 7.73 
12.28 49.73 45.16 1002.28 12.36 
7.79 34.28 1479.15 280.81 94.32 
5.97 44.55 1395.76 42.82 95.67 
5.86 174.16 907.09 888.66 91.35 
6.62 289.55 63.91 1691.43 164.76 
52.35 94.84 1403.36 1195.99 224.71 
9.06 157.52 1531.79 222.76 104.49 
375.97 
 
990.71 821.44 26.08 
 
A.21. Effect of different chemokines on AV calcification (Figure 5.5A) 










5.66 278.40 453.06 952.05 551.34 842.57 
1054.8
6 
212.25 283.08 1295.44 1628.90 424.62 275.42 17.06 
10.86 539.08 10.42 448.17 747.73 429.37 490.66 
7.66 272.66 16.53 743.91 581.80 796.23 29.69 
22.59 477.83 14.91 1690.94 435.43 364.62 113.23 
187.50 352.07 1117.43 617.65 437.01 540.01 541.96 
274.52 385.15 2025.46 1035.91 831.58 444.26   






A.21.1 Warfarin and AV calcification (Figure 5.6A) 
Control IP  Warfarin IP+Warfarin 
8.77 3370.09 15.04 2295.75 
8.19 526.44 719.05 15.37 
10.15 266.62 22.64 143.55 
5.51 1077.63 15.02 15.02 
4.73 432.31 25.39 3207.43 
9.53 234.17 16.05 2352.85 
10.44 373.59 155.03 2160.51 
7.73 328.24 23.18 41.53 
12.36 1002.28 117.99 210.84 
94.32 280.81 316.86 370.62 
95.67 42.82 158.46 340.21 
91.35 888.66 503.25 275.16 
164.76 1691.43 186.22 415.38 
224.71 1195.99 254.92 1251.85 
104.49 222.76 186.07 588.14 
26.08 821.44 460.42 287.82 
 



















8.77 1002.28 460.75 2.97 3.73 
8.19 280.81 317.47 23.12 3.51 
10.15 42.82 141.74 2.27 4.62 
5.51 888.66 10.17 1.93 7.39 
4.73 1691.43 35.97 2.72 2.03 
9.53 1195.99 34.95 7.20 2.20 
10.44 222.76 12.41 3.08 2.98 
7.73 821.44 185.27 37.10 2.86 
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A.21.3 Synthesis of pyrophosphate from AV leaflets (Figure 5.11)  
Control MLS 
1.00 2.50 5.00 1.00 2.50 5.00 
0.0186 0.0228 0.0222 0.0106 0.0117 0.0266 
0.0155 0.0261 0.0204 0.0179 0.0210 0.0248 
0.0103 0.0058 0.0115 0.0251 0.0243 0.0241 





ATP MLS 38949 
0.2357 0.0664 0.3407 
0.2551 0.0880 0.5233 




A.22. Target list of miR-214 and miR-181a 



















































































































































































































































































































































































































































































































































































































































































































































































A.23. Stretch and pressure – AV calcification ex vivo  
 
A.23.1 Rationale and hypothesis 
Aortic valve sclerosis leads to leaflet calcification and results in aortic stenosis 
and regurgitation. It has been shown that hypertension is significantly associated 
with AV sclerosis with odds ratio ranging from 1.23 to 1.74 (78); however the 
molecular mechanisms are not understood well. It is hypothesized that 
pathological hypertensive pressure can lead to earlier AV calcification compared 
to normal disease progression. The role of combined effects of both physiological 
and pathological cyclic stretch and pressure on AV calcification was investigated. 
 
A.23.2 Methods 
Fresh porcine AV leaflets were cultured in a novel ex vivo cyclic stretch and 
pressure bioreactor (83) under different conditions for 2, 4, 6 and 8 days. 
Osteogenic media was used to accelerate the calcification process (17). Six 
conditions tested were tested: 1) 10% stretch alone, 2) 120/80 mmHg pressure 
alone, 3) combined 10% stretch and 120/80 mmHg pressure, 4) 15% stretch 
alone, 5) 160/100 mmHg pressure alone, and 6) combined 15% stretch and 
160/100 mmHg pressure. The first three conditions correspond to the 
physiological stretch and pressure, whereas, the last three conditions represent 
severe hypertension. The leaflets were assayed for calcium using quantitative 




Calcium levels increased significantly in the presence of 10% cyclic stretch after 
6 and 8 days culture (Figure A.23. 1). On the other hand, the isolated pressure 
alone induced significant calcification only after 8 days; however, its effect was 
about 2.5 folds significantly lower than the 10% stretch. Interestingly, combined 




Figure A.23. 1 Time course of AV calcification induced by physiological stretch 
and pressure ex vivo. Calcium induced by 10% stretch alone increased 
significantly with culture duration after 6 days, and continued to increase after 8 
days culture. Calcium induced after 8 days culture in the presence of 10% stretch 
alone was statistically higher compared to the isolated pressure. However when 
stretch and pressure was combined, no calcification was observed even after 8 
days culture in osteogenic media. *p<0.05, #p<0.05 vs. 10% stretch, 120 mmHg 





As expected, the amount of calcium significantly increased in case of isolated 
15% stretch or isolated hypertensive pressure of 160/100 mmHg after 8 days 
culture compared to that of 4 days (p<0.05) (Figure A.23. 2). However, the 
calcification induced by the combined 15% stretch and 160/100 mmHg was 
significantly higher (p<0.05) than the isolated stimuli after 8 days culture.  
 
 
Figure A.23. 2 Time course of AV calcification induced by pathological stretch 
andpressure ex vivo. Calcium induced by 15% stretch alone or 160/100 mm Hg 
pressure alone or by combined 15% stretch and 160/100 mmHg pressure 
significantly increased after 4 days culture and continued to increase after 8 
days. After 8 days culture, the calcium induced by combined 15% stretch and 
160/100 mmHg pressure was significantly higher than the 15% stretch or 




A.23.4 Discussion and conclusions 
Our results suggest that cyclic stretch alone upregulates calcification, perhaps 
due to deformational trauma, while the concurrent presence of normal pressure 
depressed this calcification response suggesting that different physiological 
forces play a role to maintain healthy valve physiology. However, exposure to 
hypertensive pressure increased the calcification significantly compared to 
isolated stretch, indicating that the altered mechanical environment as a result of 
hypertension may be an important step in the pathway linking hypertension to 
clinically observed increased risk of calcification. Additional investigation is 
required to test this hypothesis, and was not pursued as part of this thesis work.  
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A.24. Functional role of miR-214 in AV static culture 
A.24.1 Approach 
The delivery of anti-miR to the AV tissues was optimized using statically cultured 
leaflets (specific aim-2). After successful silencing of miR-214, the selected 
targets genes of miR-214 were then validated. Also the functional effect of miR-
214 silencing on AV endothelial-to-mesenchymal transition (Endo-MT) and 
inflammation was tested. This appendix includes all the results from these 
studies, which were not part of the specific aim-2.  
 
A.24.2 Methods 
The workflow of this protocol is shown in the Figure A.24.1. Freshly isolated AV 
leaflets were passively transfected with 400 nM tagged non-targeting (NT) anti-
miR or anti-miR-214 (Exiqon, Denmark). The samples were then incubated in 
OptiMEM for 4 h (Life Technologies, NY). After this, the leaflets tissues were 
quenched with regular DMEM and cultured under static conditions for 48 h. Each 
sample was then washed well in nuclease-free sterile dPBS. Total RNA was 
isolated from the other half of each of the tissues and qPCR analysis was done. 
Selected mRNA target genes of miR-214 (Klf4, Enos, Ctnnb1, Col1a1, Sma and 
Bcl2l11) were validated. The effect of miR-214 silencing on AV Endo-MT (Mcp1 
and VE-Cadherin) and inflammation (Tgfβ1, Icam1, Bmp4 and Vcam1) was also 
investigated. Statistical analysis was carried out as discussed previously.  
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As shown in the Figure A.24. 2, out of 6 targets tested, only Klf4 was significantly 
upregulated (p=0.05). This confirms that klf4 is a potential target of miR-214 in 
AV. Also, upon miR-214 silencing, the expression of Mcp1 increased significantly 
(p=0.04) while the expression of VE-Cadherin did not change (Figure A.24. 3A). 
Silencing of miR-214 tended to increase an inflammation marker (also a key 
transcription factor) Tgfβ1 (p=0.09), but did not affect the expression of Icam1, 
Bmp4 and Vcam1 (Figure A.24. 3B).  
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Figure A.24. 2 Validation of mRNA targets by silencing miR-214 in statically 
cultured AVs. Out of 6 mRNA targets tested, only Klf4 appeared to be a target of 





Figure A.24. 3 The effect of miR-214 silencing on AV Endo-MT and inflammation 
in static conditions. A) Silencing of miR-214 significantly increased Mcp1 levels. 
B) Silencing of miR-214 downregulated Tgfβ1 only. *p=0.04, #p=0.09. n=6 
(pooled 2 samples/isolation). 
 
 
A.24.4 Discussion and conclusions 
The findings in this study can be summarized as follows: 1) klf4 is a validated 
target of miR-214, 2) miR-214 plays a role in AV Endo-MT via Mcp1 via Tgfβ1, 3) 
miR-214 may not play a significant role in AV inflammation. Similar results were 
observed in specific aim-2 when miR-214 was silenced in fibrosa exposed to OS. 
Silencing of miR-214 significantly upregulated the expression of klf4, Tgfβ1, but 
did not affect the Endo-MT markers. Further, the regulation of Mcp1 by miR-214 
is mechanical stimuli dependent (static vs. oscillatory shear). Overall, miR-214 
may be involved in AV Endo-MT via klf4 and Tgfβ1 dependent pathway. 
Additional investigation is required to support this speculation, and was not 
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